Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,A1BG,Alpha-1B-glycoprotein,1639,170,2.43 [1.01-5.86],0.0478649783479196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,1575,165,1.19 [0.90-1.56],0.219504869885915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,1846,195,0.97 [0.78-1.21],0.7671431116267544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,1581,166,1.02 [0.67-1.58],0.9110109363957364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABHD14B,Protein ABHD14B,1830,194,1.01 [0.81-1.26],0.9145978346680016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,1846,195,1.06 [0.89-1.26],0.5492673078817409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABO,Histo-blood group ABO system transferase,1634,169,1.05 [0.95-1.16],0.2942130191683815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABRAXAS2,BRISC complex subunit Abraxas 2,1581,166,0.98 [0.78-1.23],0.8695952970933806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1794,193,1.05 [0.91-1.20],0.4993588576367461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1594,162,0.91 [0.71-1.17],0.4636858147072631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1627,168,0.91 [0.77-1.08],0.2765835563145895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAN,Aggrecan core protein,1842,197,1.08 [0.71-1.66],0.7111583066620655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE,Angiotensin-converting enzyme,1634,169,1.47 [0.86-2.54],0.1623535837045497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE2,Angiotensin-converting enzyme 2,1827,197,0.85 [0.69-1.04],0.1103632729130135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACHE,Acetylcholinesterase,1596,165,1.01 [0.68-1.50],0.96500923997389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOT13,Acyl-coenzyme A thioesterase 13,1620,168,1.02 [0.90-1.16],0.7241611395902056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1860,197,1.07 [0.84-1.36],0.5973623395888237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,1578,168,0.79 [0.56-1.10],0.1640828443750102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,1876,198,1.63 [1.15-2.33],0.0067755735146687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP6,Lysophosphatidic acid phosphatase type 6,1872,196,1.21 [0.98-1.50],0.0830010925457887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRBP,Acrosin-binding protein,1623,169,1.10 [0.78-1.56],0.5732878914305373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,1578,168,1.17 [1.00-1.37],0.0472786620714687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,1581,166,0.72 [0.44-1.19],0.2055299509992055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",1827,197,1.56 [1.21-2.01],0.0005958696393851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN2,Alpha-actinin-2,1581,166,1.01 [0.80-1.29],0.9110587746406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,1817,191,0.84 [0.52-1.36],0.4874682292122501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1833,194,2.40 [1.55-3.71],7.88967509911787e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY1,Aminoacylase-1,1860,197,0.88 [0.74-1.04],0.1438269801728283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1581,166,1.24 [0.99-1.55],0.0578941401730621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACYP1,Acylphosphatase-1,1589,163,0.93 [0.74-1.16],0.5049376615346352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,1882,195,1.26 [0.89-1.78],0.1936777935711091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,1858,195,2.28 [1.78-2.91],7.150941980461964e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1578,168,1.51 [1.05-2.18],0.0268639090272721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1827,197,1.44 [0.97-2.14],0.0696045452800054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1839,194,1.32 [0.94-1.86],0.1044396047992808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1882,195,1.37 [0.94-1.99],0.1049885835930467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1865,195,1.48 [0.98-2.23],0.0603429616019983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1620,168,2.34 [1.59-3.43],1.471752533296582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1578,168,1.19 [0.75-1.87],0.4561303374965871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1885,199,1.32 [0.80-2.19],0.2748357119541804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1846,195,0.89 [0.68-1.16],0.3913052776656704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1827,197,0.99 [0.66-1.48],0.9560488469218752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1578,168,0.94 [0.62-1.41],0.7676138849747892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1855,194,0.81 [0.63-1.04],0.1007632916715678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,1634,170,1.34 [0.95-1.89],0.093001242862719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL4,ADAMTS-like protein 4,1575,165,1.41 [0.77-2.56],0.2640003233942019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL5,ADAMTS-like protein 5,1627,168,1.05 [0.73-1.51],0.7914960415623227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1794,193,1.15 [0.82-1.61],0.4133049554599681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADD1,Alpha-adducin,1596,165,0.86 [0.69-1.07],0.1674337302780919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,1833,194,2.06 [1.43-2.97],0.0001088779972291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,1596,165,1.53 [1.11-2.10],0.0095085670914752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE1,Adhesion G protein-coupled receptor E1,1620,168,1.04 [0.81-1.34],0.7472904079144864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,1862,196,2.95 [2.03-4.29],1.4924080290800765e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,1881,199,2.67 [1.97-3.60],1.7664327814359487e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRF5,Adhesion G protein-coupled receptor F5,1627,168,1.39 [0.81-2.37],0.2272845208623763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,1846,195,1.22 [1.09-1.37],0.0007301091064649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,1860,197,0.42 [0.27-0.66],0.0001355719694743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRV1,Adhesion G-protein coupled receptor V1,1575,168,1.05 [0.85-1.30],0.6224911453666082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,1596,165,0.82 [0.69-0.97],0.0182045267538933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1827,197,0.77 [0.67-0.88],0.0001873866075907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADIPOQ,Adiponectin,1639,170,1.14 [0.93-1.39],0.1960879174373797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,1875,196,1.64 [1.05-2.55],0.0288265734226196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADRA2A,Alpha-2A adrenergic receptor,1581,166,0.84 [0.65-1.08],0.1643533159522249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFAP1,Actin filament-associated protein 1,1596,165,1.04 [0.87-1.24],0.6560387550371578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,1639,170,0.46 [0.25-0.85],0.0137519165110635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,1831,193,0.69 [0.56-0.86],0.0007310753012334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGBL2,Cytosolic carboxypeptidase 2,1575,168,1.07 [0.92-1.25],0.3771113909319638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGER,Advanced glycosylation end product-specific receptor,1853,195,0.91 [0.68-1.22],0.5415766148654872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,1783,192,1.43 [1.26-1.62],2.1787919662759272e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,1792,193,1.07 [0.87-1.32],0.529042102642723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,1862,196,1.85 [1.41-2.42],7.031255127718617e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,1882,195,1.08 [0.87-1.35],0.4902612721273818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGT,Angiotensinogen,1634,169,0.77 [0.40-1.48],0.4293710149418801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGXT,Serine--pyruvate aminotransferase,1860,197,0.95 [0.82-1.10],0.5016622992035501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,1860,197,0.91 [0.76-1.10],0.3362122903790767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,1575,165,0.90 [0.57-1.42],0.6535597365368393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,1575,165,1.22 [0.74-2.01],0.4381793251357186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1623,169,0.86 [0.67-1.11],0.2398060794926492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSG,Alpha-2-HS-glycoprotein,1634,169,0.74 [0.46-1.17],0.1971011702875766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,1860,195,0.94 [0.82-1.08],0.4030044120241505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIDA,"Axin interactor, dorsalization-associated protein",1585,165,0.94 [0.78-1.14],0.5190729714400488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1,Allograft inflammatory factor 1,1794,193,1.02 [0.80-1.29],0.8921669375587962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1L,Allograft inflammatory factor 1-like,1575,165,1.05 [0.80-1.38],0.7282546324720527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1842,195,1.01 [0.90-1.13],0.926057061568934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,1860,197,0.92 [0.75-1.12],0.3922120235330112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK2,"Adenylate kinase 2, mitochondrial",1614,168,1.00 [0.87-1.14],0.9977741503999557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,1596,165,1.23 [0.61-2.48],0.5543039837008705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B1,Aldo-keto reductase family 1 member B1,1794,193,1.18 [1.00-1.39],0.0433969491749346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B10,Aldo-keto reductase family 1 member B10,1585,165,0.92 [0.76-1.12],0.4223766847385621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1C4,Aldo-keto reductase family 1 member C4,1827,197,1.15 [0.91-1.45],0.2550667727590864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,1578,168,1.01 [0.83-1.23],0.8878785998990779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT1S1,Proline-rich AKT1 substrate 1,1796,193,1.01 [0.84-1.22],0.8878353501494713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT2,RAC-beta serine/threonine-protein kinase,1631,171,0.99 [0.88-1.10],0.8371794489617577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT3,RAC-gamma serine/threonine-protein kinase,1778,190,1.07 [0.86-1.32],0.5575044698295369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,1885,199,2.40 [1.35-4.26],0.0028614528407736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,1864,195,0.81 [0.67-0.99],0.0408869733745992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",1623,169,1.02 [0.77-1.36],0.8886029927256938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1854,196,1.08 [0.94-1.24],0.2899741749907411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1631,171,1.12 [0.84-1.50],0.4262208582965225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALMS1,Alstrom syndrome protein 1,1594,162,1.14 [0.81-1.62],0.4455006765255144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,1578,168,1.12 [1.00-1.25],0.0503352199381933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",1846,195,1.09 [0.97-1.22],0.1570477588257114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBN,Ameloblastin,1817,191,0.73 [0.41-1.27],0.2628214250857092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,1871,195,5.17 [3.00-8.90],3.254178615543977e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1634,170,1.24 [0.68-2.25],0.4811419338501986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMFR,E3 ubiquitin-protein ligase AMFR,1796,193,0.93 [0.75-1.15],0.4960816634298307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO1,Amphoterin-induced protein 1,1585,165,0.90 [0.66-1.24],0.5160003898729997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,1846,195,2.19 [1.27-3.79],0.0049687762795932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMN,Protein amnionless,1817,191,0.82 [0.63-1.07],0.1384373256022991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,1596,165,0.75 [0.52-1.08],0.1256864172290092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOTL2,Angiomotin-like protein 2,1620,169,0.97 [0.73-1.30],0.8579749645718049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMPD3,AMP deaminase 3,1614,168,1.11 [0.91-1.36],0.2923341336059114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1523,159,0.94 [0.71-1.25],0.6670557792026606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2A,Pancreatic alpha-amylase,1783,193,1.02 [0.79-1.31],0.8917452585478188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2B,Alpha-amylase 2B,1728,186,0.99 [0.77-1.27],0.9183606480961874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,1864,196,1.70 [1.21-2.39],0.0023189318607614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT1,Angiopoietin-1,1847,193,1.07 [0.92-1.24],0.3796717468938099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,1875,196,1.56 [1.13-2.15],0.0071126654276944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,1832,193,1.07 [0.70-1.61],0.7616179847307514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL2,Angiopoietin-related protein 2,1855,196,1.27 [0.94-1.70],0.1142752276424386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,1866,196,0.82 [0.59-1.15],0.2583036355640574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,1860,196,2.02 [1.57-2.61],6.631352959508119e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,1875,196,1.29 [0.97-1.71],0.075454686427201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANK2,Ankyrin-2,1581,166,0.87 [0.68-1.12],0.2917061611780947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1578,168,1.03 [0.87-1.23],0.733651314033023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRA2,Ankyrin repeat family A protein 2,1563,161,0.98 [0.76-1.26],0.8597228724854713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,1794,193,0.85 [0.67-1.07],0.1711055346313073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1575,165,0.84 [0.54-1.31],0.443743652836666
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,1867,197,1.41 [0.93-2.14],0.1103506563325603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA1,Annexin A1,1587,164,0.96 [0.69-1.32],0.7883612225015482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,1796,193,1.24 [1.08-1.42],0.0022127299410246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,1856,196,0.93 [0.77-1.12],0.4420492840265597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,1555,162,1.07 [0.87-1.32],0.4970577333374485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA3,Annexin A3,1865,195,1.01 [0.85-1.20],0.9037219723547434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,1849,196,0.91 [0.77-1.07],0.2525845101946633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,1787,191,2.14 [1.46-3.15],0.0001047832568783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],1817,191,0.86 [0.67-1.11],0.2557624629768258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,1871,198,3.37 [2.33-4.88],1.1897774632731034e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP1G2,AP-1 complex subunit gamma-like 2,1623,169,0.97 [0.82-1.16],0.7568297771580301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP2B1,AP-2 complex subunit beta,1585,165,0.94 [0.69-1.26],0.658505048210299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3B1,AP-3 complex subunit beta-1,1620,168,1.07 [0.89-1.28],0.4914483376860955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3S2,AP-3 complex subunit sigma-2,1614,168,1.04 [0.78-1.38],0.8019878066567584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1846,195,1.12 [0.86-1.47],0.3916379015764224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,1624,170,0.80 [0.52-1.25],0.3284649944642335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1870,195,1.02 [0.82-1.26],0.8743577765959025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,1860,197,0.85 [0.67-1.08],0.1869777890001172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,1639,170,0.77 [0.41-1.45],0.4169442208538537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,1634,169,1.19 [0.90-1.56],0.227890925418401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,1639,170,2.39 [1.71-3.33],3.1557945424795333e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOB,Apolipoprotein B-100,1634,169,0.87 [0.46-1.65],0.6701022864968396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,1575,165,0.78 [0.55-1.10],0.1615764588037485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,1634,170,0.52 [0.36-0.73],0.000231138165005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,1581,162,0.79 [0.51-1.23],0.2976404569361152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,1639,170,0.65 [0.48-0.87],0.0035722050252492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOF,Apolipoprotein F,1634,169,1.16 [0.84-1.62],0.3667643235505278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,1864,195,1.46 [1.05-2.03],0.024453819507131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,1634,169,0.98 [0.79-1.22],0.8499144998373438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,1870,197,0.84 [0.54-1.29],0.4188621850956648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APP,Amyloid-beta precursor protein,1864,195,1.09 [0.90-1.31],0.3771722960988821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APPL2,DCC-interacting protein 13-beta,1596,165,1.01 [0.89-1.15],0.8628639081081744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,1838,194,0.93 [0.72-1.20],0.5624659993442798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARAF,Serine/threonine-protein kinase A-Raf,1594,162,1.13 [0.92-1.39],0.2513255387674473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,1846,195,2.03 [1.60-2.57],3.566054277743265e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARF6,ADP-ribosylation factor 6,1620,168,1.02 [0.89-1.16],0.7900795864933321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARFIP1,Arfaptin-1,1631,171,1.03 [0.84-1.26],0.7682060930213163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,1853,194,0.83 [0.66-1.05],0.1268516923154286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG2,"Arginase-2, mitochondrial",1623,169,1.05 [0.75-1.46],0.7804001276080255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP1,Rho GTPase-activating protein 1,1794,193,0.86 [0.65-1.12],0.2614842432338442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP25,Rho GTPase-activating protein 25,1794,193,0.94 [0.76-1.17],0.5925771368713297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP30,Rho GTPase-activating protein 30,1594,162,1.00 [0.69-1.46],0.9895067779939312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP45,Rho GTPase-activating protein 45,1596,165,1.01 [0.85-1.20],0.9463748602512696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP5,Rho GTPase-activating protein 5,1563,161,1.00 [0.82-1.22],0.9861920917281246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,1614,168,1.05 [0.89-1.24],0.5295868006479938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,1631,171,1.04 [0.89-1.20],0.639950433074478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,1858,196,1.03 [0.92-1.16],0.600195644177971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,1575,168,1.18 [0.99-1.41],0.0707903687195851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID3A,AT-rich interactive domain-containing protein 3A,1575,168,0.88 [0.59-1.30],0.5173992589883669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID4B,AT-rich interactive domain-containing protein 4B,1796,193,0.90 [0.64-1.26],0.534901262056211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL13B,ADP-ribosylation factor-like protein 13B,1581,166,1.02 [0.83-1.26],0.8215607919518166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1581,166,1.00 [0.70-1.43],0.9844248134446152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,1575,168,0.84 [0.62-1.12],0.2284908417558043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,1817,191,1.03 [0.75-1.41],0.8488799501107003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1581,166,0.89 [0.63-1.25],0.4951286305073269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSA,Arylsulfatase A,1864,195,1.04 [0.81-1.34],0.7337171869353776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSB,Arylsulfatase B,1846,195,0.89 [0.72-1.12],0.3215247305245218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,1871,198,1.58 [1.15-2.19],0.0052945330408876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART5,Ecto-ADP-ribosyltransferase 5,1575,168,0.98 [0.77-1.26],0.900992984268014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARTN,Artemin,1817,191,0.96 [0.70-1.31],0.7939095664468032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH1,Acid ceramidase,1625,168,1.16 [0.85-1.57],0.3509740590466703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH2,Neutral ceramidase,1839,194,0.95 [0.76-1.18],0.6167802363118058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,1839,194,1.59 [1.11-2.27],0.0113824583779983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,1634,169,2.33 [1.43-3.79],0.0006731459104852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPN,Asporin,1627,168,1.38 [0.84-2.24],0.2001389273785344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPSCR1,Tether containing UBX domain for GLUT4,1631,171,1.02 [0.82-1.26],0.8487090914934173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,1575,165,1.01 [0.87-1.17],0.9250990042350806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,1581,166,0.98 [0.83-1.15],0.7721742563263186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,1796,193,1.14 [0.99-1.32],0.0690233150756282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,1563,161,0.91 [0.59-1.41],0.6686945894461012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG16L1,Autophagy-related protein 16-1,1620,168,1.03 [0.87-1.21],0.760209273018662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,1794,193,1.06 [0.86-1.30],0.5821384491422186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,1855,194,1.05 [0.88-1.25],0.5624849222774355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1581,166,1.26 [0.97-1.65],0.087136718368759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1581,166,1.10 [0.73-1.65],0.661862593318454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1581,166,0.95 [0.64-1.42],0.8127362963538304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B4,Protein ATP1B4,1563,161,0.84 [0.56-1.25],0.3932779181779227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,1581,166,0.94 [0.73-1.21],0.6317608201031855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",1581,166,1.03 [0.77-1.39],0.8422311301385492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5IF1,"ATPase inhibitor, mitochondrial",1862,196,1.04 [0.93-1.17],0.4783013483235572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",1796,193,0.97 [0.72-1.30],0.837090486656308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6AP2,Renin receptor,1794,193,1.29 [0.98-1.71],0.0703604757378532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,1846,195,1.98 [1.36-2.89],0.0003888888747775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,1790,193,0.88 [0.72-1.06],0.182794688026644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G1,V-type proton ATPase subunit G 1,1575,165,0.98 [0.81-1.20],0.8749622636855585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G2,V-type proton ATPase subunit G 2,1581,166,0.95 [0.80-1.13],0.5599445856493723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1620,168,2.04 [1.42-2.92],0.0001041450877315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRN,"Attractin, Isoform 2",1639,170,1.43 [0.60-3.38],0.421219002761957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN10,Ataxin-10,1796,193,1.09 [0.92-1.30],0.3078490850545414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2,Ataxin-2,1575,168,0.98 [0.85-1.13],0.7546162004508848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2L,Ataxin-2-like protein,1631,171,1.01 [0.77-1.33],0.9509094400268342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN3,Ataxin-3,1614,168,0.96 [0.75-1.21],0.7170072859804364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXIN1,Axin-1,1858,196,1.00 [0.88-1.13],0.996217836006794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,1871,198,1.72 [1.11-2.65],0.0143620068322171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZI2,5-azacytidine-induced protein 2,1631,171,1.04 [0.81-1.32],0.7671697814189439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZU1,Azurocidin,1816,195,0.95 [0.81-1.11],0.4984575932471417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,1639,170,2.27 [1.54-3.34],3.193931569023499e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1581,166,1.16 [0.60-2.25],0.6555489834324805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1575,165,4.56 [3.08-6.76],4.344890522552295e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",1862,196,2.61 [1.83-3.71],1.0138421850113405e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",1864,195,1.41 [0.84-2.35],0.1910310479000422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BABAM1,BRISC and BRCA1-A complex member 1,1578,168,0.94 [0.55-1.62],0.8322844872149197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,1858,196,1.02 [0.86-1.20],0.8546876651568561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG3,BAG family molecular chaperone regulator 3,1833,194,0.74 [0.55-0.99],0.0443751072298247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG4,BAG family molecular chaperone regulator 4,1578,168,0.89 [0.66-1.19],0.4249902934324744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG6,Large proline-rich protein BAG6,1827,197,0.97 [0.70-1.34],0.8342405865349946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1794,193,1.15 [0.97-1.36],0.1088323645031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,1794,193,1.46 [1.06-2.00],0.0191833478435248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BANK1,B-cell scaffold protein with ankyrin repeats,1858,196,1.03 [0.92-1.16],0.5810055369388327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAP18,Chromatin complexes subunit BAP18,1614,168,0.90 [0.72-1.11],0.3250368115957857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BATF,Basic leucine zipper transcriptional factor ATF-like,1585,165,0.97 [0.80-1.19],0.7855939553735726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAX,Apoptosis regulator BAX,1793,192,1.06 [0.93-1.22],0.3945784371947974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,1864,195,2.00 [1.22-3.26],0.0057671644778938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,1839,194,0.61 [0.43-0.85],0.0040884987298606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1627,168,0.68 [0.42-1.12],0.1322827663175938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1575,168,0.82 [0.60-1.13],0.2319741344771754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCHE,Cholinesterase,1607,166,1.12 [0.68-1.85],0.6640940510984243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,1620,168,1.33 [1.06-1.67],0.0122539466036191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L1,Bcl-2-like protein 1,1614,168,0.98 [0.85-1.13],0.7820273005035182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1858,196,1.72 [1.24-2.39],0.0011473983365422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,1578,168,1.10 [0.88-1.37],0.4195853830630943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,1563,161,1.03 [0.82-1.30],0.789499919209822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,1623,169,0.80 [0.55-1.16],0.2329478132543634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCR,Breakpoint cluster region protein,1858,196,1.04 [0.91-1.18],0.6062948366628913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BDNF,Brain-derived neurotrophic factor,1634,170,1.07 [0.90-1.28],0.4230524727072364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BECN1,Beclin-1,1575,165,1.10 [0.86-1.40],0.442912562581877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,1563,161,0.96 [0.68-1.34],0.8017402551680365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,1634,170,0.79 [0.69-0.91],0.0009468212465903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGN,Biglycan,1790,192,1.01 [0.90-1.12],0.900946387056385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHLHE40,Class E basic helix-loop-helix protein 40,1575,168,1.13 [0.93-1.37],0.2122934694644684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1581,166,0.89 [0.48-1.63],0.7003634930476048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BID,BH3-interacting domain death agonist,1858,196,1.04 [0.87-1.25],0.6347173195527036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIN2,Bridging integrator 2,1864,195,1.01 [0.88-1.16],0.8659562140994963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,1794,193,1.02 [0.84-1.24],0.829100763158838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,1885,199,0.84 [0.59-1.18],0.3147586410892143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLNK,B-cell linker protein,1578,168,0.99 [0.70-1.40],0.9479704217629672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1575,168,0.94 [0.77-1.16],0.5827103180033719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1614,168,0.98 [0.70-1.37],0.9059116963313036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLVRB,Flavin reductase,1864,195,0.93 [0.77-1.12],0.4636835747433714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,1596,165,1.28 [0.76-2.17],0.3553125318896276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP4,Bone morphogenetic protein 4,1833,194,1.10 [0.86-1.40],0.4439986909197552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP6,Bone morphogenetic protein 6,1826,197,0.91 [0.67-1.24],0.5506458613507741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,1596,165,2.73 [1.55-4.81],0.0004889286707493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1627,168,0.94 [0.60-1.47],0.7834189317549176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1578,168,0.97 [0.70-1.33],0.8294832172474941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,1827,197,2.45 [1.42-4.20],0.0012139391610684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,1575,168,1.13 [0.88-1.45],0.3429840350612808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,1575,165,0.90 [0.68-1.18],0.4484625530763344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFA2,BPI fold-containing family A member 2,1534,162,1.07 [0.94-1.22],0.2839926848184312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB1,BPI fold-containing family B member 1,1859,196,1.07 [0.89-1.29],0.4567156899204161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,1625,167,0.84 [0.69-1.03],0.1003383352066979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRAP,BRCA1-associated protein,1603,167,1.08 [0.94-1.23],0.2738773672672862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD1,Bromodomain-containing protein 1,1594,162,1.28 [0.86-1.90],0.2241584338213016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD2,Bromodomain-containing protein 2,1575,168,0.84 [0.53-1.34],0.4739600969181219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD3,Bromodomain-containing protein 3,1581,166,0.91 [0.63-1.30],0.5931434608677062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRDT,Bromodomain testis-specific protein,1581,166,1.15 [0.77-1.72],0.4856469501031727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,1796,193,1.06 [0.82-1.37],0.6700612924081741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRME1,Break repair meiotic recombinase recruitment factor 1,1575,168,1.17 [0.81-1.69],0.4138852680543942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRSK2,Serine/threonine-protein kinase BRSK2,1631,171,1.15 [0.80-1.66],0.4529960724266521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,1879,195,1.84 [1.05-3.21],0.0319400486768021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSND,Barttin,1563,161,1.51 [1.07-2.12],0.0198580934766101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1868,195,1.11 [0.82-1.50],0.4969588924323055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST2,Bone marrow stromal antigen 2,1868,195,1.17 [0.96-1.42],0.1164784904679832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTC,Probetacellulin,1794,193,0.99 [0.83-1.18],0.8924793268443024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTD,Biotinidase,1639,170,3.12 [1.51-6.44],0.0021441734067842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTLA,B- and T-lymphocyte attenuator,1563,161,1.11 [0.96-1.29],0.1705929200581749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN1A1,Butyrophilin subfamily 1 member A1,1620,169,1.16 [0.83-1.61],0.3866739983294838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,1862,196,3.10 [2.20-4.36],7.893932564130335e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,1858,196,1.78 [1.28-2.48],0.0006740602986482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTNL10,Butyrophilin-like protein 10,1563,161,0.98 [0.66-1.45],0.924162751771004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,1796,193,0.85 [0.72-1.00],0.0498446603147102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1GALT1C1,C1GALT1-specific chaperone 1,1581,166,1.19 [0.73-1.93],0.4869978753464239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,1871,195,1.17 [0.68-2.01],0.5638826047098711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1631,171,1.01 [0.80-1.27],0.9549941783198952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,1578,168,0.82 [0.58-1.16],0.2621565898328378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1871,198,1.80 [1.39-2.32],6.522010833923638e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1596,165,0.73 [0.50-1.06],0.0981638670917011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1631,171,0.86 [0.52-1.42],0.5453466450626809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1593,165,0.98 [0.73-1.31],0.8785094303307759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,1639,170,0.62 [0.26-1.51],0.2952696741329533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,1635,170,2.17 [1.03-4.58],0.0416008617283027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1S,Complement C1s subcomponent,1639,170,0.92 [0.49-1.73],0.8048893015501303
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,1870,197,5.48 [2.90-10.34],1.518520013612319e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2CD2L,Phospholipid transfer protein C2CD2L,1790,193,1.00 [0.74-1.35],0.9989677725142602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2orf69,UPF0565 protein C2orf69,1585,165,1.04 [0.81-1.34],0.7688046310348228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C3,Complement C3,1554,166,0.96 [0.69-1.34],0.8273558736302318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C4BPB,C4b-binding protein beta chain,1855,194,1.37 [1.01-1.87],0.0456904809213129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C5,Complement C5,1639,170,1.67 [0.70-3.98],0.2470326375009159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,1599,168,3.02 [2.00-4.54],1.182764907294712e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7orf50,Uncharacterized protein C7orf50,1614,168,1.09 [0.62-1.90],0.7622144752964868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,1639,170,1.09 [0.70-1.70],0.7091547603932596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9,Complement component C9,1634,169,1.08 [0.86-1.36],0.4976792336020776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9orf40,Uncharacterized protein C9orf40,1620,168,0.87 [0.73-1.05],0.1458108509095296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA1,Carbonic anhydrase 1,1831,193,0.88 [0.72-1.08],0.2254038097796645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA11,Carbonic anhydrase-related protein 11,1794,193,1.03 [0.72-1.47],0.8820539358793401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,1846,195,2.21 [1.73-2.81],1.6606707945356123e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA13,Carbonic anhydrase 13,1840,195,1.02 [0.91-1.15],0.6937701990610888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,1875,196,1.33 [0.96-1.82],0.0826694980199151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,1858,195,0.96 [0.81-1.15],0.6773026490195138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,1882,199,1.02 [0.83-1.24],0.8731845398061511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,1885,199,1.78 [1.10-2.89],0.0192019955985259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",1827,197,0.96 [0.85-1.09],0.5325707105784079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA6,Carbonic anhydrase 6,1855,192,0.97 [0.80-1.18],0.7600088905497608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA7,Carbonic anhydrase 7,1594,162,0.98 [0.58-1.63],0.9232527531581938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA8,Carbonic anhydrase-related protein,1578,168,0.67 [0.34-1.35],0.2613476291576718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,1875,196,1.56 [1.28-1.92],1.6618805976312504e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CABP2,Calcium-binding protein 2,1585,165,0.95 [0.75-1.21],0.6757250374728189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1575,168,1.23 [0.74-2.04],0.4295544019462226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1581,166,0.93 [0.70-1.24],0.6245255875301015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1575,168,0.89 [0.69-1.15],0.3807326748012998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1631,171,0.99 [0.84-1.17],0.928546961114165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACYBP,Calcyclin-binding protein,1591,163,0.98 [0.85-1.13],0.767689718867369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CADPS,Calcium-dependent secretion activator 1,1585,165,1.01 [0.71-1.43],0.9506755439169288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,1846,195,1.23 [0.92-1.66],0.1621403217279575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,1796,193,1.94 [1.27-2.97],0.0023606750824562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,1833,194,1.25 [1.06-1.49],0.0096242886760934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,1614,168,1.21 [0.86-1.69],0.2717345483511382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1867,195,0.96 [0.85-1.08],0.4860520485628762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1575,165,1.11 [0.92-1.34],0.2850768363209482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALY,Neuron-specific vesicular protein calcyon,1581,166,0.72 [0.45-1.14],0.1627027670576976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1794,193,1.19 [0.90-1.55],0.2171102222058157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1585,165,1.07 [0.82-1.40],0.5974296791003345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1631,171,0.97 [0.85-1.11],0.6267456316024597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CANT1,Soluble calcium-activated nucleotidase 1,1852,197,1.53 [0.84-2.77],0.163218266036462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,1845,191,1.05 [0.86-1.30],0.6106430635179879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPN3,Calpain-3,1623,169,0.77 [0.51-1.18],0.230118788945112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPS,Calcyphosin,1614,168,0.91 [0.75-1.10],0.3159400564308318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,1796,193,0.95 [0.75-1.22],0.7022455243760797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASC3,Protein CASC3,1585,165,1.02 [0.74-1.41],0.8874977366063176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP1,Caspase-1,1796,193,0.96 [0.80-1.16],0.6853749526792212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,1796,193,0.98 [0.83-1.17],0.8445748432424307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP2,Caspase-2,1858,196,1.01 [0.85-1.21],0.8903816403544342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP3,Caspase-3,1885,199,1.02 [0.89-1.17],0.8265978423528246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP4,Caspase-4,1594,162,0.96 [0.87-1.05],0.346353605513463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP7,Caspase-7,1614,168,1.03 [0.87-1.23],0.6951294317417487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP8,Caspase-8,1868,195,0.97 [0.80-1.18],0.7945318345360377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP9,Caspase-9,1578,168,1.00 [0.80-1.26],0.9670243403278124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASQ2,Calsequestrin-2,1581,166,0.97 [0.68-1.37],0.8497151664802449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAT,Catalase,1610,164,0.91 [0.69-1.19],0.472733385929606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,1859,196,1.32 [1.13-1.54],0.0004459753111717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN1,Cerebellin-1,1575,168,1.03 [0.87-1.22],0.7388095009064926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,1875,196,0.62 [0.43-0.89],0.008943204752769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBS,Cystathionine beta-synthase,1575,165,0.84 [0.64-1.09],0.1887339004901022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBX2,Chromobox protein homolog 2,1581,166,1.07 [0.74-1.53],0.7299030194397158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1839,194,1.01 [0.85-1.19],0.9450759345293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,1614,168,1.02 [0.78-1.32],0.8876926357005175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC134,Coiled-coil domain-containing protein 134,1623,169,1.14 [0.85-1.52],0.3816402945229903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC28A,Coiled-coil domain-containing protein 28A,1585,165,1.16 [0.68-1.96],0.5857059251530422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC50,Coiled-coil domain-containing protein 50,1631,171,1.11 [0.95-1.31],0.1879862804594821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC80,Coiled-coil domain-containing protein 80,1860,197,1.45 [1.01-2.09],0.045022010441929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1575,165,1.04 [0.84-1.30],0.6970828574654211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,1882,195,1.93 [1.43-2.62],1.9969282533994787e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL13,C-C motif chemokine 13,1878,195,1.09 [0.91-1.31],0.332522306063245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,1864,196,1.46 [1.10-1.93],0.0086644122283455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,1885,199,1.90 [1.50-2.40],7.718333984570384e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,1885,199,1.29 [1.05-1.60],0.0175691434307888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL17,C-C motif chemokine 17,1855,196,0.95 [0.83-1.09],0.459342410934191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL18,C-C motif chemokine 18,1848,196,0.91 [0.75-1.11],0.3525531639455346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL19,C-C motif chemokine 19,1868,195,1.02 [0.92-1.13],0.6935202313356397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL2,C-C motif chemokine 2,1833,194,1.15 [0.91-1.45],0.2537688960658721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL20,C-C motif chemokine 20,1882,195,1.05 [0.91-1.20],0.5125808451752545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,1862,196,1.46 [1.18-1.81],0.0004313171532463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL22,C-C motif chemokine 22,1843,196,0.85 [0.67-1.09],0.2014806477320868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL23,C-C motif chemokine 23,1862,196,0.86 [0.65-1.13],0.2798970204197695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL24,C-C motif chemokine 24,1860,196,1.00 [0.86-1.16],0.9839829942496088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,1882,195,1.60 [1.24-2.05],0.0002712020840864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL26,C-C motif chemokine 26,1858,196,0.88 [0.76-1.01],0.0677143613900076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL27,C-C motif chemokine 27,1860,197,0.86 [0.72-1.03],0.108213992068869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,1852,196,1.15 [0.95-1.40],0.1459993822511416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL3,C-C motif chemokine 3,1858,196,1.10 [0.99-1.22],0.0809530351148195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL4,C-C motif chemokine 4,1860,196,1.20 [1.00-1.44],0.0463055786756252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL5,C-C motif chemokine 5,1871,198,1.01 [0.90-1.14],0.8613269861114734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,1858,196,1.18 [0.96-1.45],0.1138283454056299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL8,C-C motif chemokine 8,1871,195,1.29 [1.05-1.58],0.014894693681295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,1842,194,0.92 [0.78-1.08],0.3158165662885894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN2,CCN family member 2,1854,195,1.08 [0.87-1.33],0.5025068918686901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,1878,199,1.31 [0.93-1.83],0.1196470446401264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,1875,196,1.78 [1.36-2.33],2.237243152536944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,1864,195,1.41 [1.03-1.92],0.0318374171122105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCND2,G1/S-specific cyclin-D2,1594,162,1.10 [0.73-1.65],0.6398653594331754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCNE1,G1/S-specific cyclin-E1,1578,168,0.96 [0.80-1.16],0.6777415385791494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,1839,194,0.83 [0.63-1.08],0.1601301294924496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,1794,193,0.73 [0.54-0.99],0.0424674995626863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,1620,168,1.16 [0.79-1.70],0.4626239975299467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,1864,195,1.76 [1.23-2.52],0.0018112063461838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,1831,192,2.42 [1.82-3.22],1.311555467236013e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,1882,195,1.71 [1.35-2.16],8.179430229357447e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,1871,198,1.26 [0.96-1.64],0.0936893706561327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,1864,195,1.57 [1.29-1.91],7.569126299839039e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,1585,165,1.06 [0.72-1.56],0.7589497840042676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD177,CD177 antigen,1861,195,1.02 [0.92-1.13],0.7658918063789306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,1855,194,0.86 [0.55-1.36],0.5309773569187364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2,T-cell surface antigen CD2,1581,166,1.17 [0.82-1.65],0.3862069293273944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,1858,196,2.54 [1.66-3.89],1.610006725773292e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,1851,196,1.06 [0.74-1.53],0.7435168280633537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,1814,190,1.70 [1.26-2.31],0.0005727371205008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD209,CD209 antigen,1863,197,1.08 [0.78-1.51],0.6417153189120728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD22,B-cell receptor CD22,1882,195,1.36 [1.02-1.81],0.033440777658239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD226,CD226 antigen,1578,168,1.22 [0.87-1.71],0.2513131517874348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD244,Natural killer cell receptor 2B4,1882,195,1.41 [0.92-2.16],0.1146577838046956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,1634,170,0.70 [0.49-0.99],0.0409782260380672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,1855,194,2.71 [2.16-3.40],8.010432648142059e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,1839,194,1.51 [1.06-2.16],0.0238668448731818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,1855,196,2.34 [1.73-3.16],2.7957451287771627e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,1794,193,1.49 [1.08-2.06],0.0144308674103731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,1860,197,0.98 [0.80-1.19],0.8065946634879654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,1596,165,1.64 [1.04-2.58],0.0337873135239603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,1868,195,1.46 [1.05-2.02],0.0231433226799267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,1869,196,1.61 [1.22-2.12],0.0008130832956839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,1875,196,1.11 [0.92-1.33],0.2836037615626418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,1864,195,1.84 [1.33-2.54],0.0002184991318661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,1846,195,1.73 [1.23-2.43],0.0014555268277443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD33,Myeloid cell surface antigen CD33,1855,194,1.09 [0.92-1.29],0.3434587958508702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD34,Hematopoietic progenitor cell antigen CD34,1862,195,1.28 [0.78-2.10],0.3371013999944823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD36,Platelet glycoprotein 4,1578,168,1.15 [0.87-1.54],0.3241458936255834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1846,195,0.98 [0.67-1.44],0.9119437273456352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3D,T-cell surface glycoprotein CD3 delta chain,1575,168,1.10 [0.71-1.70],0.6690548756794374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,1594,162,0.75 [0.44-1.28],0.2969163104752452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,1578,168,0.98 [0.83-1.17],0.8566162366467958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,1856,196,1.35 [0.90-2.04],0.1506407566704995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,1858,196,1.31 [1.05-1.63],0.0173179173952013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40LG,CD40 ligand,1882,195,1.05 [0.89-1.23],0.5672016075929114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,1855,194,2.42 [1.63-3.59],1.281938033149493e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,1860,196,2.42 [1.59-3.68],3.573481681189725e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,1871,195,2.16 [1.54-3.02],7.407267096841792e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,1799,188,2.44 [1.54-3.84],0.0001301676449958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD58,Lymphocyte function-associated antigen 3,1850,194,1.03 [0.51-2.10],0.9359040794312624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,1803,189,2.11 [1.35-3.32],0.0011134680492395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5L,CD5 antigen-like,1631,170,0.97 [0.73-1.30],0.8534210035854112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD6,T-cell differentiation antigen CD6,1879,195,0.86 [0.68-1.10],0.2399701879249277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD63,CD63 antigen,1833,194,1.13 [0.87-1.47],0.3624846205900813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD69,Early activation antigen CD69,1852,195,0.94 [0.82-1.09],0.415287471091311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,1573,168,1.50 [1.06-2.11],0.0211928906306255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,1858,196,1.48 [1.10-1.98],0.0088004896880517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD72,B-cell differentiation antigen CD72,1596,165,1.41 [1.02-1.95],0.0366575599958157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,1868,195,2.17 [1.57-3.00],2.941968036190744e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1882,195,1.90 [1.49-2.41],1.484603089387398e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,1627,168,1.95 [1.36-2.81],0.0003296552708155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD82,CD82 antigen,1594,162,1.06 [0.77-1.46],0.7398814459355149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,1858,196,1.78 [1.28-2.47],0.0006117734006088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD84,SLAM family member 5,1858,196,0.95 [0.65-1.39],0.7994184532750204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD86,T-lymphocyte activation antigen CD86,1620,168,0.72 [0.45-1.16],0.1746331239685878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,1868,195,1.28 [1.00-1.65],0.0530895838503118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,1793,187,1.47 [1.00-2.17],0.0528234129766957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,1864,195,2.10 [1.13-3.89],0.0190091662462768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,1864,195,1.64 [1.01-2.67],0.0468811872039963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,1625,168,0.78 [0.57-1.07],0.1214976800757903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDAN1,Codanin-1,1614,168,0.72 [0.36-1.43],0.3479775404623865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC123,Cell division cycle protein 123 homolog,1563,161,0.98 [0.77-1.26],0.8898694343877731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC25A,M-phase inducer phosphatase 1,1563,161,0.96 [0.64-1.44],0.8358475730820409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC26,Anaphase-promoting complex subunit CDC26,1619,168,1.04 [0.85-1.27],0.7288440490476447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,1794,193,1.13 [0.93-1.38],0.2136022072883281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC37,Hsp90 co-chaperone Cdc37,1855,194,1.02 [0.88-1.18],0.771208248255511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,1620,168,1.00 [0.88-1.15],0.9533007427502898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDCP1,CUB domain-containing protein 1,1839,194,1.23 [1.00-1.52],0.0514139522305679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,1805,193,2.11 [1.74-2.56],1.8012733572557417e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,1862,195,1.08 [0.92-1.26],0.3294018662015214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,1860,197,1.72 [1.47-2.01],5.0435476449933695e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH2,Cadherin-2,1860,197,1.25 [0.91-1.72],0.1607341283124211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH22,Cadherin-22,1594,162,1.07 [0.62-1.83],0.8117451910244544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,1614,168,1.71 [1.00-2.93],0.0491954359894296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,1868,195,1.47 [1.06-2.03],0.0200869015907455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH4,Cadherin-4,1575,168,0.80 [0.55-1.14],0.2141138246773393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,1885,199,1.32 [0.90-1.93],0.1583578237232477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,1860,197,1.03 [0.76-1.40],0.8360526437276694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR1,Cadherin-related family member 1,1796,193,0.97 [0.72-1.31],0.8399818890916886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,1846,195,0.87 [0.73-1.03],0.1071796737956466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR5,Cadherin-related family member 5,1860,197,0.91 [0.66-1.26],0.5820432085713341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK1,Cyclin-dependent kinase 1,1563,161,0.85 [0.55-1.32],0.4712455217404933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1631,171,0.96 [0.75-1.23],0.7729457388159249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKL5,Cyclin-dependent kinase-like 5,1575,168,1.11 [0.83-1.49],0.4689841222058772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,1846,195,0.99 [0.89-1.11],0.9006024661808169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1846,195,0.98 [0.86-1.12],0.7877308005408242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,1846,195,1.17 [0.81-1.68],0.4025846117896066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1857,196,1.56 [0.99-2.46],0.0550505094562286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,1874,195,1.08 [0.82-1.43],0.5912427866349068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1854,194,1.22 [0.82-1.83],0.3289739160869661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1620,168,0.87 [0.72-1.04],0.1148592465824654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1594,162,1.01 [0.85-1.22],0.8748553715858012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1620,168,1.07 [0.74-1.56],0.7173404453286798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1594,162,1.54 [1.11-2.15],0.0105363911858048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1858,196,1.13 [0.98-1.29],0.0817867948342274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1794,193,1.04 [0.80-1.35],0.7697978651083716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1774,191,1.41 [1.16-1.72],0.0007282189394824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1634,170,1.22 [0.86-1.72],0.2597612079677237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1827,197,1.02 [0.80-1.29],0.8970051153890055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPA,CCAAT/enhancer-binding protein alpha,1578,168,0.81 [0.50-1.31],0.3950278515087863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPB,CCAAT/enhancer-binding protein beta,1827,197,0.77 [0.55-1.06],0.1113708822116108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA2A,Chymotrypsin-like elastase family member 2A,1634,170,0.99 [0.80-1.22],0.9221742567622412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA3A,Chymotrypsin-like elastase family member 3A,1883,199,1.00 [0.83-1.21],0.9951965258390562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1596,165,0.82 [0.49-1.38],0.4599144075308079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEMIP2,Cell surface hyaluronidase,1578,168,0.80 [0.48-1.32],0.3865300281790736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,1575,168,1.11 [0.88-1.40],0.3820851003856502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPF,Centromere protein F,1594,162,0.95 [0.72-1.25],0.7181033122647407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,1594,162,0.99 [0.80-1.23],0.955924370481406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP112,Centrosomal protein of 112 kDa,1581,166,0.96 [0.69-1.32],0.7802680448857255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP152,Centrosomal protein of 152 kDa,1563,161,0.88 [0.60-1.28],0.4923032484936532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP164,Centrosomal protein of 164 kDa,1817,191,1.20 [1.03-1.41],0.0205937858684755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP170,Centrosomal protein of 170 kDa,1575,165,1.00 [0.83-1.21],0.9923303989398472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,1794,193,1.02 [0.86-1.21],0.7988549315487437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP290,Centrosomal protein of 290 kDa,1594,162,0.95 [0.70-1.28],0.7349122082609696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP350,Centrosome-associated protein 350,1563,161,1.06 [0.68-1.65],0.7932719820334589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,1813,194,1.11 [0.93-1.32],0.2560315570058252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,1794,193,0.99 [0.82-1.21],0.94546669441876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CERT,Ceramide transfer protein,1796,193,1.02 [0.83-1.25],0.8653262159140298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,1859,197,0.98 [0.87-1.10],0.7069364795971547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,1846,195,1.23 [0.99-1.52],0.0591706103208178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES3,Carboxylesterase 3,1846,195,0.96 [0.82-1.14],0.6740060180228824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN2,Centrin-2,1796,193,1.08 [0.90-1.29],0.4138718678057927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN3,Centrin-3,1620,168,1.00 [0.83-1.20],0.9954189457969322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFB,Complement factor B,1614,169,1.82 [1.16-2.86],0.0097398851229754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,1794,193,1.31 [1.02-1.68],0.0334283385165362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,1639,170,1.30 [0.64-2.65],0.4629541133860008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFH,Complement factor H,1549,164,1.44 [0.76-2.74],0.2653174109189874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,1630,170,1.15 [0.88-1.50],0.2966542114912482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR4,Complement factor H-related protein 4,1635,170,1.19 [0.97-1.48],0.1013906319231211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR5,Complement factor H-related protein 5,1607,166,1.34 [0.94-1.89],0.1022489488434744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFI,Complement factor I,1639,170,1.75 [0.87-3.53],0.1188996894749151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,1639,170,0.52 [0.27-1.01],0.05297540990863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,1864,195,1.32 [1.13-1.55],0.000529267119267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1634,169,1.11 [0.87-1.42],0.3968082594453943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGN,Cingulin,1585,165,0.86 [0.58-1.27],0.4398641849329106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1860,197,1.98 [1.54-2.53],7.859635109663096e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1794,193,1.01 [0.81-1.26],0.9496616880524522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,1596,165,0.40 [0.31-0.52],1.0565540855174727e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1614,168,1.49 [1.07-2.08],0.0182073191712288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD6,MICOS complex subunit MIC25,1623,169,1.15 [0.76-1.75],0.4987457430620394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHEK2,Serine/threonine-protein kinase Chk2,1827,197,0.88 [0.59-1.33],0.5521869684333176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,1634,170,1.23 [1.08-1.39],0.0012301608891971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,1858,195,1.44 [1.09-1.91],0.0107043240919912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,1812,188,1.25 [1.09-1.43],0.0016003209184776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHIT1,Chitotriosidase-1,1874,198,1.03 [0.95-1.11],0.4554297269318106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,1869,198,1.38 [0.92-2.06],0.1160707956087077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHM,Rab proteins geranylgeranyltransferase component A 1,1585,165,0.95 [0.74-1.21],0.678879350882112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP1A,Charged multivesicular body protein 1a,1839,194,1.02 [0.87-1.20],0.8069751738539123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP6,Charged multivesicular body protein 6,1627,168,0.90 [0.70-1.16],0.4158882463975406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHP1,Calcineurin B homologous protein 1,1575,168,0.85 [0.68-1.05],0.1328533898151432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,1860,196,1.96 [1.36-2.83],0.000306486933881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL2,Chordin-like protein 2,1860,197,0.71 [0.56-0.90],0.0048634631130812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,1585,165,1.11 [0.78-1.58],0.5696776261386421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,1855,194,1.06 [0.87-1.29],0.5702934832025806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,1634,170,1.77 [1.34-2.34],5.44717947406071e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CINP,Cyclin-dependent kinase 2-interacting protein,1594,162,0.98 [0.69-1.38],0.8976635899439067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIRBP,Cold-inducible RNA-binding protein,1620,168,0.98 [0.84-1.14],0.7844965881143772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,1585,165,0.98 [0.71-1.34],0.8764792230341306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,1877,195,2.73 [1.87-3.98],1.767908562033263e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,1634,170,1.43 [1.15-1.78],0.0015318898477565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1851,194,1.39 [1.14-1.70],0.0011837139506661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLASP1,CLIP-associating protein 1,1563,161,0.93 [0.75-1.15],0.5001181685275468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,1856,197,1.10 [0.92-1.31],0.2980228949507414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,1839,194,1.37 [0.97-1.94],0.0763375088175838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC11A,C-type lectin domain family 11 member A,1858,195,0.88 [0.67-1.14],0.3166122681816884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC12A,C-type lectin domain family 12 member A,1578,168,0.63 [0.29-1.39],0.2554073366063574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,1864,195,1.87 [1.29-2.71],0.0009275197457322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,1827,197,1.67 [1.19-2.34],0.0031541832347722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1B,C-type lectin domain family 1 member B,1868,195,1.02 [0.90-1.16],0.7589565549571156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,1585,165,0.97 [0.71-1.31],0.8212660216253277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,1606,169,0.31 [0.17-0.56],0.0001213392342101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4A,C-type lectin domain family 4 member A,1858,196,1.07 [0.77-1.49],0.6923068256765184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,1858,196,1.04 [0.80-1.35],0.7640916305107047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,1858,196,1.21 [1.01-1.45],0.0390854363411747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4G,C-type lectin domain family 4 member G,1858,196,1.29 [0.89-1.86],0.1773479482638981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4M,C-type lectin domain family 4 member M,1633,170,0.77 [0.57-1.06],0.1059593774883143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,1858,197,1.86 [1.28-2.70],0.0012091539125779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,1794,193,1.29 [1.02-1.63],0.0322103658612474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,1882,195,1.29 [1.02-1.63],0.0365759223889749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLGN,Calmegin,1585,165,1.20 [0.85-1.70],0.2931106298119406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIC5,Chloride intracellular channel protein 5,1585,165,0.80 [0.48-1.32],0.3811111710430729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLINT1,Clathrin interactor 1,1563,161,0.93 [0.64-1.34],0.6812456569222856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIP2,CAP-Gly domain-containing linker protein 2,1858,196,1.00 [0.90-1.12],0.9714414286523848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,1875,196,1.87 [1.12-3.13],0.0167503415831617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLNS1A,Methylosome subunit pICln,1585,165,0.67 [0.41-1.09],0.1066922984260193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1833,194,1.05 [0.93-1.19],0.4464549577380816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPS,Colipase,1860,195,1.07 [0.91-1.25],0.4222476253553867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSPN,Claspin,1790,193,0.67 [0.43-1.05],0.0805425147665104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,1796,193,0.66 [0.49-0.88],0.0054293976055502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,1882,195,1.38 [1.05-1.82],0.0226732338287728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN3,Calsyntenin-3,1614,168,1.07 [0.68-1.70],0.764971787181369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,1827,197,1.12 [0.84-1.48],0.4504022215173658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLU,Clusterin,1639,170,1.69 [1.18-2.44],0.0047153402196922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLUL1,Clusterin-like protein 1,1855,197,0.84 [0.64-1.09],0.1880818421374998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMC1,COX assembly mitochondrial protein homolog,1627,168,0.97 [0.83-1.14],0.7352835890271124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMIP,C-Maf-inducing protein,1623,169,1.00 [0.84-1.18],0.9686241491326396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,1871,198,1.36 [1.03-1.80],0.0316591025017113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,1575,168,0.98 [0.75-1.27],0.856829143561422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1573,164,1.03 [0.85-1.24],0.7850257435556369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY2,Protein canopy homolog 2,1827,197,0.99 [0.80-1.24],0.9620310216655256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY4,Protein canopy homolog 4,1846,195,1.03 [0.88-1.21],0.720686921710473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNST,Consortin,1860,197,0.99 [0.89-1.11],0.8923721453594949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTF,Ciliary neurotrophic factor,1575,168,0.95 [0.61-1.48],0.8162202335943793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,1885,199,1.85 [1.19-2.88],0.0060128971626278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,1875,196,1.44 [1.10-1.88],0.0078260590145783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN3,Contactin-3,1864,195,1.17 [0.81-1.71],0.4048852995887356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,1864,195,2.35 [1.39-3.96],0.0013697000824803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,1854,194,0.74 [0.53-1.04],0.0856453991638815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP2,Contactin-associated protein-like 2,1858,196,1.34 [1.01-1.78],0.0429253338687568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP4,Contactin-associated protein-like 4,1585,165,0.98 [0.85-1.13],0.7771397921788809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COCH,Cochlin,1627,168,0.97 [0.72-1.31],0.8406566517187222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,1634,170,0.40 [0.24-0.68],0.0006161174753625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,1871,196,2.75 [1.71-4.43],2.978829125769928e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,1885,199,0.38 [0.22-0.64],0.00027390341891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL24A1,Collagen alpha-1(XXIV) chain,1620,168,0.89 [0.71-1.11],0.3030096141467939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL28A1,Collagen alpha-1(XXVIII) chain,1585,165,1.10 [0.93-1.29],0.2602665026683356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL2A1,Collagen alpha-1(II) chain,1575,165,1.04 [0.87-1.25],0.6292839030528121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL3A1,Collagen alpha-1(III) chain,1634,170,1.00 [0.56-1.78],0.995619281485675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,1860,197,1.87 [1.47-2.38],3.535162629800139e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A4,Collagen alpha-4(IV) chain,1587,161,1.18 [0.87-1.61],0.2795200780162495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL5A1,Collagen alpha-1(V) chain,1596,165,1.03 [0.76-1.39],0.8502831647237935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,1885,199,1.70 [1.25-2.31],0.0007960111777906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A1,Collagen alpha-1(IX) chain,1858,196,1.00 [0.77-1.30],0.9970509509504673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A2,Collagen alpha-2(IX) chain,1594,162,1.08 [0.78-1.51],0.6437056177282732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,1855,196,2.29 [1.53-3.44],6.167016555063189e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD1,COMM domain-containing protein 1,1575,165,1.05 [0.83-1.33],0.6608729381007851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD9,COMM domain-containing protein 9,1623,169,0.94 [0.65-1.36],0.7378636607223924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,1853,196,0.62 [0.43-0.89],0.0096952776018441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMT,Catechol O-methyltransferase,1809,197,0.99 [0.85-1.16],0.9212974370294772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPB2,Coatomer subunit beta',1581,166,0.98 [0.71-1.37],0.9216910774310316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPE,Coatomer subunit epsilon,1796,193,0.91 [0.67-1.24],0.5663342289742508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1575,165,1.32 [0.97-1.80],0.0822665996657564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO1A,Coronin-1A,1827,194,1.07 [0.93-1.23],0.3713324543643146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,1575,168,1.14 [0.82-1.58],0.429098380963848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1846,195,1.13 [0.95-1.35],0.1752816710220553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX6B1,Cytochrome c oxidase subunit 6B1,1627,168,0.98 [0.64-1.49],0.91536500494587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,1885,199,0.83 [0.69-0.99],0.0361611239513766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,1860,195,1.42 [1.22-1.65],7.049125633248055e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,1560,157,0.60 [0.44-0.83],0.0020591014539152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB1,Carboxypeptidase B,1885,199,0.85 [0.70-1.02],0.0770864279469354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB2,Carboxypeptidase B2,1634,170,1.29 [0.69-2.41],0.4205709160765631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,1863,194,0.85 [0.63-1.14],0.2684657313930073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPLX2,Complexin-2,1563,161,1.12 [0.71-1.77],0.6188323294513146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,1857,194,1.50 [1.09-2.05],0.0122916531077115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1578,168,0.65 [0.37-1.13],0.1259623038787332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,1868,195,0.95 [0.79-1.15],0.6203237438022184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPQ,Carboxypeptidase Q,1633,170,0.94 [0.69-1.27],0.6703380387771088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPTP,Ceramide-1-phosphate transfer protein,1581,166,1.03 [0.68-1.54],0.8965855159429436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,1872,196,1.31 [0.95-1.80],0.1013056116469717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM1,Probable carboxypeptidase X1,1855,194,1.12 [0.95-1.34],0.1803559385808958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,1627,168,2.16 [1.26-3.70],0.0051011447585483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR1,Complement receptor type 1,1628,168,1.03 [0.71-1.51],0.8652762830642589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,1871,198,1.54 [1.19-2.00],0.0009796200135022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1794,193,0.98 [0.84-1.13],0.761183319162246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRADD,Death domain-containing protein CRADD,1833,194,1.00 [0.85-1.18],0.9967130202900896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREB3,Cyclic AMP-responsive element-binding protein 3,1563,161,0.84 [0.61-1.16],0.2825947798040069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREBZF,CREB/ATF bZIP transcription factor,1563,161,0.96 [0.51-1.82],0.901764152415538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,1824,189,0.53 [0.41-0.69],1.9822774342651456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,1596,165,1.80 [1.25-2.60],0.0016780101035996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,1860,196,1.35 [1.10-1.67],0.0045983071335925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRH,Corticoliberin,1790,193,0.88 [0.76-1.02],0.0977341460131074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,1855,196,2.08 [1.35-3.20],0.0008345970185765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHR1,Corticotropin-releasing factor receptor 1,1827,197,1.00 [0.80-1.25],0.985062444047115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,1862,196,2.15 [1.24-3.73],0.0062810882271495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,1839,194,1.49 [1.09-2.04],0.011658065070746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,1875,196,0.82 [0.67-1.01],0.0669249624401695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,1613,167,0.43 [0.27-0.70],0.0005770149064208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRKL,Crk-like protein,1855,194,1.02 [0.91-1.15],0.7073149563308048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRLF1,Cytokine receptor-like factor 1,1862,196,1.40 [0.87-2.26],0.1713243331614243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRNN,Cornulin,1798,191,1.10 [0.92-1.32],0.2902597967588736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,1885,199,0.65 [0.45-0.95],0.0279749331903235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,1839,194,1.48 [1.15-1.89],0.0020868232181953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAP,Cartilage-associated protein,1585,165,0.87 [0.63-1.21],0.407226532727994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRX,Cone-rod homeobox protein,1827,197,1.01 [0.89-1.15],0.8930944608437106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB1,Beta-crystallin B1,1627,168,1.02 [0.82-1.25],0.887602347327665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,1614,168,1.07 [0.91-1.26],0.3954973948664434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYGD,Gamma-crystallin D,1614,168,1.08 [0.94-1.25],0.2895914334836356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYM,Ketimine reductase mu-crystallin,1575,168,1.19 [0.99-1.43],0.0581141838844909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYZL1,Quinone oxidoreductase-like protein 1,1575,165,0.98 [0.83-1.15],0.8114674401048669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSDE1,Cold shock domain-containing protein E1,1581,166,0.96 [0.84-1.09],0.5448194388729402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,1862,196,1.97 [1.32-2.96],0.0009680526685267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,1634,169,1.32 [0.95-1.84],0.0992526151723662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2,Granulocyte-macrophage colony-stimulating factor,1581,166,1.11 [0.75-1.65],0.5947435063600841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1839,194,1.06 [0.86-1.31],0.5908845051407515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RB,Cytokine receptor common subunit beta,1578,168,1.13 [0.81-1.59],0.4678270640066653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3,Granulocyte colony-stimulating factor,1817,191,0.72 [0.54-0.94],0.0176804231725879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3R,Granulocyte colony-stimulating factor receptor,1578,168,0.82 [0.53-1.26],0.3597704381317432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSH1,Chorionic somatomammotropin hormone 1,1634,169,0.77 [0.46-1.28],0.3129903984267693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK1D,Casein kinase I isoform delta,1578,168,0.83 [0.64-1.08],0.1687753435995518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK2A1,Casein kinase II subunit alpha,1631,171,1.12 [0.82-1.55],0.4702952920257645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,1634,170,1.08 [0.71-1.64],0.7273002125502561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,1575,168,0.90 [0.65-1.26],0.5479332646092291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSRP3,Cysteine and glycine-rich protein 3,1581,166,1.01 [0.87-1.18],0.857397954152232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST1,Cystatin-SN,1429,152,1.03 [0.89-1.21],0.6705165909108527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,1863,198,1.90 [1.30-2.78],0.0008718677126025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,1823,193,1.14 [0.90-1.43],0.269775063489411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST6,Cystatin-M,1808,192,0.99 [0.77-1.28],0.9417415417598072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST7,Cystatin-F,1860,196,1.05 [0.93-1.19],0.4324545933925827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,1841,197,1.08 [0.81-1.43],0.5981748776636198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,1588,162,0.77 [0.56-1.06],0.1141914529662598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTBS,Di-N-acetylchitobiase,1600,163,1.47 [0.96-2.25],0.0734767393399017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTF1,Cardiotrophin-1,1827,197,1.00 [0.86-1.15],0.963768942152507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,1634,170,1.98 [1.25-3.14],0.003461697722609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,1634,170,0.91 [0.53-1.55],0.7316549851476339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,1575,168,1.01 [0.65-1.58],0.9629664319547684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRB1,Chymotrypsinogen B,1864,195,0.90 [0.74-1.10],0.3083036310968668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,1853,196,0.91 [0.76-1.09],0.3099694698620933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRL,Chymotrypsin-like protease CTRL-1,1614,168,0.89 [0.73-1.08],0.230461598834753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,1864,197,1.34 [1.05-1.71],0.0189260167024088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSC,Dipeptidyl peptidase 1,1849,192,1.02 [0.77-1.36],0.8655995105583345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSD,Cathepsin D,1751,186,1.20 [0.90-1.60],0.2060940184320292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,1596,165,1.49 [1.17-1.89],0.0012976820205852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSF,Cathepsin F,1855,194,1.18 [0.87-1.60],0.279561956913793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,1825,197,1.12 [0.95-1.33],0.1816988676407522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,1860,197,1.69 [1.03-2.78],0.0362964827242665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,1882,195,1.73 [1.18-2.52],0.0044732110751615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,1456,146,3.28 [1.79-5.99],0.0001127199599078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,1869,195,0.86 [0.64-1.14],0.2873067916012159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,1866,197,1.86 [1.29-2.68],0.0009241289338121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,1585,165,1.35 [1.05-1.75],0.0209723675682996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CWC15,Spliceosome-associated protein CWC15 homolog,1611,168,0.97 [0.77-1.22],0.79387825631379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,1839,194,1.99 [1.42-2.79],6.2823068245351e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,1858,196,1.17 [0.92-1.49],0.2022502774704619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL1,Growth-regulated alpha protein,1858,196,1.07 [0.95-1.21],0.261257310082571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL10,C-X-C motif chemokine 10,1862,196,0.96 [0.79-1.17],0.6933431001449235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL11,C-X-C motif chemokine 11,1868,195,0.99 [0.85-1.16],0.9155237802421116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL12,Stromal cell-derived factor 1,1817,191,1.12 [0.83-1.52],0.4595705085739595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL13,C-X-C motif chemokine 13,1868,195,0.98 [0.78-1.22],0.8410063327318834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL14,C-X-C motif chemokine 14,1817,191,1.06 [0.88-1.29],0.5303957229599547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,1884,199,2.43 [1.50-3.92],0.0002865680283064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL17,C-X-C motif chemokine 17,1882,195,0.86 [0.65-1.15],0.307344021552447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL3,C-X-C motif chemokine 3,1858,196,1.05 [0.93-1.20],0.4309965791155103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL5,C-X-C motif chemokine 5,1858,197,1.12 [1.01-1.24],0.0306831157896237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL6,C-X-C motif chemokine 6,1882,195,1.18 [1.00-1.38],0.0447049711293711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,1841,191,1.15 [0.99-1.33],0.0601982178101636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,1862,196,1.35 [1.14-1.60],0.0005771771461279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5A,Cytochrome b5,1563,161,0.73 [0.56-0.94],0.0159307866013516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5R2,NADH-cytochrome b5 reductase 2,1596,168,1.13 [0.90-1.42],0.278749567864836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1581,166,1.01 [0.83-1.22],0.94453687671899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTH3,Cytohesin-3,1563,161,0.89 [0.71-1.12],0.3335154429021936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,1634,170,0.44 [0.24-0.78],0.0052433926609794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAAM1,Disheveled-associated activator of morphogenesis 1,1596,165,0.97 [0.81-1.15],0.7156378029983554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAB2,Disabled homolog 2,1875,196,1.01 [0.91-1.13],0.8195294464113089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,1862,196,1.41 [1.09-1.83],0.0088844724774046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAND5,DAN domain family member 5,1578,168,1.00 [0.80-1.24],0.978093441882774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPK2,Death-associated protein kinase 2,1578,168,0.80 [0.59-1.06],0.1221961366823397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1858,196,1.02 [0.93-1.13],0.6391837297613923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",1833,194,0.96 [0.81-1.15],0.6656256037095514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBH,Dopamine beta-hydroxylase,1632,169,0.91 [0.81-1.03],0.1529938082580342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,1852,192,1.07 [0.91-1.26],0.4054817139880102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBN1,Drebrin,1578,168,0.94 [0.71-1.25],0.6906283678931935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBNL,Drebrin-like protein,1862,196,1.01 [0.89-1.16],0.8566203175152503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1855,194,2.76 [2.00-3.82],8.392801710213853e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,1585,165,0.36 [0.16-0.83],0.015906945015314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCDC2C,Doublecortin domain-containing protein 2C,1563,161,0.96 [0.75-1.23],0.7609540321364261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,1563,161,0.79 [0.47-1.32],0.3633563417705543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,1827,197,2.67 [1.56-4.56],0.0003543876407834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTD,Deoxycytidylate deaminase,1596,165,1.01 [0.87-1.17],0.928602248376458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN1,Dynactin subunit 1,1875,196,0.89 [0.73-1.07],0.2085430165681091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN2,Dynactin subunit 2,1846,195,1.04 [0.91-1.18],0.5613950104574259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,1796,193,0.88 [0.73-1.07],0.2036372567975841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,1860,197,0.64 [0.43-0.96],0.0308652384548256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D1,DCN1-like protein 1,1575,168,0.91 [0.73-1.13],0.3906578689278857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D2,DCN1-like protein 2,1563,161,1.07 [0.90-1.26],0.4476798533211467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,1855,194,0.79 [0.64-0.97],0.0276326730842311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDA1,DET1- and DDB1-associated protein 1,1581,166,0.76 [0.50-1.17],0.2167530337698081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1846,195,1.14 [0.88-1.48],0.3142374367496937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDC,Aromatic-L-amino-acid decarboxylase,1859,196,1.00 [0.79-1.26],0.9960528869692984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDHD2,Phospholipase DDHD2,1631,171,1.07 [0.86-1.33],0.5320734105563301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,1596,165,0.87 [0.72-1.05],0.1557129761035348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,1868,195,1.92 [1.15-3.22],0.0128459151541386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,1634,170,0.76 [0.54-1.07],0.1180137751222892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,1620,168,0.94 [0.69-1.29],0.7071396791927368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,1585,165,1.19 [0.85-1.68],0.3137787270189664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX39A,ATP-dependent RNA helicase DDX39A,1578,168,1.24 [0.62-2.49],0.5397142940293722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX4,Probable ATP-dependent RNA helicase DDX4,1578,168,0.68 [0.48-0.98],0.0376946184649431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX53,Probable ATP-dependent RNA helicase DDX53,1585,165,0.73 [0.48-1.11],0.1417333980782346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,1794,193,1.07 [0.89-1.30],0.468068989023455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1858,196,1.06 [0.93-1.20],0.3947755634049857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFA1_DEFA1B,Neutrophil defensin 1,1829,197,1.28 [1.04-1.58],0.0224934337395656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,1570,167,1.12 [0.84-1.49],0.4326843162984403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB104A_DEFB104B,Beta-defensin 104,1575,168,0.91 [0.67-1.24],0.5520723214351009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB116,Beta-defensin 116,1575,168,1.15 [0.98-1.35],0.0852038118117432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB118,Beta-defensin 118,1575,168,1.04 [0.82-1.33],0.7387084208137232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB4A_DEFB4B,Beta-defensin 4A,1829,193,1.02 [0.94-1.11],0.5930666147441218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENND2B,DENN domain-containing protein 2B,1581,166,0.91 [0.64-1.30],0.6135299867571643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENR,Density-regulated protein,1578,168,0.74 [0.56-0.98],0.0372267132838513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,1882,195,1.03 [0.86-1.24],0.7475887082236294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGCR6,Protein DGCR6,1575,168,0.88 [0.60-1.28],0.5073313036987513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKA,Diacylglycerol kinase alpha,1578,168,1.04 [0.80-1.34],0.785789347051819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,1817,191,0.97 [0.67-1.41],0.8910458137561392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHODH,Dihydroorotate dehydrogenase,1581,166,1.12 [0.78-1.59],0.5448301298513633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHPS,Deoxyhypusine synthase,1623,169,1.20 [0.86-1.68],0.2754829822950293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1614,168,0.90 [0.66-1.24],0.5210584329176182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIABLO,"Diablo homolog, mitochondrial",1858,197,1.00 [0.89-1.12],0.9854109396195389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK1C,Divergent protein kinase domain 1C,1585,165,1.04 [0.73-1.47],0.8285119070205097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK2B,Divergent protein kinase domain 2B,1596,165,0.74 [0.44-1.23],0.2454265788332426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK1,Dickkopf-related protein 1,1868,195,1.11 [0.90-1.36],0.3260859833929382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,1885,199,1.44 [0.95-2.18],0.0824960898203664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,1837,194,1.99 [1.59-2.48],1.400329953702117e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKKL1,Dickkopf-like protein 1,1846,195,1.12 [0.96-1.31],0.1609186624061069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLG4,Disks large homolog 4,1614,168,1.00 [0.83-1.21],0.9929629640641964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLGAP5,Disks large-associated protein 5,1631,171,0.87 [0.60-1.24],0.4318106773333671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLK1,Protein delta homolog 1,1885,199,0.85 [0.69-1.05],0.1313176549167546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,1855,194,3.63 [2.59-5.10],9.260157601990837e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL4,Delta-like protein 4,1575,165,0.89 [0.71-1.11],0.3129166275595558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMD,Dystrophin,1575,165,1.27 [0.99-1.63],0.0636945684056818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,1575,165,0.58 [0.49-0.70],1.7076472823076485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA1,DnaJ homolog subfamily A member 1,1563,161,0.90 [0.61-1.31],0.5680228397605621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA2,DnaJ homolog subfamily A member 2,1880,195,1.01 [0.87-1.18],0.872734879185318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA4,DnaJ homolog subfamily A member 4,1614,168,1.03 [0.85-1.25],0.7615469211639068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,1846,195,1.01 [0.88-1.17],0.8646175350621227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB14,DnaJ homolog subfamily B member 14,1620,168,1.00 [0.81-1.24],0.9945960302843984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,1596,165,0.97 [0.74-1.27],0.8134699063285089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB6,DnaJ homolog subfamily B member 6,1579,162,1.00 [0.84-1.18],0.9869098335344404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB8,DnaJ homolog subfamily B member 8,1827,197,1.07 [0.86-1.35],0.5396587872526304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC21,DnaJ homolog subfamily C member 21,1614,168,1.09 [0.77-1.55],0.6345631672000827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,1575,165,0.98 [0.83-1.16],0.8071683359792917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,1620,168,0.97 [0.80-1.18],0.7625119285938757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,1846,195,1.08 [0.69-1.71],0.7258884332266324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNLZ,DNL-type zinc finger protein,1575,168,0.97 [0.79-1.19],0.7454577467504003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM1,Dynamin-1,1620,168,0.97 [0.86-1.10],0.6218644450138764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM3,Dynamin-3,1631,171,1.24 [0.99-1.57],0.0659820170320408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNMBP,Dynamin-binding protein,1839,194,1.05 [0.86-1.27],0.6532730328909684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPEP,Aspartyl aminopeptidase,1614,168,0.82 [0.65-1.04],0.10754205013467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1857,194,1.04 [0.82-1.32],0.7535952375388796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOC2B,Double C2-like domain-containing protein beta,1585,165,0.64 [0.38-1.06],0.0829411194792912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOCK9,Dedicator of cytokinesis protein 9,1575,168,0.95 [0.82-1.10],0.5029831529637412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK1,Docking protein 1,1614,168,1.02 [0.91-1.13],0.7616685642795362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK2,Docking protein 2,1860,197,0.99 [0.90-1.09],0.8180176730949544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP1,Dipeptidase 1,1833,194,0.78 [0.61-1.00],0.0510855320009403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,1846,195,1.35 [0.89-2.05],0.1621586604573343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP10,Inactive dipeptidyl peptidase 10,1858,196,1.11 [0.83-1.48],0.4683594487834086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP4,Dipeptidyl peptidase 4,1838,191,0.96 [0.64-1.43],0.8297665962461778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1846,195,2.44 [1.80-3.30],8.031469761590692e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP7,Dipeptidyl peptidase 2,1847,197,0.96 [0.79-1.18],0.7206212318981253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,1885,199,2.32 [1.40-3.85],0.001078229943214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,1870,195,1.12 [0.93-1.36],0.2269418174187212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRAXIN,Draxin,1839,194,1.55 [1.15-2.09],0.0042980453567544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRG2,Developmentally-regulated GTP-binding protein 2,1846,195,1.02 [0.82-1.26],0.8774004136278202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,1838,188,2.15 [1.73-2.67],3.43047245099158e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,1631,171,1.51 [1.05-2.18],0.0279908808020224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,1864,195,3.20 [2.14-4.78],1.6309786845538294e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG3,Desmoglein-3,1868,194,0.86 [0.60-1.23],0.4125839415610242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,1835,194,0.66 [0.52-0.85],0.0012991777968244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTD1,D-aminoacyl-tRNA deacylase 1,1596,165,1.00 [0.85-1.18],0.9955847583667996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,1622,169,1.24 [0.92-1.66],0.1615179285856195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,1585,165,0.84 [0.63-1.12],0.2368871015941265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,1846,195,1.86 [1.16-2.97],0.0098723551668574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,1627,168,0.93 [0.76-1.14],0.5010391964165248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUOX2,Dual oxidase 2,1827,197,0.94 [0.78-1.15],0.5639176712537681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,1623,169,0.62 [0.43-0.89],0.0093650040743683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP29,Dual specificity phosphatase 29,1585,165,0.94 [0.73-1.21],0.6365390805420679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,1796,193,0.98 [0.83-1.15],0.7967622606842808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1620,168,1.06 [0.93-1.22],0.3778568805375877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DXO,Decapping and exoribonuclease protein,1614,168,1.11 [0.81-1.52],0.5112917162795081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1623,169,1.05 [0.75-1.48],0.7851962865322316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT1,Dynein light chain Tctex-type 1,1585,165,0.94 [0.78-1.13],0.523341531094321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,1623,169,0.96 [0.70-1.31],0.7774565411712958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1839,194,1.02 [0.89-1.16],0.8099333014464101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,1872,196,1.99 [1.37-2.90],0.0003338953230986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECE1,Endothelin-converting enzyme 1,1796,193,0.74 [0.52-1.05],0.0874078975002465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1627,168,1.07 [0.90-1.26],0.4463192609035674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",1575,165,1.06 [0.91-1.23],0.4717170678366791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECI2,Enoyl-CoA delta isomerase 2,1581,166,1.01 [0.79-1.29],0.9380811475660644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECM1,Extracellular matrix protein 1,1597,167,0.93 [0.65-1.34],0.7082334520011426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECSCR,Endothelial cell-specific chemotaxis regulator,1575,168,0.87 [0.62-1.22],0.4082630484570082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1875,196,2.18 [1.69-2.82],1.872530532615614e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,1858,196,1.11 [0.97-1.27],0.1336718515751676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,1623,169,1.00 [0.77-1.31],0.9757597025617312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1581,166,1.56 [1.11-2.19],0.0099758805618862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDF1,Endothelial differentiation-related factor 1,1631,171,1.07 [0.85-1.33],0.5702059819114438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1827,197,1.56 [1.11-2.21],0.0115194516541199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,1575,165,1.82 [1.13-2.92],0.013058051041141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDNRB,Endothelin receptor type B,1578,168,1.06 [0.76-1.46],0.7425826827376617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EEF1D,Elongation factor 1-delta,1627,168,0.99 [0.85-1.16],0.913425121027618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1620,168,1.97 [1.30-2.98],0.0013853654511749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB2,Dynein regulatory complex protein 8,1594,162,1.11 [0.73-1.69],0.6196505487843643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1870,198,1.97 [1.37-2.84],0.0002564505515876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,1631,171,0.98 [0.66-1.45],0.9167595954004796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,1861,194,3.07 [2.16-4.37],4.2156304887863325e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,1833,194,3.71 [2.71-5.09],3.744443845615164e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,1585,165,1.16 [0.94-1.43],0.1567058026340687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGF,Pro-epidermal growth factor,1847,195,1.04 [0.93-1.18],0.4845932946661712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFL7,Epidermal growth factor-like protein 7,1794,193,1.30 [0.96-1.78],0.0915515784836482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFLAM,Pikachurin,1620,168,1.16 [0.73-1.85],0.5222717499447971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,1885,199,3.26 [1.56-6.81],0.0016955893192033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGLN1,Egl nine homolog 1,1858,196,1.08 [0.88-1.31],0.4721021709786347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHBP1,EH domain-binding protein 1,1627,168,0.93 [0.77-1.13],0.4865262433868629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHD3,EH domain-containing protein 3,1575,165,1.00 [0.89-1.14],0.959724787604312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1614,168,0.93 [0.71-1.21],0.5748808878550893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1616,168,1.00 [0.88-1.13],0.9906418117886578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1581,166,0.84 [0.67-1.07],0.1573263340400053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1575,165,1.06 [0.76-1.49],0.7161880954454897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,1839,194,0.99 [0.80-1.24],0.9520309334991572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4E,Eukaryotic translation initiation factor 4E,1578,168,0.92 [0.78-1.08],0.3151874027623877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1860,197,0.97 [0.80-1.17],0.7248520278701611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1882,195,0.98 [0.86-1.12],0.7764161612515542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1631,171,0.95 [0.77-1.17],0.6399625460939118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5,Eukaryotic translation initiation factor 5,1581,166,0.98 [0.70-1.37],0.905346735506825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,1817,191,0.62 [0.40-0.97],0.0381192544449729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,1631,171,1.01 [0.86-1.20],0.8821154581728798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAVL4,ELAV-like protein 4,1575,168,1.00 [0.84-1.19],0.9987483677286784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELN,Elastin,1627,168,1.21 [0.82-1.78],0.3403100146393625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,1846,195,1.01 [0.81-1.25],0.9364432697333108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOB,Elongin-B,1581,166,1.14 [0.81-1.60],0.4483116111844224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,1817,191,1.21 [0.93-1.58],0.1620152338307986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENDOU,Poly(U)-specific endoribonuclease,1489,156,1.00 [0.76-1.31],0.988804877815384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,1885,199,1.96 [0.99-3.89],0.0551531853957141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO1,Alpha-enolase,1854,194,0.95 [0.81-1.12],0.5723759669297506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO2,Gamma-enolase,1868,195,1.00 [0.83-1.20],0.9986577544141172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,1575,165,0.66 [0.52-0.84],0.000619733770695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOPH1,Enolase-phosphatase E1,1623,169,0.93 [0.67-1.29],0.6692803419629929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1581,166,1.05 [0.66-1.68],0.8292372123609475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPEP,Glutamyl aminopeptidase,1581,166,1.04 [0.73-1.49],0.824855468311994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1885,199,1.14 [0.74-1.75],0.555893944023559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1862,196,0.93 [0.71-1.22],0.608757420752811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1575,165,1.83 [1.24-2.70],0.0024608610794788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1796,188,0.96 [0.83-1.11],0.5551495851879332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENSA,Alpha-endosulfine,1623,169,1.04 [0.81-1.35],0.7445917749171973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1794,193,1.07 [0.83-1.38],0.6003086853228532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1827,197,0.85 [0.49-1.50],0.5798480808067881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1827,197,1.52 [0.87-2.65],0.1412696701911509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,1575,165,0.92 [0.75-1.14],0.4535877936910479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EP300,Histone acetyltransferase p300,1578,168,1.05 [0.67-1.64],0.8465885311048598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPB41L5,Band 4.1-like protein 5,1585,165,1.16 [0.95-1.43],0.1530303722924764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPCAM,Epithelial cell adhesion molecule,1854,196,0.98 [0.85-1.13],0.8152450852597478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPGN,Epigen,1623,169,1.05 [0.77-1.43],0.7558818497619664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,1857,194,1.20 [0.84-1.71],0.3114235945146016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA10,Ephrin type-A receptor 10,1796,193,0.91 [0.73-1.14],0.4288234508158888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,1787,189,2.96 [2.18-4.01],2.966401745075791e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,1596,165,1.33 [0.81-2.18],0.2655979542254738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,1885,199,3.49 [2.37-5.15],2.636623522041405e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,1833,194,1.59 [1.10-2.28],0.013156376989106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHX2,Bifunctional epoxide hydrolase 2,1827,197,0.82 [0.66-1.03],0.0890749203452749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPN1,Epsin-1,1594,162,0.93 [0.63-1.38],0.7339375360651847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,1858,196,1.10 [0.95-1.28],0.2084007520288949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPPK1,Epiplakin,1575,165,1.01 [0.84-1.21],0.9002912868104711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1873,195,1.12 [0.78-1.63],0.5348183764054768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,1855,194,0.88 [0.57-1.34],0.5373306761353859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,1850,194,4.04 [2.25-7.28],3.1208348725071137e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,1855,194,4.01 [2.58-6.23],6.838886773108635e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBIN,Erbin,1846,195,0.99 [0.88-1.12],0.8717512800818497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERC2,ERC protein 2,1585,165,1.06 [0.85-1.32],0.587373898940613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERCC1,DNA excision repair protein ERCC-1,1563,161,0.65 [0.38-1.11],0.1125569021575252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EREG,Proepiregulin,1833,194,0.99 [0.85-1.15],0.91385978143946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERI1,3'-5' exoribonuclease 1,1594,162,1.25 [0.83-1.88],0.2935940060210114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,1578,168,1.05 [0.76-1.44],0.763233953162719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1623,169,1.24 [0.82-1.86],0.310585432226481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP29,Endoplasmic reticulum resident protein 29,1596,165,0.99 [0.88-1.12],0.8659139121128416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP44,Endoplasmic reticulum resident protein 44,1842,194,0.80 [0.50-1.27],0.3355979403724667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1581,166,1.36 [1.02-1.81],0.0339539508648334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,1885,199,1.90 [1.35-2.69],0.0002630602902266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESM1,Endothelial cell-specific molecule 1,1855,196,0.98 [0.69-1.37],0.8870416026578513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,1563,161,1.25 [1.00-1.57],0.0551290000426279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESR1,Estrogen receptor,1578,168,0.78 [0.55-1.10],0.1545298872595379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESYT2,Extended synaptotagmin-2,1614,168,1.03 [0.87-1.22],0.7478235986063375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI2B,Protein EVI2B,1563,161,0.93 [0.59-1.48],0.7698057168652723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI5,Ecotropic viral integration site 5 protein homolog,1578,168,0.95 [0.81-1.11],0.4928418989408756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVPL,Envoplakin,1594,162,1.52 [0.98-2.36],0.0585554902364952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,1581,166,0.67 [0.47-0.96],0.0281226478401513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXTL1,Exostosin-like 1,1581,166,0.93 [0.67-1.28],0.6433149444516182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EZR,Ezrin,1868,195,1.01 [0.61-1.68],0.9589746841195896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F10,Coagulation factor X,1634,169,1.09 [0.67-1.78],0.7253824087722223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,1618,169,2.58 [1.68-3.96],1.401178027937558e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11R,Junctional adhesion molecule A,1864,195,1.06 [0.85-1.31],0.6251396370854381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F12,Coagulation factor XII,1639,170,1.24 [0.87-1.76],0.2322137757757832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F13B,Coagulation factor XIII B chain,1631,170,0.98 [0.58-1.66],0.9450583464021524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,1639,170,0.73 [0.27-1.94],0.5285259485853078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,1860,196,1.35 [1.10-1.67],0.0045122339686705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,1861,195,1.89 [1.28-2.80],0.00134058583187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F7,Coagulation factor VII,1870,198,1.04 [0.71-1.51],0.8511875458649801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F9,Coagulation factor IX,1870,197,1.57 [0.79-3.15],0.2013120142884603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",1855,196,1.23 [1.09-1.39],0.0006492112576992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",1860,197,1.16 [1.00-1.33],0.0486893610505484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",1627,168,1.46 [1.15-1.85],0.001696661620439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",1885,199,1.61 [1.32-1.95],1.5793871869455414e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,1865,195,1.09 [0.90-1.31],0.3811095518267139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP6,Gastrotropin,1823,196,1.00 [0.81-1.24],0.980652995682474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP9,Fatty acid-binding protein 9,1858,196,0.88 [0.70-1.10],0.2527529607067417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FADD,FAS-associated death domain protein,1860,197,0.97 [0.82-1.13],0.67214970837767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM13A,Protein FAM13A,1620,168,1.01 [0.82-1.25],0.8918515866922037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171A2,Protein FAM171A2,1631,171,0.96 [0.87-1.05],0.3852600656658267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171B,Protein FAM171B,1623,169,0.74 [0.40-1.37],0.341458706557369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM172A,Cotranscriptional regulator FAM172A,1575,165,1.06 [0.84-1.34],0.6059683165760936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM20A,Pseudokinase FAM20A,1627,168,1.04 [0.63-1.72],0.8834689543876619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,1846,195,1.96 [1.42-2.69],3.427885982947026e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,1859,196,3.16 [2.27-4.41],1.2250136446635056e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,1620,168,1.37 [1.16-1.62],0.0002094498242991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAP,Prolyl endopeptidase FAP,1885,199,0.89 [0.60-1.32],0.5720829172891128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,1585,165,1.00 [0.81-1.23],0.965578033729387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,1883,199,1.55 [1.19-2.01],0.0011605211078774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FASLG,Tumor necrosis factor ligand superfamily member 6,1882,195,1.14 [0.82-1.60],0.4325075612621457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,1634,170,1.09 [0.74-1.60],0.6588251429413527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBN2,Fibrillin-2,1585,165,1.15 [0.89-1.48],0.2779676998189638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",1860,197,0.90 [0.77-1.05],0.1889343307797896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1627,168,1.08 [0.89-1.31],0.4499302572905843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAR,Immunoglobulin alpha Fc receptor,1858,196,1.09 [0.85-1.40],0.5191568070051966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1631,171,1.63 [0.98-2.73],0.0619704783616858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,1864,195,1.45 [1.17-1.80],0.000633867481427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1862,196,1.26 [0.99-1.60],0.0551941440543244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1794,193,0.94 [0.76-1.15],0.5344889868740519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1869,198,0.99 [0.77-1.25],0.9026482690513032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN1,Ficolin-1,1632,169,0.86 [0.69-1.08],0.1978107784311203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,1858,195,0.70 [0.53-0.92],0.0099362403693677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL1,Fc receptor-like protein 1,1860,197,1.15 [0.88-1.50],0.314258790552046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,1869,194,1.46 [1.15-1.85],0.0018948304701501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL3,Fc receptor-like protein 3,1817,191,1.24 [1.00-1.55],0.0550031367497248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL5,Fc receptor-like protein 5,1864,195,1.35 [1.10-1.65],0.0039967073365732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,1858,196,1.00 [0.83-1.21],0.9875677500072364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,1794,193,1.12 [0.91-1.38],0.2704101839408396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX1,"Adrenodoxin, mitochondrial",1581,166,1.12 [0.91-1.38],0.2827052711923987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX2,"Ferredoxin-2, mitochondrial",1581,166,1.19 [0.94-1.51],0.1576552754183977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FEN1,Flap endonuclease 1,1794,193,1.01 [0.84-1.22],0.8825679730255169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FES,Tyrosine-protein kinase Fes/Fps,1794,193,1.01 [0.78-1.32],0.9338725864099332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FETUB,Fetuin-B,1870,197,1.06 [0.71-1.57],0.7889205649891822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGA,Fibrinogen alpha chain,1601,168,1.37 [0.87-2.17],0.1798134054929088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1631,171,1.04 [0.88-1.23],0.6578341642287404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF12,Fibroblast growth factor 12,1578,168,1.23 [0.95-1.58],0.1170308002076447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,1578,168,0.69 [0.49-0.98],0.0389307724998187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF19,Fibroblast growth factor 19,1862,196,0.96 [0.82-1.12],0.619631000279368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF2,Fibroblast growth factor 2,1858,196,1.03 [0.86-1.23],0.7256417043184791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF20,Fibroblast growth factor 20,1578,168,1.05 [0.72-1.53],0.7887106443155546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF21,Fibroblast growth factor 21,1872,196,1.02 [0.93-1.13],0.6534166403712556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,1868,195,1.15 [0.95-1.38],0.1454715911770677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,1578,168,1.35 [0.81-2.27],0.2521187733534479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,1817,191,1.81 [1.34-2.45],0.0001112148010019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF6,Fibroblast growth factor 6,1578,168,1.13 [0.78-1.64],0.5258789880971773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF7,Fibroblast growth factor 7,1563,161,0.85 [0.67-1.09],0.1992932639297008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF9,Fibroblast growth factor 9,1559,161,1.11 [0.79-1.55],0.5503723615903777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,1855,194,0.61 [0.45-0.81],0.0007856211649278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,1634,170,0.61 [0.46-0.82],0.0007752859899241
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,1614,168,0.56 [0.38-0.82],0.0031752386446796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR2,Fibroblast growth factor receptor 2,1855,194,1.45 [0.91-2.31],0.1174067971537638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR4,Fibroblast growth factor receptor 4,1596,165,0.97 [0.74-1.27],0.80479844858335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,1634,169,1.84 [1.49-2.27],1.923114686380924e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGR,Tyrosine-protein kinase Fgr,1796,193,0.96 [0.79-1.18],0.7212669660716807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FH,"Fumarate hydratase, mitochondrial",1575,168,1.00 [0.84-1.19],0.9752387029168136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,1581,166,1.11 [0.82-1.50],0.4888152114407793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,1796,193,0.94 [0.79-1.11],0.4728508372336634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FIS1,Mitochondrial fission 1 protein,1855,194,1.04 [0.89-1.21],0.6408736615215602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1631,171,1.03 [0.89-1.18],0.7308051161284093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1864,194,1.03 [0.93-1.15],0.528997344288602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1839,194,0.99 [0.74-1.32],0.9329034175452228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1839,194,1.05 [0.91-1.20],0.516773062631105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1790,193,1.08 [0.84-1.38],0.5671352358434678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBPL,FK506-binding protein-like,1620,168,1.01 [0.79-1.29],0.9523035019560466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLI1,Friend leukemia integration 1 transcription factor,1794,193,1.01 [0.91-1.13],0.833988015499753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1839,194,1.30 [0.85-1.98],0.2246523451735844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,1845,195,1.21 [0.70-2.11],0.4960779227203117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,1794,193,1.06 [0.69-1.62],0.8060476319153751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,1882,195,1.02 [0.71-1.48],0.8995056203436034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,1855,194,1.16 [0.81-1.67],0.4236086460826537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMNL1,Formin-like protein 1,1796,193,1.00 [0.84-1.20],0.960075185696737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMR1,Synaptic functional regulator FMR1,1794,193,1.04 [0.73-1.49],0.8087477533974154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,1639,170,0.51 [0.30-0.85],0.010521806346755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNDC1,Fibronectin type III domain-containing protein 1,1614,168,0.69 [0.51-0.93],0.0133071218007586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1623,169,1.06 [0.68-1.64],0.7953032029303535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLH1,Glutamate carboxypeptidase 2,1578,168,0.88 [0.73-1.05],0.1550394295745484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,1848,191,2.00 [1.36-2.92],0.0003896482868034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,1868,195,1.10 [0.73-1.66],0.64375034920128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR3,Folate receptor gamma,1852,194,1.00 [0.93-1.06],0.8846758375983655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOS,Proto-oncogene c-Fos,1559,161,0.95 [0.62-1.45],0.8124775924754617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOSB,Protein fosB,1796,193,0.85 [0.59-1.22],0.3791482774225486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXJ3,Forkhead box protein J3,1578,168,0.82 [0.59-1.15],0.2473078359584329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO1,Forkhead box protein O1,1858,196,1.12 [0.97-1.29],0.1213377169574025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO3,Forkhead box protein O3,1794,193,1.14 [1.00-1.30],0.0530886339618794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD4B,FERM domain-containing protein 4B,1581,166,0.96 [0.78-1.18],0.6851239297154351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD7,FERM domain-containing protein 7,1585,165,1.02 [0.67-1.56],0.9293788892894778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRZB,Secreted frizzled-related protein 3,1830,194,0.86 [0.56-1.32],0.4783398847312179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,1575,165,1.40 [1.07-1.83],0.0141841095963502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FST,Follistatin,1860,196,1.19 [0.92-1.55],0.1783039907653325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,1575,165,1.93 [1.04-3.58],0.0379690784872386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,1852,194,1.79 [1.29-2.47],0.0004178998883361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,1613,168,0.89 [0.78-1.03],0.1166297738144727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUCA1,Tissue alpha-L-fucosidase,1876,198,1.04 [0.88-1.23],0.6228640088644021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,1596,165,0.86 [0.70-1.06],0.1538028314686762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,1855,194,0.80 [0.57-1.11],0.1802692693354426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,1787,192,1.17 [0.85-1.61],0.3355072651732964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1589,161,0.94 [0.74-1.20],0.6398760998164282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1868,195,1.33 [1.03-1.72],0.0309777135401289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT8,"Alpha-(1,6)-fucosyltransferase",1839,194,0.97 [0.78-1.20],0.7858115708043447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXN,"Frataxin, mitochondrial",1875,196,1.08 [0.91-1.27],0.3893357921960132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXYD5,FXYD domain-containing ion transport regulator 5,1817,191,1.15 [0.95-1.38],0.146675593852929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FYB1,FYN-binding protein 1,1860,195,1.02 [0.89-1.17],0.7780794274491127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD10,Frizzled-10,1585,165,1.05 [0.82-1.35],0.7134149287654437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD8,Frizzled-8,1575,168,1.13 [0.80-1.60],0.4835665428855978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,1623,169,1.02 [0.76-1.37],0.8938487342617787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1594,162,1.02 [0.83-1.25],0.8790975403100741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1575,168,0.92 [0.71-1.18],0.4971692806414954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD1,Glutamate decarboxylase 1,1563,161,0.75 [0.41-1.35],0.3336780344224274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD2,Glutamate decarboxylase 2,1578,168,0.87 [0.60-1.27],0.4780358629182417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1594,162,0.86 [0.60-1.24],0.4121946876816483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1575,165,1.15 [0.88-1.49],0.305170706339765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAGE2A,G antigen 2A,1563,161,0.81 [0.61-1.09],0.1611857212471593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,1862,196,0.92 [0.76-1.12],0.4143402988649607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1846,195,1.17 [0.76-1.80],0.4848195136597096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1875,196,0.53 [0.34-0.82],0.0050473648737122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1817,191,1.55 [1.17-2.04],0.0019306477678132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1627,168,0.75 [0.46-1.23],0.2544644684262152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,1846,195,2.44 [1.30-4.58],0.005741875773688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAMT,Guanidinoacetate N-methyltransferase,1581,166,0.83 [0.54-1.28],0.4007468557822474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1559,156,1.13 [0.64-1.99],0.6695529146209497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GART,Trifunctional purine biosynthetic protein adenosine-3,1631,171,0.81 [0.43-1.54],0.5178392991145653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,1594,162,0.72 [0.51-1.02],0.0648379032226269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,1878,199,1.55 [0.98-2.47],0.0613682630134327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,1581,166,0.58 [0.42-0.80],0.0009348683439519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,1614,168,1.11 [1.01-1.22],0.0284008094859831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1563,161,0.67 [0.37-1.20],0.1777973095191798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1575,165,1.10 [0.92-1.32],0.2840948833874969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBA,Lysosomal acid glucosylceramidase,1585,165,1.13 [0.87-1.47],0.3507319988831495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,1611,168,1.01 [0.81-1.26],0.9087689674852546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP2,Guanylate-binding protein 2,1817,191,1.03 [0.83-1.28],0.7903281390564465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP4,Guanylate-binding protein 4,1796,193,1.10 [0.86-1.42],0.4403335514661649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP6,Guanylate-binding protein 6,1581,166,1.04 [0.77-1.41],0.7764461074488402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GC,Vitamin D-binding protein,1639,170,1.47 [0.84-2.56],0.1790970363135252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCC1,GRIP and coiled-coil domain-containing protein 1,1614,168,0.98 [0.86-1.12],0.818963580313033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,1794,193,1.24 [1.13-1.37],1.6491423813642433e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1556,160,0.99 [0.75-1.30],0.9335469016088273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCLM,Glutamate--cysteine ligase regulatory subunit,1581,166,0.84 [0.59-1.20],0.3370840789348971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1846,195,2.04 [1.44-2.88],5.643621620792439e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,1885,199,2.31 [1.96-2.72],1.2820524716622973e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,1860,197,1.04 [0.74-1.48],0.8094377391967563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,1796,193,1.18 [0.86-1.63],0.2946123406391377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GET3,ATPase GET3,1627,168,0.72 [0.53-0.98],0.0373141680592197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFAP,Glial fibrillary acidic protein,1792,193,1.00 [0.75-1.32],0.9735582748490188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFER,FAD-linked sulfhydryl oxidase ALR,1794,193,1.00 [0.83-1.21],0.9838377921798044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1794,193,0.96 [0.86-1.07],0.466861116361003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,1872,196,2.97 [2.04-4.31],1.2153796921669845e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,1846,195,1.32 [0.71-2.44],0.38110699140304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,1836,193,1.68 [1.08-2.61],0.0209649247297008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRAL,GDNF family receptor alpha-like,1572,165,1.00 [0.78-1.26],0.9679195184330548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGA1,ADP-ribosylation factor-binding protein GGA1,1796,193,0.84 [0.68-1.05],0.1271541865977065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGACT,Gamma-glutamylaminecyclotransferase,1627,168,0.94 [0.76-1.16],0.5578058954253824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGCT,Gamma-glutamylcyclotransferase,1626,168,0.86 [0.63-1.17],0.329228985913187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,1841,193,0.59 [0.40-0.87],0.0081644797861916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT1,Glutathione hydrolase 1 proenzyme,1861,194,1.01 [0.81-1.27],0.899184203360157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,1839,194,1.89 [1.19-3.00],0.0069175041142772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,1859,196,1.07 [1.00-1.14],0.0516009187690553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH2,Growth hormone variant,1794,193,1.00 [0.92-1.08],0.9065856634189778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,1596,165,0.37 [0.23-0.60],3.957185728313886e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRHR,Growth hormone-releasing hormone receptor,1796,193,1.03 [0.80-1.31],0.8247934476537261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRL,Appetite-regulating hormone,1860,197,0.96 [0.82-1.12],0.597440609147341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,1631,171,1.30 [0.92-1.83],0.139176867811141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,1631,171,1.07 [0.89-1.28],0.4944898056966884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP7,GTPase IMAP family member 7,1596,165,1.07 [0.70-1.63],0.7685179237836359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP8,GTPase IMAP family member 8,1563,161,1.01 [0.74-1.38],0.9495419160918052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,1575,165,1.55 [1.15-2.08],0.0036890353411265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,1614,168,1.69 [1.09-2.62],0.0200629919134443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC3,PDZ domain-containing protein GIPC3,1620,168,1.03 [0.89-1.20],0.6589969590243853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPR,Gastric inhibitory polypeptide receptor,1578,168,1.20 [0.89-1.62],0.2386749504238537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIT1,ARF GTPase-activating protein GIT1,1578,168,0.98 [0.84-1.13],0.757312468567695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,1563,161,0.92 [0.69-1.23],0.5686294562133948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,1752,188,1.05 [0.66-1.65],0.8505788577395318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLA,Alpha-galactosidase A,1591,163,1.35 [0.91-1.98],0.1317567882134767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLB1,Beta-galactosidase,1839,194,1.10 [0.82-1.46],0.5291165639850612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLI2,Zinc finger protein GLI2,1578,168,0.70 [0.40-1.20],0.192610698558518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLO1,Lactoylglutathione lyase,1827,197,1.02 [0.82-1.27],0.8429736167915924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,1853,194,1.00 [0.70-1.43],0.9782279701569544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,1575,168,1.31 [0.89-1.93],0.175052105160046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX,Glutaredoxin-1,1846,196,0.92 [0.74-1.14],0.4265410827426376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1596,165,1.03 [0.88-1.21],0.7310678438227689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1796,193,0.98 [0.75-1.29],0.8768153699152813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLYR1,Putative oxidoreductase GLYR1,1623,169,0.83 [0.63-1.11],0.2104295624557204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,1600,164,1.57 [1.09-2.25],0.0141626199041233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMFG,Glia maturation factor gamma,1627,168,0.99 [0.81-1.21],0.9200587032017302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,1882,195,0.89 [0.69-1.14],0.3400366910559526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR2,GMP reductase 2,1596,165,0.93 [0.74-1.16],0.4935513978293278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNAS,Neuroendocrine secretory protein 55,1631,171,0.87 [0.73-1.04],0.1255856438271928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1794,193,0.95 [0.78-1.16],0.6266727403389665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1585,165,1.08 [0.84-1.39],0.5323088778490304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,1864,195,0.94 [0.77-1.14],0.531668693058369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,1575,165,0.70 [0.42-1.18],0.1841937530080273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,1596,165,0.71 [0.49-1.04],0.0791299052326189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLGA3,Golgin subfamily A member 3,1631,171,1.18 [0.98-1.42],0.0762912430306418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,1868,195,2.01 [1.22-3.30],0.0061874168026129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1858,196,1.04 [0.92-1.17],0.5586289159352307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GORASP2,Golgi reassembly-stacking protein 2,1620,168,0.93 [0.69-1.26],0.6395851331153107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",1634,170,0.61 [0.44-0.84],0.0022165326861607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,1857,196,1.08 [0.74-1.55],0.6969372012901351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BB,Platelet glycoprotein Ib beta chain,1581,166,0.89 [0.71-1.10],0.2824249491391014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1801,197,1.17 [1.04-1.31],0.0112055381035529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP5,Platelet glycoprotein V,1596,165,1.03 [0.68-1.55],0.8979289588920535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP6,Platelet glycoprotein VI,1860,195,1.02 [0.88-1.17],0.8266927720430475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,1846,195,0.88 [0.80-0.97],0.0132006903688818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,1875,196,1.41 [0.94-2.13],0.0984666015739528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,1839,194,0.97 [0.78-1.21],0.7883437510764748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPD1,Glycerol-3-phosphate dehydrogenase,1623,169,0.88 [0.69-1.11],0.2645274787073561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPHA2,Glycoprotein hormone alpha-2,1620,168,1.01 [0.73-1.40],0.9511070968756368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPI,Glucose-6-phosphate isomerase,1634,169,0.97 [0.73-1.30],0.8621229653540567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1620,168,1.26 [1.01-1.56],0.0386295673884971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,1796,193,1.14 [0.78-1.67],0.4877741104793173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,1811,192,2.47 [1.62-3.78],2.814937847073425e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,1575,168,1.07 [0.86-1.32],0.557180012750653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR158,Probable G-protein coupled receptor 158,1631,171,1.33 [0.95-1.88],0.1012541853273179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR15L,Protein GPR15L,1620,168,0.92 [0.74-1.15],0.4640517668801044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,1827,197,1.37 [1.13-1.65],0.0010970092387658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,1623,169,1.07 [0.84-1.35],0.5876563224060278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRAP2,GRB2-related adapter protein 2,1860,197,1.01 [0.92-1.11],0.8690922485829496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1627,168,1.00 [0.80-1.25],0.9790550795030024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",1631,171,0.77 [0.50-1.17],0.2202709901587088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1575,168,0.97 [0.73-1.30],0.8526928775004103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRK5,G protein-coupled receptor kinase 5,1827,197,1.05 [0.86-1.30],0.61465790695129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,1855,194,4.63 [2.84-7.55],7.6012314095457e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRP,Gastrin-releasing peptide,1575,165,0.83 [0.63-1.09],0.187371750964906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",1846,195,1.12 [0.93-1.35],0.2265979168116398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRSF1,G-rich sequence factor 1,1554,161,0.97 [0.81-1.16],0.7102557249348749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSAP,Gamma-secretase-activating protein,1794,193,0.98 [0.83-1.15],0.7918796276424342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,1625,168,0.51 [0.30-0.84],0.0088361972818684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",1624,167,0.58 [0.38-0.90],0.0140863952110273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,1856,197,0.82 [0.72-0.94],0.0033375235208719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,1794,193,0.83 [0.72-0.96],0.0141715339422381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTM4,Glutathione S-transferase Mu 4,1581,166,0.89 [0.71-1.12],0.3199783352312023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTP1,Glutathione S-transferase P,1785,192,1.01 [0.83-1.22],0.9449199122870794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTT2B,Glutathione S-transferase theta-2B,1614,168,0.96 [0.90-1.02],0.1699522065465651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1594,162,1.10 [0.91-1.32],0.3438250840316804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTPBP2,GTP-binding protein 2,1585,165,1.02 [0.85-1.22],0.8354933138048698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,1852,195,1.61 [1.16-2.22],0.0043104896170087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCY2C,Heat-stable enterotoxin receptor,1594,162,0.94 [0.76-1.16],0.573541494381214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUK1,Guanylate kinase,1581,166,1.09 [0.70-1.70],0.7015677527012399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,1876,198,0.86 [0.72-1.02],0.0906201034825719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",1827,197,0.91 [0.79-1.04],0.1632961057179415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMA,Granzyme A,1882,195,1.09 [0.76-1.54],0.6495898264424264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,1858,196,0.88 [0.71-1.08],0.2199559506344952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMH,Granzyme H,1827,197,0.96 [0.81-1.14],0.642917586896653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,H2AP,Huntingtin-interacting protein M,1563,161,0.81 [0.55-1.19],0.2770969823807315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1581,166,1.06 [0.84-1.34],0.642762919072809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1868,195,0.93 [0.78-1.11],0.4332985221348757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAO1,Hydroxyacid oxidase 1,1875,196,0.94 [0.85-1.03],0.1738188807172718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",1864,195,1.02 [0.87-1.20],0.7859269190532839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,1871,195,1.68 [1.47-1.92],1.6953295565873306e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,1864,195,2.23 [1.62-3.05],6.314994842933449e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBEGF,Proheparin-binding EGF-like growth factor,1868,195,1.00 [0.85-1.18],0.982303406714007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,1875,196,0.86 [0.70-1.05],0.1438455909710107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBZ,Hemoglobin subunit zeta,1627,168,0.98 [0.86-1.12],0.7552256699006725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCG22,Protein PBMUCL2,1581,166,1.15 [0.96-1.39],0.1342173696000326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,1882,195,0.90 [0.71-1.13],0.35750038847231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC8,Histone deacetylase 8,1578,168,0.86 [0.63-1.17],0.3311964876119609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC9,Histone deacetylase 9,1575,168,1.14 [0.92-1.40],0.2319072417503481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDDC2,5'-deoxynucleotidase HDDC2,1620,168,0.85 [0.61-1.19],0.34352261904018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGF,Hepatoma-derived growth factor,1872,196,0.97 [0.85-1.12],0.6859036345679113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,1614,168,1.12 [0.90-1.39],0.2989167988131157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEBP1,Heme-binding protein 1,1827,197,0.77 [0.58-1.03],0.0758423383144582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEG1,Protein HEG homolog 1,1596,165,1.65 [0.99-2.73],0.0537290494689487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPACAM2,HEPACAM family member 2,1614,168,0.70 [0.50-0.98],0.0362326797914397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,1627,168,3.23 [1.89-5.50],1.640232244752935e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEXIM1,Protein HEXIM1,1858,196,1.01 [0.86-1.18],0.9259787189473652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGF,Hepatocyte growth factor,1882,195,0.92 [0.66-1.28],0.6330661845769727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,1621,167,2.03 [1.20-3.43],0.0083161127683527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1794,193,0.98 [0.83-1.15],0.7947298649300141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,1614,168,0.96 [0.80-1.15],0.642181485090439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIF1A,Hypoxia-inducible factor 1-alpha,1578,168,1.09 [0.87-1.36],0.4645809492288401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1,Huntingtin-interacting protein 1,1581,166,0.78 [0.49-1.25],0.307103125659359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,1614,168,1.02 [0.79-1.31],0.8781009601172375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HJV,Hemojuvelin,1631,171,1.17 [0.84-1.65],0.3550459450580876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HK2,Hexokinase-2,1827,197,0.75 [0.47-1.20],0.2314012229977317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1631,171,1.62 [1.02-2.55],0.0398831441490293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1854,196,1.57 [1.13-2.17],0.0072453274632796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1858,196,1.94 [1.37-2.75],0.000184099995585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,1875,196,0.78 [0.59-1.04],0.0942469839448308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMCN2,Hemicentin-2,1593,164,1.14 [0.89-1.45],0.3108219637194313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1575,165,1.09 [0.82-1.44],0.5443212600229645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1581,166,1.01 [0.73-1.38],0.9667592755210416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMMR,Hyaluronan mediated motility receptor,1562,161,0.89 [0.64-1.23],0.4731728019086625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,1844,195,1.05 [0.81-1.35],0.7100411395371174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,1796,193,1.04 [0.79-1.36],0.7810851526118924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNF1A,Hepatocyte nuclear factor 1-alpha,1585,165,0.97 [0.81-1.17],0.7646440053948862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNMT,Histamine N-methyltransferase,1826,194,1.07 [0.86-1.35],0.5408285667666077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1822,197,1.04 [0.89-1.22],0.6144379268090631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1631,171,1.08 [0.83-1.42],0.5594641899278958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPCAL1,Hippocalcin-like protein 1,1882,195,0.96 [0.81-1.13],0.5970936141721123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPGDS,Hematopoietic prostaglandin D synthase,1794,193,0.73 [0.52-1.02],0.0626741564896774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPSE,Heparanase,1619,167,1.04 [0.89-1.22],0.593731083358774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRAS,GTPase Hras,1592,162,0.86 [0.71-1.04],0.1287149008265407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1575,165,1.24 [0.81-1.89],0.3273814988365228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRG,Histidine-rich glycoprotein,1631,170,1.67 [1.06-2.64],0.0278012941765993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS1BP3,HCLS1-binding protein 3,1575,165,1.04 [0.89-1.22],0.6226182876316151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1846,195,1.09 [0.79-1.50],0.6098343961344151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1875,196,1.10 [0.77-1.57],0.5860154702693885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1578,168,1.11 [0.76-1.64],0.5851945303764524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,1575,165,1.01 [0.87-1.18],0.848866721263502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1858,196,0.81 [0.61-1.07],0.1357857974847093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1614,168,1.08 [0.87-1.35],0.4771051932882802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,1581,166,1.04 [0.76-1.42],0.7983432258099932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1575,165,1.00 [0.74-1.35],0.9987888804413148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSP90B1,Endoplasmin,1791,192,0.96 [0.78-1.18],0.6817522261200286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA1A,Heat shock 70 kDa protein 1A,1857,194,1.03 [0.87-1.22],0.7183764700539469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,1623,169,0.92 [0.62-1.39],0.7045177741635786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB1,Heat shock protein beta-1,1829,195,0.96 [0.80-1.15],0.6510121846989274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,1875,196,1.23 [0.91-1.65],0.1781644663921309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1856,195,1.56 [1.04-2.34],0.0316239901311189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1A,5-hydroxytryptamine receptor 1A,1575,168,0.98 [0.81-1.19],0.8687457990311579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,1575,168,1.01 [0.72-1.43],0.9517701196731227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTRA2,"Serine protease HTRA2, mitochondrial",1855,194,1.03 [0.85-1.25],0.7892317264588918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,1849,197,1.67 [0.97-2.88],0.0640649845770941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,1885,199,2.61 [1.58-4.30],0.0001644518089506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICA1,Islet cell autoantigen 1,1817,191,1.00 [0.85-1.17],0.9936214233424348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM1,Intercellular adhesion molecule 1,1862,196,1.44 [0.96-2.14],0.0748794628135181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,1885,199,2.20 [1.48-3.29],0.0001104878510107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,1885,199,2.22 [1.49-3.33],0.0001022576466029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM4,Intercellular adhesion molecule 4,1858,196,0.90 [0.71-1.15],0.4109816053642908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM5,Intercellular adhesion molecule 5,1860,197,1.11 [0.85-1.46],0.4361354030398714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,1846,195,1.03 [0.54-1.98],0.9240232622318284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ID4,DNA-binding protein inhibitor ID-4,1594,162,1.04 [0.77-1.42],0.7909643583182313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,1796,193,0.89 [0.67-1.17],0.3894090427715138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDO1,"Indoleamine 2,3-dioxygenase 1",1575,165,1.11 [0.89-1.39],0.3644297479582699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDS,Iduronate 2-sulfatase,1882,195,0.52 [0.14-1.97],0.3343059233634747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDUA,Alpha-L-iduronidase,1875,196,0.95 [0.73-1.24],0.6993701662680554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1570,162,1.26 [0.87-1.84],0.2180051167240621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1594,162,1.08 [0.81-1.44],0.6063471856787899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1594,162,1.13 [0.80-1.61],0.4789613311280442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNAR1,Interferon alpha/beta receptor 1,1620,168,0.89 [0.49-1.64],0.7165928530004895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,1817,191,0.99 [0.89-1.11],0.8608853049516417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,1862,196,2.23 [1.30-3.84],0.0036186240115351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR2,Interferon gamma receptor 2,1839,194,1.25 [1.00-1.56],0.0465669101061144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,1796,193,0.94 [0.71-1.23],0.6289856338398883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL2,Interferon lambda-2,1575,168,1.21 [0.96-1.53],0.1036614244744092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNLR1,Interferon lambda receptor 1,1858,196,1.48 [1.11-1.96],0.0069743767252594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNW1,Interferon omega-1,1581,166,0.77 [0.47-1.26],0.3043884922193088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFT20,Intraflagellar transport protein 20 homolog,1585,165,1.03 [0.75-1.42],0.8673405820504958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGBP1,Immunoglobulin-binding protein 1,1631,171,1.01 [0.80-1.28],0.901374853613429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1575,168,1.07 [0.80-1.44],0.6294062914067958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1634,170,1.01 [0.60-1.69],0.9675965222692856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,1846,195,3.27 [1.89-5.65],2.32224366622116e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1581,166,0.75 [0.51-1.10],0.1436968651886612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,1864,195,1.86 [1.11-3.10],0.0176933419184375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,1882,199,1.20 [1.09-1.32],0.0002234469173575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,1883,199,1.48 [1.25-1.75],5.198243625670355e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,1871,198,0.66 [0.49-0.89],0.0067599537990545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,1834,191,1.87 [1.48-2.36],1.8988949321241146e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,1862,196,1.59 [1.11-2.28],0.0110865284417491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,1885,199,1.90 [1.38-2.62],8.567004252931294e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1860,197,1.10 [0.81-1.50],0.5357097284817975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFL4,Insulin growth factor-like family member 4,1578,168,0.93 [0.74-1.18],0.5638160380055417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,1581,166,1.10 [0.86-1.41],0.4356784392600185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,1634,170,1.71 [1.13-2.58],0.0118153243790373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLON5,IgLON family member 5,1563,161,0.97 [0.80-1.18],0.779884657785516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,1575,165,1.07 [0.76-1.51],0.6939834495261404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,1846,195,1.43 [1.09-1.88],0.0105424385893219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,1860,197,1.75 [1.18-2.57],0.0049027033479397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,1627,168,0.99 [0.85-1.15],0.916053566805348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKBKG,NF-kappa-B essential modulator,1858,196,1.02 [0.89-1.17],0.7736842842192421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKZF2,Zinc finger protein Helios,1794,193,1.04 [0.90-1.19],0.6134933128358019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,1817,191,1.23 [1.08-1.41],0.0022503036173208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RA,Interleukin-10 receptor subunit alpha,1817,191,0.99 [0.80-1.22],0.90859314287516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,1862,196,2.24 [1.52-3.28],4.114823422177203e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL11,Interleukin-11,1817,191,1.04 [0.84-1.27],0.7406282555892456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,1846,195,1.07 [0.92-1.25],0.3926666994636129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,1882,195,1.12 [0.90-1.40],0.3080153052291081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,1817,191,1.34 [0.96-1.87],0.0814145995193766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB2,Interleukin-12 receptor subunit beta-2,1578,168,0.96 [0.67-1.37],0.8283644017451328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13,Interleukin-13,1817,191,0.94 [0.71-1.24],0.6650545140233103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,1827,193,1.68 [1.00-2.84],0.0519862054109321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,1575,168,1.06 [0.63-1.80],0.8167908576225784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,1858,196,1.65 [1.23-2.22],0.0009346370840461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,1817,191,1.70 [1.23-2.33],0.0011358141437127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,1882,195,1.11 [0.84-1.45],0.4697612438986394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17A,Interleukin-17A,1815,191,1.16 [0.89-1.53],0.2747300532964657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,1817,191,1.42 [1.22-1.65],4.481518472582195e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17D,Interleukin-17D,1817,191,1.33 [0.89-2.00],0.1624332667873612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,1817,191,0.97 [0.81-1.17],0.7414062728150216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,1864,195,1.23 [0.93-1.64],0.1491328031515593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,1833,194,1.35 [1.08-1.69],0.008608903989428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,1850,194,1.42 [1.10-1.83],0.0065791042476877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,1871,198,2.28 [1.63-3.19],1.5755965942176967e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,1882,195,1.85 [1.35-2.52],0.0001119259532685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,1820,193,0.89 [0.81-0.96],0.0045891139817152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,1812,194,1.32 [1.14-1.55],0.0003592485746682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,1817,191,0.89 [0.70-1.14],0.3590130344160253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1B,Interleukin-1 beta,1810,190,0.97 [0.78-1.19],0.7476036944243698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,1861,194,6.18 [4.14-9.22],5.015167986895872e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R2,Interleukin-1 receptor type 2,1854,196,2.29 [1.29-4.07],0.0046094369830473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RAP,Interleukin-1 receptor accessory protein,1864,195,1.48 [1.11-1.95],0.0066020218009087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,1883,199,1.36 [1.04-1.78],0.023625230137275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL2,Interleukin-1 receptor-like 2,1817,191,0.99 [0.72-1.37],0.9586153664455844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RN,Interleukin-1 receptor antagonist protein,1848,193,1.04 [0.86-1.26],0.6765313257401415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2,Interleukin-2,1817,191,1.10 [0.73-1.64],0.6568489445396588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20,Interleukin-20,1817,191,0.86 [0.64-1.15],0.3035443692145687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RA,Interleukin-20 receptor subunit alpha,1817,191,1.19 [0.93-1.52],0.1757895867985007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RB,Interleukin-20 receptor subunit beta,1578,168,0.81 [0.57-1.14],0.2239666632697201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL21R,Interleukin-21 receptor,1578,168,0.88 [0.65-1.20],0.414403624758808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,1623,169,1.01 [0.82-1.26],0.8974778293285867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,1817,191,1.24 [0.94-1.64],0.1251761401925812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL24,Interleukin-24,1817,191,1.16 [0.88-1.52],0.2852912684258202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL25,Interleukin-25,1557,161,0.92 [0.59-1.41],0.6915880681682746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,1859,197,1.88 [1.42-2.48],9.402747376559038e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RB,Interleukin-2 receptor subunit beta,1817,191,0.93 [0.64-1.35],0.7087914204791506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,1623,169,1.28 [0.95-1.72],0.1081391290225251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3,Interleukin-3,1563,161,1.01 [0.78-1.31],0.9335754032671026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31,Interleukin-31,1578,168,0.79 [0.59-1.08],0.140983899561056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31RA,Interleukin-31 receptor subunit alpha,1571,166,0.91 [0.62-1.33],0.6266937957018707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL32,Interleukin-32,1858,196,1.01 [0.80-1.27],0.9407243017831532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL33,Interleukin-33,1817,191,1.03 [0.75-1.42],0.8394649990311818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL34,Interleukin-34,1793,192,1.01 [0.70-1.45],0.9601586763780292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36A,Interleukin-36 alpha,1578,168,1.02 [0.82-1.27],0.8753790320292102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36G,Interleukin-36 gamma,1576,168,0.82 [0.64-1.05],0.1120848501033789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3RA,Interleukin-3 receptor subunit alpha,1817,191,1.33 [0.89-2.00],0.1689033059000922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4,Interleukin-4,1817,191,0.95 [0.82-1.10],0.51095327470559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,1858,196,1.93 [1.41-2.64],3.681705487519426e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5,Interleukin-5,1817,191,1.03 [0.94-1.12],0.5784430358373913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,1858,196,1.15 [0.93-1.42],0.1950056794824937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6,Interleukin-6,1846,195,1.00 [0.84-1.18],0.9963261317420942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,1858,196,1.32 [0.92-1.89],0.1334766822425762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,1860,197,2.70 [1.35-5.37],0.0047527696943477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7,Interleukin-7,1858,196,0.95 [0.79-1.16],0.6221164173768163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7R,Interleukin-7 receptor subunit alpha,1864,195,0.99 [0.78-1.26],0.9448224681844026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,1594,162,1.14 [0.89-1.45],0.3151090762666267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1794,192,0.98 [0.79-1.21],0.8226893139744019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,1623,169,1.22 [0.93-1.60],0.1577714298954498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPA1,Inositol monophosphatase 1,1839,194,0.95 [0.78-1.17],0.6372308875549045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,1614,168,0.91 [0.70-1.18],0.4660606376473617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,1575,168,0.98 [0.61-1.58],0.9341785252550214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ING1,Inhibitor of growth protein 1,1790,193,1.06 [0.82-1.36],0.6774175172051552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,1596,165,1.41 [1.09-1.82],0.0084158300024274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBC,Inhibin beta C chain,1864,195,0.88 [0.64-1.20],0.4221875180576507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP1,Inositol polyphosphate 1-phosphatase,1846,195,1.01 [0.80-1.27],0.9358384028968144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1575,165,1.29 [1.01-1.65],0.0443842178172594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1631,171,0.84 [0.56-1.26],0.3993913881898543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1846,195,0.96 [0.85-1.09],0.5735537222675271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL3,Insulin-like 3,1614,168,0.87 [0.73-1.04],0.1211816936447526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,1623,169,1.42 [1.14-1.77],0.0016187816216482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,1620,168,1.12 [0.98-1.29],0.0945609373441129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,1578,168,2.74 [1.26-5.96],0.0109433839555112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,1833,194,1.09 [0.95-1.25],0.2401306406850916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,1846,195,1.03 [0.82-1.29],0.7749652054870312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1827,197,0.97 [0.85-1.12],0.7078887728611972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,1817,191,1.04 [0.87-1.23],0.6907159378617387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK4,Interleukin-1 receptor-associated kinase 4,1858,196,1.01 [0.90-1.14],0.8236195544982158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1761,188,0.91 [0.65-1.28],0.5948954811130103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM1,Isthmin-1,1858,196,0.80 [0.59-1.08],0.1520163461657851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,1634,170,1.22 [0.97-1.54],0.0866187678572501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IST1,IST1 homolog,1608,168,1.01 [0.87-1.18],0.8690637616599778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA11,Integrin alpha-11,1858,196,1.16 [0.81-1.66],0.4218469940864457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA2,Integrin alpha-2,1596,165,0.90 [0.59-1.37],0.6329327527128292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA5,Integrin alpha-5,1864,195,1.65 [1.07-2.55],0.0230138034101573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,1858,196,0.92 [0.73-1.17],0.4993019145606605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAL,Integrin alpha-L,1578,168,0.94 [0.68-1.30],0.7076685944488317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,1864,195,2.14 [1.51-3.05],2.08955754544902e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAV,Integrin alpha-V,1875,196,0.60 [0.30-1.19],0.1402650985276914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAX,Integrin alpha-X,1594,162,0.97 [0.72-1.31],0.8463585083669432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1,Integrin beta-1,1866,198,1.90 [1.10-3.29],0.0219305053470259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP1,Integrin beta-1-binding protein 1,1794,193,1.24 [0.91-1.71],0.1769414037934998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP2,Integrin beta-1-binding protein 2,1827,197,1.02 [0.91-1.14],0.7444757898969583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,1857,198,2.71 [1.89-3.88],5.3523447352734763e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB5,Integrin beta-5,1855,194,1.25 [0.94-1.66],0.1289968626758039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,1817,191,2.07 [1.36-3.15],0.00068512393414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,1875,196,1.44 [1.13-1.85],0.0037469663982173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,1634,170,1.02 [0.76-1.38],0.8932652846109808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1639,170,1.42 [0.71-2.85],0.3268164892388281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1871,198,2.26 [1.66-3.08],2.659553958528027e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1639,170,1.34 [0.79-2.29],0.2769708817415059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1623,169,0.90 [0.63-1.27],0.5383918668233512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITM2A,Integral membrane protein 2A,1858,196,1.19 [0.97-1.46],0.0982983519185811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPA,Inosine triphosphate pyrophosphatase,1581,166,0.88 [0.71-1.09],0.2252110086922046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1575,165,1.09 [0.89-1.32],0.4072142257949278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1575,168,1.07 [0.79-1.46],0.644580533631748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1796,193,0.87 [0.67-1.15],0.3310456919331794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IZUMO1,Izumo sperm-egg fusion protein 1,1563,161,1.12 [0.84-1.51],0.4385023581495477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,1868,195,2.49 [1.66-3.74],1.00062112650871e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,1596,165,1.20 [0.92-1.58],0.1762420845050426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,1817,191,0.95 [0.77-1.17],0.6307968213209572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1563,161,1.13 [0.88-1.46],0.3452288773348693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JPT2,Jupiter microtubule associated homolog 2,1620,168,1.06 [0.90-1.25],0.4881887022583989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JUN,Transcription factor AP-1,1817,191,1.07 [0.83-1.38],0.5922786163450341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1846,195,1.22 [0.91-1.63],0.1790178145955981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZN,Kazrin,1620,168,1.01 [0.88-1.16],0.8915074151427629
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,1575,168,0.72 [0.51-1.01],0.0535591307021623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,1585,165,0.99 [0.80-1.22],0.9041190152181352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,1796,193,0.84 [0.64-1.10],0.2089574288432062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCTD5,BTB/POZ domain-containing protein KCTD5,1590,162,0.99 [0.74-1.32],0.9305084868458756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDM3A,Lysine-specific demethylase 3A,1578,168,0.92 [0.76-1.10],0.355557261163243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,1855,194,1.55 [0.94-2.55],0.0871207809277784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KEL,Kell blood group glycoprotein,1796,193,0.95 [0.67-1.35],0.7774011224377207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,1563,161,1.19 [0.99-1.44],0.0705451221212783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHK,Ketohexokinase,1575,165,0.89 [0.72-1.11],0.3011832222297486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,1614,168,1.05 [0.66-1.67],0.8507339513397978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549,UPF0606 protein KIAA1549,1594,162,0.96 [0.78-1.19],0.7383957094858995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549L,UPF0606 protein KIAA1549L,1594,162,0.78 [0.44-1.37],0.3882153489746539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA2013,Uncharacterized protein KIAA2013,1623,169,0.74 [0.53-1.03],0.0784731314253746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,1581,166,1.08 [0.69-1.71],0.7301764953776086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF20B,Kinesin-like protein KIF20B,1575,168,1.02 [0.86-1.22],0.8128278091204707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF22,Kinesin-like protein KIF22,1581,166,0.96 [0.84-1.08],0.4782006330482355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIFBP,KIF-binding protein,1846,195,1.03 [0.88-1.19],0.7403802804055788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1623,169,1.14 [0.97-1.34],0.1019392197759775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1794,193,1.12 [0.96-1.31],0.1454299639232729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1620,168,1.01 [0.93-1.10],0.7735651072621432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1794,193,1.01 [0.91-1.13],0.7825680246112305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1563,161,0.84 [0.67-1.06],0.1369740819933662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,1575,168,1.06 [0.80-1.40],0.7041291267094334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL2,Kin of IRRE-like protein 2,1796,193,1.16 [0.86-1.55],0.3295555771161603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIT,Mast/stem cell growth factor receptor Kit,1870,197,1.05 [0.70-1.58],0.798246491721765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,1860,197,1.35 [1.00-1.83],0.0534325802849456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,1796,193,1.24 [1.05-1.47],0.0113578229384294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLF4,Krueppel-like factor 4,1575,168,0.93 [0.64-1.35],0.707061553824184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,1631,171,0.84 [0.61-1.14],0.262611547708154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK1,Kallikrein-1,1835,188,1.00 [0.91-1.11],0.9611807628113196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK10,Kallikrein-10,1850,194,1.12 [0.83-1.50],0.4601113820336691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,1833,191,1.97 [1.47-2.64],6.435770471028663e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK12,Kallikrein-12,1794,193,1.02 [0.92-1.12],0.7349265702560961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK13,Kallikrein-13,1800,192,0.92 [0.71-1.19],0.5251846125470883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK14,Kallikrein-14,1875,196,0.96 [0.74-1.25],0.7603335284514534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK15,Kallikrein-15,1621,169,0.97 [0.71-1.33],0.8619852363551808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK3,Prostate-specific antigen,1634,170,0.86 [0.73-1.01],0.0653695461792445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,1875,196,1.51 [1.28-1.78],1.0241152925258606e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK6,Kallikrein-6,1853,194,1.39 [0.94-2.06],0.095590861783081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,1554,159,0.48 [0.32-0.72],0.0003654169390923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK8,Kallikrein-8,1779,185,1.22 [0.87-1.72],0.24861255823503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLKB1,Plasma kallikrein,1603,169,1.47 [0.84-2.58],0.1764399940758927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1882,195,2.58 [1.92-3.46],2.3541439708334924e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1575,168,0.94 [0.72-1.22],0.6350650889559338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,1882,195,1.75 [1.35-2.28],2.3505335964297773e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,1578,168,1.18 [0.92-1.51],0.1986538497408373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,1614,168,1.22 [0.88-1.69],0.2349434437741347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT14,"Keratin, type I cytoskeletal 14",1733,179,0.79 [0.49-1.28],0.3470067669379053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT17,"Keratin, type I cytoskeletal 17",1581,166,1.23 [0.86-1.76],0.250271522888964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT18,"Keratin, type I cytoskeletal 18",1846,195,0.98 [0.86-1.10],0.6913004498615145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",1854,196,1.74 [1.48-2.04],7.693481337347291e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT5,"Keratin, type II cytoskeletal 5",1796,193,0.81 [0.63-1.05],0.1096078698990467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT6C,"Keratin, type II cytoskeletal 6C",1581,166,0.83 [0.54-1.27],0.3906215594070089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT8,"Keratin, type II cytoskeletal 8",1575,168,1.03 [0.92-1.15],0.6587283728179637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,1859,197,0.91 [0.74-1.12],0.3803442666103719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,1882,195,0.75 [0.59-0.94],0.0150461838699655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L1CAM,Neural cell adhesion molecule L1,1855,194,1.34 [0.90-2.01],0.148936002593305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1627,168,1.03 [0.88-1.22],0.7097593457598945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACRT,Extracellular glycoprotein lacritin,1616,169,1.32 [0.96-1.81],0.0910540753694261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,1860,197,0.97 [0.81-1.17],0.7498382284857228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,1846,195,1.65 [1.36-2.01],5.800481265076644e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1855,196,1.63 [1.32-2.01],4.434201313214614e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1839,194,1.04 [0.91-1.18],0.5643424774586929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA1,Laminin subunit alpha-1,1581,166,0.81 [0.58-1.13],0.209113515718312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA4,Laminin subunit alpha-4,1862,196,1.38 [0.97-1.95],0.0714900139625044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,1575,165,1.68 [1.05-2.70],0.0316611927551923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP1,Lysosome-associated membrane glycoprotein 1,1597,167,1.80 [1.05-3.08],0.0322125740386861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP2,Lysosome-associated membrane glycoprotein 2,1795,188,1.02 [0.55-1.92],0.9422090125904606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP3,Lysosome-associated membrane glycoprotein 3,1879,195,1.07 [0.84-1.35],0.592986893057893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,1623,169,0.75 [0.50-1.11],0.1457583329958415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAP3,Cytosol aminopeptidase,1817,191,0.85 [0.65-1.12],0.2598067880368395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LARP1,La-related protein 1,1623,169,0.92 [0.72-1.18],0.5166136920248756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT,Linker for activation of T-cells family member 1,1882,195,1.07 [0.91-1.26],0.4349914481715818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT2,Linker for activation of T-cells family member 2,1846,195,1.03 [0.93-1.13],0.589240417776588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LATS1,Serine/threonine-protein kinase LATS1,1578,168,0.92 [0.78-1.09],0.3463484910849653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,1833,194,2.51 [1.93-3.26],7.684473190593774e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,1871,198,1.26 [1.02-1.55],0.0334373239578882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,1868,195,1.06 [0.89-1.25],0.5338587259499781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCAT,Phosphatidylcholine-sterol acyltransferase,1634,169,0.98 [0.52-1.83],0.9503778334727474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,1631,171,1.40 [1.21-1.62],8.912675984850715e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,1817,194,1.58 [1.20-2.10],0.0013660768509992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,1634,170,0.72 [0.52-0.99],0.0442236673999788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,1863,197,0.82 [0.65-1.03],0.0856045748431291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,1631,171,0.98 [0.85-1.13],0.8207623210405341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LECT2,Leukocyte cell-derived chemotaxin-2,1627,168,1.08 [0.86-1.35],0.5063951797104438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,1872,196,0.97 [0.77-1.22],0.8196568977495147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEG1,Protein LEG1 homolog,1534,163,1.20 [0.98-1.46],0.0721371711145993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LELP1,Late cornified envelope-like proline-rich protein 1,1575,168,0.99 [0.79-1.22],0.899825539640264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEO1,RNA polymerase-associated protein LEO1,1631,171,1.04 [0.64-1.70],0.8744255104678946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,1860,197,0.84 [0.70-1.01],0.0693840411061477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,1860,197,2.52 [1.82-3.49],2.397502173048533e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,1631,171,1.17 [0.92-1.48],0.2003412480466556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,1860,197,1.08 [0.76-1.51],0.6745686773168607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,1866,198,2.22 [1.48-3.33],0.0001190775788213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3BP,Galectin-3-binding protein,1639,170,1.16 [0.76-1.76],0.4904933939368273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,1855,196,1.92 [1.60-2.29],1.1957439419014973e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,1860,191,0.89 [0.66-1.21],0.4646651626244327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS8,Galectin-8,1868,195,1.16 [0.96-1.41],0.1312952000722207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,1858,196,1.68 [1.16-2.43],0.0055469664090095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGMN,Legumain,1862,196,1.53 [1.10-2.13],0.0108695058834875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,1794,193,1.04 [0.90-1.20],0.6048904454077887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1850,193,0.95 [0.77-1.17],0.6138764116170541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIF,Leukemia inhibitory factor,1796,193,0.83 [0.64-1.08],0.1741221497878378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,1858,196,5.31 [3.55-7.94],4.04704606494579e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1864,195,1.08 [0.79-1.48],0.6239876415594358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1634,170,1.01 [0.90-1.13],0.8767510300915378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1581,166,0.85 [0.60-1.20],0.3465870445862663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1859,196,1.54 [1.04-2.28],0.0295226151493892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1627,168,1.12 [0.93-1.35],0.2248421484677002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1885,199,1.14 [0.73-1.76],0.5708546410533555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1881,199,1.51 [1.06-2.17],0.0242620015106205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1817,191,1.45 [1.09-1.91],0.0096328494643609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1885,199,1.12 [0.93-1.35],0.2424413790768617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,1575,165,1.15 [0.93-1.44],0.1979295444913347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB1,Lamin-B1,1615,168,0.94 [0.75-1.19],0.6174324617517246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,1614,168,1.04 [0.64-1.70],0.8788778749113311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,1631,171,1.55 [1.13-2.13],0.0062762139143317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD2,Leiomodin-2,1575,168,1.00 [0.79-1.26],0.9881087610084516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LONP1,"Lon protease homolog, mitochondrial",1575,165,1.14 [0.97-1.34],0.1104005036131094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),1596,168,1.02 [0.94-1.11],0.6990864044195402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,1846,195,1.04 [0.81-1.35],0.739201635005011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPL,Lipoprotein lipase,1860,197,0.81 [0.64-1.04],0.0943507085542288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,1797,189,1.82 [1.53-2.18],1.9058398815059185e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPP,Lipoma-preferred partner,1581,166,1.01 [0.81-1.26],0.9291729185908072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1581,166,1.09 [0.88-1.35],0.4281568346245775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1585,165,1.10 [0.83-1.46],0.504688402504801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRG1,Leucine-rich alpha-2-glycoprotein,1639,170,2.30 [1.37-3.89],0.0017312101093594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1868,195,1.84 [1.28-2.63],0.0008745586327394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1571,167,0.90 [0.53-1.55],0.7123945185073033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,1846,195,1.20 [0.75-1.92],0.4539066283919852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,1860,197,1.65 [1.21-2.25],0.001516507558933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,1585,165,0.80 [0.51-1.28],0.3574529557832901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2BP,LRP2-binding protein,1585,165,0.96 [0.79-1.16],0.6575882365344626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1868,195,1.10 [0.89-1.36],0.4000771588306167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC25,Leucine-rich repeat-containing protein 25,1846,195,0.94 [0.68-1.30],0.7134419189122942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,1620,168,1.37 [0.98-1.92],0.063588857764071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC38,Leucine-rich repeat-containing protein 38,1585,165,1.28 [0.93-1.78],0.1344771935923314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC59,Leucine-rich repeat-containing protein 59,1627,168,0.88 [0.65-1.18],0.3912556918782034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1623,169,1.01 [0.76-1.34],0.9686526097518882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,1817,191,0.66 [0.48-0.91],0.0116575422625811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1585,165,0.79 [0.53-1.19],0.2585045204222376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1631,171,0.82 [0.48-1.40],0.4640789682676665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,1794,193,1.16 [0.93-1.46],0.1913336849581958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,1594,162,0.88 [0.72-1.07],0.2058903503031798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSP1,Lymphocyte-specific protein 1,1858,196,1.15 [0.85-1.57],0.3591012254659584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA,Lymphotoxin-alpha,1858,196,0.94 [0.67-1.30],0.6863004311176959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA4H,Leukotriene A-4 hydrolase,1875,196,0.84 [0.68-1.05],0.1226782320896222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTB,Lymphotoxin-beta,1623,169,1.08 [0.71-1.66],0.7094234648469794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1885,199,2.17 [1.57-2.99],2.3568407314097777e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,1794,193,1.26 [1.04-1.52],0.0168624668657588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1848,194,2.05 [1.45-2.88],3.979745110988043e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTO1,Protein LTO1 homolog,1817,191,1.09 [0.78-1.52],0.6290015374390155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LUZP2,Leucine zipper protein 2,1623,169,1.19 [0.88-1.59],0.2541466474337376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,1829,194,0.90 [0.74-1.09],0.2759542972216708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,1837,192,1.12 [0.82-1.52],0.4747946786636825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY75,Lymphocyte antigen 75,1858,196,1.30 [0.94-1.80],0.1195172133396324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,1832,190,2.20 [1.47-3.28],0.0001275688551369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY96,Lymphocyte antigen 96,1839,194,1.35 [0.99-1.85],0.0612465113387027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYAR,Cell growth-regulating nucleolar protein,1794,193,1.08 [0.86-1.34],0.5107631268325568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYN,Tyrosine-protein kinase Lyn,1846,195,1.07 [0.93-1.24],0.3461321246616583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD1,Ly6/PLAUR domain-containing protein 1,1796,193,0.88 [0.70-1.11],0.278027889977765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,1835,191,1.89 [1.36-2.63],0.0001565816844907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,1794,193,1.40 [1.14-1.71],0.0013588593515732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPLA2,Acyl-protein thioesterase 2,1575,168,0.90 [0.77-1.05],0.1962191210343497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1585,165,0.94 [0.80-1.10],0.4220062710797064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1639,170,1.51 [0.75-3.06],0.2491292308083642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYZL2,Lysozyme-like protein 2,1563,161,0.78 [0.50-1.21],0.2637077879204413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LZTFL1,Leucine zipper transcription factor-like protein 1,1596,165,1.00 [0.82-1.23],0.992212270797644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,M6PR,Cation-dependent mannose-6-phosphate receptor,1575,165,0.98 [0.66-1.44],0.9064237633104196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1831,194,1.12 [0.90-1.38],0.3024402822477223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,1794,193,0.76 [0.53-1.09],0.135049666729153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,1585,165,0.75 [0.55-1.03],0.0721821689344025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,1594,162,1.14 [0.94-1.37],0.18265711336695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGED1,Melanoma-associated antigen D1,1794,193,1.02 [0.78-1.33],0.891202297417658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,1627,168,1.74 [1.22-2.50],0.0023955889950817
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC4,Apical endosomal glycoprotein,1623,169,1.21 [0.94-1.54],0.1325968184484833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1575,165,2.64 [1.47-4.73],0.0011060145213809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN2B2,Epididymis-specific alpha-mannosidase,1627,168,1.02 [0.80-1.31],0.8716277252488628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1563,161,1.20 [0.90-1.60],0.2041762816251812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,1862,196,1.00 [0.90-1.10],0.972094698908464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,1855,194,1.60 [1.06-2.43],0.0258093531401969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC4,MANSC domain-containing protein 4,1581,166,0.93 [0.73-1.17],0.5267400168646725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1575,168,0.82 [0.52-1.31],0.4118414207803712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1581,166,1.14 [0.94-1.38],0.1770749761765996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2,Microtubule-associated protein 2,1614,168,1.13 [0.85-1.50],0.3909818637002624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1620,168,1.11 [0.89-1.39],0.3645019853645049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1858,196,1.03 [0.91-1.17],0.6034642489691648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1794,193,1.01 [0.89-1.16],0.8319255071491269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1833,194,1.01 [0.91-1.13],0.8123520275292619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK13,Mitogen-activated protein kinase 13,1563,161,0.84 [0.58-1.21],0.3505028624864212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK9,Mitogen-activated protein kinase 9,1858,196,1.03 [0.78-1.36],0.8269259869522635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPKAPK2,MAP kinase-activated protein kinase 2,1594,162,1.04 [0.85-1.26],0.7097164962706888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,1563,161,0.96 [0.86-1.08],0.5097018570953862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,1796,193,0.88 [0.69-1.13],0.3214246996494848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARCO,Macrophage receptor MARCO,1860,197,1.23 [0.78-1.94],0.3792507409396185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",1591,163,0.99 [0.83-1.17],0.8981763630306964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MASP1,Mannan-binding lectin serine protease 1,1833,194,0.97 [0.57-1.64],0.9011642410564686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN2,Matrilin-2,1857,196,1.12 [0.76-1.65],0.5619277582424712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,1833,194,0.75 [0.52-1.07],0.1152958469611978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAVS,Mitochondrial antiviral-signaling protein,1794,193,0.98 [0.85-1.12],0.7526815415059148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAX,Protein max,1796,193,1.01 [0.90-1.14],0.8315136801307383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MB,Myoglobin,1885,199,1.00 [0.80-1.24],0.9754651793692106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MBL2,Mannose-binding protein C,1617,169,1.02 [0.89-1.16],0.8109948121338584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,1871,198,1.91 [1.35-2.69],0.0002241754658645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1631,171,0.98 [0.68-1.43],0.9307068175449984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEMP1,Mast cell-expressed membrane protein 1,1578,168,0.95 [0.80-1.12],0.549869174959481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,1847,197,1.12 [0.86-1.46],0.3919182500736602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCTS1,Malignant T-cell-amplified sequence 1,1620,168,0.58 [0.30-1.14],0.1120142360802232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1839,194,1.24 [1.05-1.47],0.0112011717001843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",1624,168,0.83 [0.58-1.19],0.3197878232574115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,1850,194,1.76 [1.43-2.16],1.0366867819242897e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,1585,165,0.88 [0.55-1.40],0.5812398077783008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1575,165,1.10 [0.94-1.28],0.2431340760799878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED18,Mediator of RNA polymerase II transcription subunit 18,1794,193,1.03 [0.88-1.22],0.6986512297208285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED21,Mediator of RNA polymerase II transcription subunit 21,1581,166,0.88 [0.63-1.22],0.4448508167888583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,1855,196,1.26 [0.93-1.71],0.1332965468260542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,1581,166,1.00 [0.60-1.68],0.9885445277459342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,1883,199,1.35 [0.76-2.42],0.305596384740578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MELTF,Melanotransferrin,1627,168,1.03 [0.64-1.67],0.8996057433849947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MENT,Protein MENT,1596,165,1.22 [0.66-2.24],0.5239676235839243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1A,Meprin A subunit alpha,1620,168,1.10 [0.92-1.33],0.2844622709541186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,1860,197,0.96 [0.87-1.06],0.4355334232840849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,1855,196,0.37 [0.25-0.56],1.706109704720895e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,1882,195,1.52 [0.99-2.33],0.0584509022632809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MESD,LRP chaperone MESD,1864,195,1.02 [0.92-1.12],0.757814568690748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,1865,197,2.15 [1.17-3.95],0.0138450355833234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1,Methionine aminopeptidase 1,1796,193,0.76 [0.48-1.19],0.2294591942252853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1858,196,1.10 [0.94-1.27],0.2285101298433436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,1872,196,1.02 [0.81-1.28],0.8495306954265543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3,Microfibril-associated glycoprotein 3,1827,197,0.99 [0.76-1.30],0.9504435059772762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,1585,165,0.82 [0.62-1.09],0.1772831116726879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,1596,165,2.09 [1.38-3.17],0.0005000532428492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP5,Microfibrillar-associated protein 5,1885,199,1.10 [0.83-1.47],0.5085442528085673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,1864,195,1.26 [1.00-1.60],0.0537629274061202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGLL,Monoglyceride lipase,1860,196,1.01 [0.88-1.17],0.8431994303467367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,1858,196,1.03 [0.92-1.14],0.6356166747247819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIA,Melanoma-derived growth regulatory protein,1855,194,0.98 [0.71-1.35],0.9031996399323676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICALL2,MICAL-like protein 2,1585,165,0.87 [0.70-1.09],0.2376227521505192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1858,196,1.02 [0.94-1.11],0.6451959567666707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,1860,194,0.98 [0.81-1.18],0.8189761256590345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,1817,191,1.13 [0.89-1.44],0.3122130816266272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1623,169,0.99 [0.86-1.12],0.8260636700000776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINK1,Misshapen-like kinase 1,1614,168,0.94 [0.81-1.10],0.4632554742776178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MITD1,MIT domain-containing protein 1,1839,194,1.00 [0.88-1.13],0.9527894529681108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MKI67,Proliferation marker protein Ki-67,1578,168,0.90 [0.62-1.32],0.6035521615293442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLLT1,Protein ENL,1563,161,0.86 [0.66-1.11],0.2455394996264878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,1858,196,1.23 [1.07-1.42],0.0032868436745198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MME,Neprilysin,1846,195,1.00 [0.86-1.17],0.9620009694235534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,1812,187,1.25 [1.09-1.45],0.0020916630852545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,1851,195,1.56 [1.30-1.88],2.7165831649877e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,1857,193,1.50 [1.21-1.85],0.0001812961844855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,1796,193,1.05 [0.70-1.58],0.8069481727149084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,1627,168,0.95 [0.66-1.36],0.7817728442925118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,1864,195,1.31 [1.04-1.64],0.0193365701601258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,1826,197,1.71 [1.32-2.22],5.377244334286639e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP8,Neutrophil collagenase,1865,195,1.05 [0.89-1.24],0.5607150789641877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP9,Matrix metalloproteinase-9,1862,195,1.09 [0.89-1.34],0.4019589684704185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1581,166,1.40 [1.06-1.84],0.0175910477763898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MN1,Transcriptional activator MN1,1585,165,0.99 [0.76-1.29],0.9644643753665034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNAT1,CDK-activating kinase assembly factor MAT1,1594,162,0.89 [0.63-1.27],0.5308904424325022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNDA,Myeloid cell nuclear differentiation antigen,1856,197,0.97 [0.86-1.09],0.5556501496879305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOCS2,Molybdopterin synthase catalytic subunit,1596,165,0.96 [0.77-1.19],0.7120775238275756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOG,Myelin-oligodendrocyte glycoprotein,1875,196,1.25 [0.90-1.75],0.1861869682325308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORC3,MORC family CW-type zinc finger protein 3,1614,168,0.81 [0.47-1.39],0.4356931939362353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,1594,162,1.04 [0.73-1.48],0.8128145747327806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L2,Mortality factor 4-like protein 2,1563,161,0.95 [0.64-1.41],0.7957580495849137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORN4,MORN repeat-containing protein 4,1563,161,1.02 [0.86-1.21],0.8110650143479304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPHOSPH8,M-phase phosphoprotein 8,1827,197,1.06 [0.90-1.24],0.4839306192577649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPI,Mannose-6-phosphate isomerase,1846,195,1.01 [0.87-1.16],0.9383457224580988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1860,196,1.02 [0.86-1.20],0.8273874115305444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPO,Myeloperoxidase,1864,195,1.15 [0.89-1.50],0.2789887129767265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,1618,168,0.91 [0.66-1.26],0.5643589382212615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,1634,169,1.44 [0.90-2.33],0.1296110086709793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRI1,Methylthioribose-1-phosphate isomerase,1585,165,0.94 [0.76-1.17],0.5946748172627531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL24,"39S ribosomal protein L24, mitochondrial",1581,166,0.88 [0.57-1.35],0.5592640027621381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL28,"39S ribosomal protein L28, mitochondrial",1631,171,0.84 [0.55-1.29],0.4290774754724427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",1796,193,0.89 [0.55-1.44],0.6357208020614493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",1562,161,1.75 [0.98-3.13],0.0576790574444299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1631,171,1.09 [0.91-1.31],0.3299029419352726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPS16,"28S ribosomal protein S16, mitochondrial",1578,168,0.71 [0.39-1.28],0.253292667610551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLN,Mesothelin,1843,195,1.11 [0.89-1.37],0.3487423661441693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLNL,Mesothelin-like protein,1585,165,0.88 [0.56-1.38],0.5868751970604775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,1864,197,1.28 [1.07-1.53],0.0066997995261354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,1868,195,1.31 [1.01-1.69],0.0427155723972624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,1855,194,0.99 [0.84-1.17],0.9308062327871756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MST1,Hepatocyte growth factor-like protein,1606,166,0.91 [0.72-1.15],0.4378085382913584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,1827,197,0.83 [0.66-1.04],0.1055893532620951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTDH,Protein LYRIC,1578,168,0.99 [0.85-1.15],0.9160144629638068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1614,168,1.07 [0.60-1.88],0.8244300020189548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1594,162,0.99 [0.87-1.13],0.8671579300641217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",1620,168,1.03 [0.88-1.21],0.6780309230448589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTPN,Myotrophin,1827,197,1.05 [0.70-1.57],0.8183695266310853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTR,Methionine synthase,1581,166,0.99 [0.79-1.25],0.9466282861008938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS1,Protein MTSS 1,1620,168,1.03 [0.91-1.17],0.6448609167070881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS2,Protein MTSS 2,1623,169,0.94 [0.82-1.09],0.427428756905638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTUS1,Microtubule-associated tumor suppressor 1,1594,162,0.76 [0.58-0.99],0.0433843541830889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,1796,193,1.70 [1.42-2.03],1.0594518236219285e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC16,Mucin-16,1846,195,0.98 [0.92-1.05],0.5191780084323399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC2,Mucin-2,1634,170,1.18 [1.01-1.37],0.0361410622075732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUCL3,Mucin-like protein 3,1563,161,1.01 [0.71-1.45],0.939358004020896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MVK,Mevalonate kinase,1817,191,1.07 [0.93-1.22],0.349278258545776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MXRA8,Matrix remodeling-associated protein 8,1596,165,0.74 [0.46-1.18],0.2048558987907847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",1627,168,1.09 [0.90-1.31],0.3700473639292937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC2,"Myosin-binding protein C, fast-type",1575,165,0.99 [0.84-1.18],0.9492685042066707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1631,171,1.00 [0.81-1.24],0.9808496161313072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYDGF,Myeloid-derived growth factor,1627,168,1.00 [0.86-1.15],0.9503053751926296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH4,Myosin-4,1581,166,1.09 [0.78-1.51],0.6102674310684921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH7B,Myosin-7B,1563,161,0.86 [0.59-1.27],0.4597017780436436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH9,Myosin-9,1634,170,1.05 [0.92-1.19],0.4852550848594019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1581,166,1.00 [0.70-1.43],0.9977343385557976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,1575,165,1.04 [0.87-1.26],0.643928197676285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,1575,165,1.09 [0.84-1.42],0.5307893117543684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL6B,Myosin light chain 6B,1585,165,1.00 [0.84-1.17],0.9553068151407608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1585,165,1.07 [0.81-1.42],0.611995686927387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO6,Unconventional myosin-VI,1631,171,1.02 [0.71-1.45],0.9261783215123836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO9B,Unconventional myosin-IXb,1817,191,1.00 [0.83-1.20],0.9818559888656876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOC,Myocilin,1864,195,0.94 [0.73-1.22],0.659415505588256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM1,Myomesin-1,1575,168,1.14 [0.85-1.53],0.3916278468635157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,1581,166,1.06 [0.83-1.36],0.6182877735296501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,1596,165,1.03 [0.89-1.19],0.7057870532094987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,1859,196,1.07 [0.84-1.37],0.5597718440208396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,1794,193,0.87 [0.67-1.13],0.306814530279152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA10,N-alpha-acetyltransferase 10,1581,166,0.85 [0.64-1.14],0.2810944938534142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA80,N-alpha-acetyltransferase 80,1585,165,0.99 [0.88-1.11],0.8358296481890352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,1834,194,0.76 [0.61-0.95],0.0176317173550385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NACC1,Nucleus accumbens-associated protein 1,1623,169,1.03 [0.80-1.33],0.8017810558255829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NADK,NAD kinase,1860,197,0.97 [0.78-1.20],0.7960199527157383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGA,Alpha-N-acetylgalactosaminidase,1573,168,1.00 [0.76-1.32],0.9942840525593276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,1573,164,0.89 [0.70-1.13],0.3392257662217133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1596,165,2.69 [1.44-5.01],0.0018233957753269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAMPT,Nicotinamide phosphoribosyltransferase,1794,193,0.98 [0.77-1.24],0.8614139048273362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAP1L4,Nucleosome assembly protein 1-like 4,1619,168,0.98 [0.68-1.41],0.9266481769806102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,1614,168,0.66 [0.42-1.05],0.0800184577890352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",1631,171,1.02 [0.75-1.37],0.9202709324427087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1855,194,2.30 [1.51-3.51],0.0001172717014457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBN,Nibrin,1817,191,1.04 [0.84-1.28],0.7415901989487931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM1,Neural cell adhesion molecule 1,1871,198,0.97 [0.66-1.43],0.885904353989096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM2,Neural cell adhesion molecule 2,1864,195,1.37 [0.87-2.18],0.1759913346811068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,1868,195,0.52 [0.39-0.69],7.758127733964245e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCF2,Neutrophil cytosol factor 2,1855,196,0.99 [0.86-1.14],0.9333606994060514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCK2,Cytoplasmic protein NCK2,1862,196,1.03 [0.92-1.15],0.599802433734277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCLN,Nicalin,1817,191,1.00 [0.77-1.30],0.9941376149321852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,1858,196,2.18 [1.60-2.98],8.831298727852484e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1620,168,1.94 [1.34-2.80],0.000456101410767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,1875,196,1.37 [0.91-2.05],0.1303581328259634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDRG1,Protein NDRG1,1796,193,0.95 [0.77-1.17],0.6273441437016831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1623,169,1.00 [0.80-1.27],0.9697738316254808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1576,168,1.10 [0.73-1.65],0.6488418324187258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1620,168,0.96 [0.82-1.13],0.6176976061481914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1794,193,1.12 [0.94-1.32],0.1952930642478996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEB,Nebulin,1581,166,0.99 [0.64-1.53],0.9515585670147416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,1581,166,0.91 [0.72-1.15],0.4349093998461794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN1,Nectin-1,1578,168,0.77 [0.47-1.25],0.2854742053019531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,1859,196,2.61 [1.86-3.67],3.2055923097820974e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,1855,194,2.06 [1.57-2.71],2.382384569468951e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1578,168,0.90 [0.65-1.24],0.5130675482033671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD9,Enhancer of filamentation 1,1578,168,0.94 [0.61-1.45],0.7862499470225432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,1789,192,2.33 [1.93-2.82],1.0488960379940529e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEK7,Serine/threonine-protein kinase Nek7,1594,162,1.02 [0.84-1.25],0.823680224298288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,1855,194,0.64 [0.50-0.83],0.0005874821185978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL2,Protein kinase C-binding protein NELL2,1862,196,1.36 [0.90-2.05],0.1439400003521171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NENF,Neudesin,1623,169,0.99 [0.87-1.13],0.8891613033098014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEO1,Neogenin,1631,171,1.12 [0.60-2.09],0.7107019722374699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEXN,Nexilin,1634,169,0.98 [0.80-1.19],0.8085616444979399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,1882,195,3.21 [2.25-4.58],1.2322709414313612e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFAT5,Nuclear factor of activated T-cells 5,1578,168,1.05 [0.89-1.24],0.5729762980431119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1858,196,1.00 [0.88-1.13],0.9936599525030216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1817,191,0.95 [0.77-1.16],0.6020015650723581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFE2,Transcription factor NF-E2 45 kDa subunit,1575,165,1.07 [0.88-1.29],0.523210059031703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFIC,Nuclear factor 1 C-type,1631,171,0.82 [0.52-1.27],0.3694642410801046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,1581,166,1.04 [0.85-1.26],0.7313003428369094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,1594,162,0.98 [0.75-1.29],0.9065396033819376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKBIE,NF-kappa-B inhibitor epsilon,1794,193,1.15 [0.90-1.48],0.2516244623983084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1620,168,1.05 [0.91-1.20],0.501716490735101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFX1,Transcriptional repressor NF-X1,1581,166,0.96 [0.78-1.19],0.7239056046800847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFYA,Nuclear transcription factor Y subunit alpha,1581,166,0.78 [0.52-1.18],0.235263051313305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,1839,194,2.32 [0.80-6.71],0.1196273903511515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,1627,168,2.31 [1.61-3.32],5.309554616785256e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGRN,Neugrin,1614,168,1.21 [0.62-2.35],0.5758402281574966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NHLRC3,NHL repeat-containing protein 3,1556,159,1.74 [1.09-2.77],0.0200775076851973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID1,Nidogen-1,1866,196,1.05 [0.75-1.46],0.7732382913045189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID2,Nidogen-2,1864,195,1.02 [0.86-1.21],0.8198212544628977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NINJ1,Ninjurin-1,1794,193,1.12 [0.90-1.40],0.3023930498778214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,1575,165,0.86 [0.61-1.21],0.3865989442505637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT2,Omega-amidase NIT2,1621,167,0.94 [0.76-1.15],0.521269288823399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN1,Neuroligin-1,1585,165,0.99 [0.80-1.23],0.9328999646313731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN2,Neuroligin-2,1575,168,0.96 [0.69-1.33],0.794548908513408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME1,Nucleoside diphosphate kinase A,1578,168,0.63 [0.31-1.30],0.2136599291213762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME3,Nucleoside diphosphate kinase 3,1857,196,1.39 [0.84-2.31],0.1972959849544743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMI,N-myc-interactor,1614,169,0.95 [0.77-1.16],0.5828958578376118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1839,194,1.06 [0.92-1.23],0.4039517782221207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMRK2,Nicotinamide riboside kinase 2,1563,161,0.85 [0.53-1.35],0.4892384495518523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1631,171,1.03 [0.82-1.28],0.8226631080823789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOMO1,Nodal modulator 1,1864,195,0.97 [0.58-1.62],0.9123938540820612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,1581,166,0.95 [0.82-1.09],0.4686598170338213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",1796,193,1.07 [0.86-1.33],0.5609342481244188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS2,"Nitric oxide synthase, inducible",1581,166,0.90 [0.60-1.35],0.6171891399821029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",1796,193,1.15 [0.90-1.47],0.2598298264154226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,1885,199,9.34 [4.45-19.62],3.553641905361824e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,1634,170,1.96 [1.20-3.20],0.0068557687714205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,1885,199,1.11 [0.80-1.54],0.5321464885539204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,1615,164,2.14 [1.40-3.27],0.0004686718310568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,1860,197,1.50 [1.08-2.06],0.0140960538569524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS1,Nephrin,1578,168,0.71 [0.45-1.11],0.1358422348093573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS2,Podocin,1578,168,0.93 [0.79-1.09],0.3708876866099746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPL,N-acetylneuraminate lyase,1627,168,0.99 [0.74-1.34],0.9659491179432654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,1827,197,1.13 [1.03-1.24],0.0101908097743904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPC,C-type natriuretic peptide,1858,196,0.88 [0.71-1.08],0.2205345796404327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,1581,166,0.96 [0.63-1.45],0.8498211490420222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTN,Neuroplastin,1794,193,1.10 [0.94-1.28],0.2296940337763566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,1864,195,1.21 [0.91-1.60],0.1867316800029757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX2,Neuronal pentraxin-2,1634,170,0.85 [0.56-1.29],0.4416550632319108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTXR,Neuronal pentraxin receptor,1860,197,0.78 [0.55-1.09],0.147532597508237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,1875,196,1.23 [1.02-1.48],0.0278900585245273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,1860,197,2.65 [1.85-3.81],1.3202576096285514e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRGN,Neurogranin,1634,169,1.04 [0.89-1.21],0.6508149176211797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRN1,Neuritin,1631,171,0.78 [0.49-1.24],0.2893021419185073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,1875,199,2.23 [1.47-3.40],0.0001844301857103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP2,Neuropilin-2,1864,195,1.10 [0.71-1.71],0.6725838230277933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRTN,Neurturin,1817,191,0.88 [0.68-1.14],0.3397124639344889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRXN3,Neurexin-3,1585,165,0.97 [0.63-1.48],0.8741090868133264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,1868,195,0.94 [0.78-1.14],0.5198873589416709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1627,168,1.08 [0.89-1.32],0.4251778414153291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1614,168,1.08 [0.75-1.55],0.6948833020229087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,1856,196,1.01 [0.88-1.17],0.8848782111284357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5E,5'-nucleotidase,1855,194,0.99 [0.79-1.23],0.9153820787186702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,1858,196,1.59 [1.14-2.22],0.0062813611415528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF4,Neurotrophin-4,1794,193,1.06 [0.75-1.52],0.7309773822504277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK2,BDNF/NT-3 growth factors receptor,1860,197,1.55 [0.97-2.46],0.0670359670010317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK3,NT-3 growth factor receptor,1868,195,1.40 [0.82-2.40],0.2177692551868173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1860,197,1.16 [1.04-1.28],0.0058534933006919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUB1,NEDD8 ultimate buster 1,1858,196,1.06 [0.92-1.23],0.3998208561893319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1623,169,0.96 [0.83-1.13],0.6489756968231064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,1872,196,1.36 [1.00-1.85],0.0512113438946419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDC,Nuclear migration protein nudC,1882,195,0.94 [0.78-1.14],0.5435087328492715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1575,165,1.04 [0.61-1.78],0.8735221981321177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1581,166,0.81 [0.58-1.15],0.2475644832619688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT16,U8 snoRNA-decapping enzyme,1617,168,0.99 [0.84-1.17],0.913219936639361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1846,195,0.81 [0.64-1.01],0.066827247860442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,1864,195,1.12 [0.88-1.42],0.3666485180273392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUMB,Protein numb homolog,1578,168,0.94 [0.80-1.12],0.5091575955037287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUP50,Nuclear pore complex protein Nup50,1581,166,0.82 [0.51-1.32],0.4135006493961537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPE4,NXPE family member 4,1581,166,0.80 [0.48-1.32],0.3859352009250251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,1796,193,0.98 [0.70-1.37],0.8883266346083867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH3,Neurexophilin-3,1578,168,0.69 [0.43-1.12],0.1342489834865653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OBP2B,Odorant-binding protein 2b,1832,194,0.99 [0.81-1.21],0.9126417286881816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,1631,171,1.17 [0.87-1.59],0.3002506608195856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ODAM,Odontogenic ameloblast-associated protein,1793,192,1.04 [0.84-1.29],0.7161185311179337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OFD1,Oral-facial-digital syndrome 1 protein,1594,162,0.89 [0.69-1.14],0.3655441687003677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGA,Protein O-GlcNAcase,1620,168,1.10 [0.90-1.34],0.3731060067227685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGFR,Opioid growth factor receptor,1846,195,0.88 [0.60-1.29],0.5163942629900388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,1864,195,1.76 [1.34-2.30],4.474963421216379e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1594,162,0.97 [0.76-1.25],0.8286418661128385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLFM4,Olfactomedin-4,1533,159,1.09 [0.97-1.24],0.1440128347745711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLR1,Oxidized low-density lipoprotein receptor 1,1851,197,1.09 [0.89-1.34],0.3938190473559397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,1862,196,0.62 [0.48-0.80],0.0001892346980297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,1846,195,0.88 [0.73-1.05],0.1501634007123229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMP,Olfactory marker protein,1575,168,1.00 [0.72-1.38],0.9909765504497112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPHN1,Oligophrenin-1,1614,168,0.99 [0.87-1.13],0.9009244427357952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPLAH,5-oxoprolinase,1575,165,1.10 [0.90-1.36],0.3545394290738558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPTC,Opticin,1846,195,0.91 [0.68-1.23],0.5477553081128681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ORM1,Alpha-1-acid glycoprotein 1,1635,170,1.31 [0.67-2.57],0.433835978232754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,1614,168,0.82 [0.51-1.31],0.4005850116942395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,1857,196,1.35 [0.95-1.93],0.0980511629908326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSM,Oncostatin-M,1852,196,1.02 [0.85-1.21],0.8575336832426567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,1875,199,2.22 [1.19-4.14],0.0121346303814955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSTN,Osteocrin,1585,165,1.16 [0.81-1.64],0.4174374871761438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTOA,Otoancorin,1575,168,1.13 [0.88-1.44],0.3398413140311944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD6B,Deubiquitinase OTUD6B,1620,168,0.99 [0.77-1.26],0.9194244617524014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD7B,OTU domain-containing protein 7B,1631,171,1.03 [0.82-1.28],0.8112827652058053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1575,165,1.07 [0.87-1.31],0.5100725328018438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXT,Oxytocin-neurophysin 1,1868,195,0.98 [0.90-1.07],0.6957847341771715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,1842,194,1.22 [0.89-1.67],0.219783968368037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PACS2,Phosphofurin acidic cluster sorting protein 2,1581,166,0.99 [0.78-1.26],0.9546657162563398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI2,Protein-arginine deiminase type-2,1817,191,1.15 [0.93-1.43],0.1875851772059228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,1793,192,0.97 [0.83-1.14],0.6978451575979598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAEP,Glycodelin,1839,194,0.98 [0.88-1.09],0.7107058222405853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1631,171,0.96 [0.84-1.09],0.5215804830375814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1594,162,1.09 [0.79-1.49],0.6029289012066764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1827,197,1.16 [0.93-1.44],0.2006605315013658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,1575,165,1.28 [0.97-1.70],0.0835349937536517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1559,161,0.90 [0.68-1.21],0.4936612243399865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,1796,193,0.97 [0.79-1.18],0.730859352668028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALLD,Palladin,1578,168,0.86 [0.56-1.32],0.4876003538515302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,1612,168,1.33 [0.86-2.06],0.2004376775395818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,1614,168,1.30 [0.95-1.77],0.1012007359792594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM3,Paralemmin-3,1581,166,0.96 [0.78-1.19],0.7054602980034732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,1877,199,1.08 [0.70-1.68],0.7223517225491386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAMR1,Inactive serine protease PAMR1,1864,195,1.18 [0.75-1.85],0.4779413148184119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,1817,191,0.71 [0.54-0.95],0.0193578833176556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARD3,Partitioning defective 3 homolog,1594,162,0.99 [0.82-1.20],0.9339120784794293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,1864,195,1.00 [0.78-1.27],0.974794775583972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARP1,Poly [ADP-ribose] polymerase 1,1858,196,1.04 [0.86-1.27],0.6606269024094237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAXX,Protein PAXX,1596,165,0.94 [0.69-1.28],0.686595794210025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,1563,161,0.78 [0.49-1.25],0.3098951887176808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,1796,193,0.77 [0.61-0.96],0.0207752583687173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1620,168,0.95 [0.56-1.61],0.8472078340395885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCARE,Photoreceptor cilium actin regulator,1575,168,0.92 [0.77-1.09],0.3254662396460327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1592,164,0.79 [0.61-1.02],0.0714076908728687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBP2,Poly(rC)-binding protein 2,1631,171,1.01 [0.83-1.22],0.9431107401449176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,1874,195,1.76 [0.99-3.12],0.0539288555273143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,1631,171,1.17 [0.69-1.98],0.5547609151410191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,1860,197,1.60 [1.19-2.15],0.0017326472806804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,1620,168,1.49 [1.05-2.10],0.0243263766384807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,1620,168,0.86 [0.57-1.29],0.4687855344740033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDHB15,Protocadherin beta-15,1623,169,1.47 [1.07-2.03],0.0188430504750532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCNA,Proliferating cell nuclear antigen,1563,161,0.91 [0.72-1.16],0.4457076089287719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,1623,169,0.92 [0.66-1.28],0.6263731985472486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,1885,199,1.64 [1.22-2.22],0.0011940188079855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,1620,168,0.99 [0.82-1.20],0.93231549747742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,1627,168,1.03 [0.89-1.19],0.7094112397394167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,1873,196,1.44 [1.11-1.89],0.007027575224534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,1846,195,2.52 [1.73-3.66],1.4778045420511674e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,1868,195,1.06 [0.86-1.31],0.5925290713343565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,1860,197,1.05 [0.86-1.28],0.6138642319829479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCL2,Phosducin-like protein 2,1563,161,0.96 [0.72-1.28],0.7729599528251141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1563,161,0.96 [0.73-1.27],0.7867959872610867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1581,166,0.98 [0.73-1.31],0.8911099836500542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1596,165,1.03 [0.89-1.18],0.7241627659034819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFA,Platelet-derived growth factor subunit A,1885,199,1.06 [0.90-1.26],0.478957467805063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFB,Platelet-derived growth factor subunit B,1862,196,1.05 [0.91-1.21],0.5280265124217849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFC,Platelet-derived growth factor C,1794,193,1.04 [0.68-1.58],0.8554239193487615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,1860,197,1.93 [1.30-2.87],0.0011314321913306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRB,Platelet-derived growth factor receptor beta,1885,199,1.14 [0.80-1.62],0.4692625160559899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA2,Protein disulfide-isomerase A2,1563,161,1.01 [0.71-1.44],0.962988141483437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA3,Protein disulfide-isomerase A3,1596,165,0.96 [0.53-1.74],0.8884239261520512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA4,Protein disulfide-isomerase A4,1634,170,0.98 [0.78-1.23],0.8830704703738418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA5,Protein disulfide-isomerase A5,1563,161,0.79 [0.60-1.04],0.0990366011762182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM5,PDZ and LIM domain protein 5,1631,171,1.00 [0.89-1.12],0.9736192880211216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM7,PDZ and LIM domain protein 7,1862,196,1.02 [0.93-1.13],0.6343044014754011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1794,193,1.10 [0.86-1.41],0.4543496415448604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDRG1,p53 and DNA damage-regulated protein 1,1585,165,0.92 [0.69-1.22],0.5499708842252088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1563,161,0.95 [0.74-1.23],0.6970929214261044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZD2,PDZ domain-containing protein 2,1581,166,0.86 [0.67-1.10],0.2266557101708187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1578,168,0.92 [0.69-1.22],0.5422341240473252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,1885,199,2.80 [1.63-4.81],0.0001841874045699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,1864,195,1.03 [0.83-1.28],0.7774547404218539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECAM1,Platelet endothelial cell adhesion molecule,1864,195,1.30 [0.88-1.93],0.1835643846018564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,1575,165,1.16 [0.68-1.98],0.5942010654890739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PENK,Proenkephalin-A,1596,165,1.10 [0.72-1.69],0.662320410279012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,1634,169,0.46 [0.28-0.74],0.0015477624956157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,1578,168,0.94 [0.83-1.06],0.3253488541668055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PF4,Platelet factor 4,1631,170,1.04 [0.90-1.21],0.5662930458537958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN2,Prefoldin subunit 2,1796,193,0.93 [0.74-1.18],0.5610082770678972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,1563,161,1.08 [0.83-1.41],0.561511985966541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN6,Prefoldin subunit 6,1585,165,1.19 [0.98-1.45],0.0836219937823589
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1842,194,1.07 [0.91-1.26],0.3983811007602451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGA4,Pepsin A-4,1634,169,1.15 [0.96-1.39],0.1389960353357596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1627,168,1.11 [0.86-1.43],0.4248890742434619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,1882,195,1.78 [1.17-2.73],0.0075643576398431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP1,Peptidoglycan recognition protein 1,1881,199,1.11 [0.84-1.47],0.4676122276257074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1621,169,1.60 [0.96-2.67],0.07006155443069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP4,Peptidoglycan recognition protein 4,1581,166,0.99 [0.77-1.28],0.9550499231356616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGM2,Phosphoglucomutase-2,1585,165,0.73 [0.53-1.01],0.0556920837843249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGR,Progesterone receptor,1578,168,0.93 [0.78-1.10],0.3730284126209975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHACTR2,Phosphatase and actin regulator 2,1631,171,0.96 [0.85-1.08],0.4699566717165122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,1620,168,1.24 [0.96-1.60],0.1032254859688309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB2,Pleckstrin homology-like domain family B member 2,1563,161,0.92 [0.77-1.10],0.3424518226921317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1839,194,1.42 [0.93-2.17],0.1063056299637011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1596,165,0.82 [0.59-1.13],0.231574374470284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI16,Peptidase inhibitor 16,1634,169,1.21 [0.68-2.14],0.517536854571085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,1843,197,1.34 [1.10-1.65],0.0042119452668527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1631,171,1.00 [0.83-1.20],0.994442089569745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,1837,191,1.74 [1.31-2.32],0.0001440382258381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1858,196,1.00 [0.82-1.21],0.9909474517292218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1864,195,3.28 [2.33-4.62],8.918987226897544e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1578,168,0.95 [0.72-1.24],0.6844958228570115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1864,195,1.96 [1.46-2.64],9.240539351395547e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1860,197,1.48 [1.17-1.88],0.0009960813684539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1596,165,0.95 [0.76-1.18],0.6308256906223663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PITHD1,PITH domain-containing protein 1,1559,161,0.98 [0.81-1.18],0.8146260778308537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,1627,168,3.29 [1.98-5.47],4.182776023125717e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD2,Polycystin-2,1581,166,0.99 [0.77-1.26],0.90473765754225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKLR,Pyruvate kinase PKLR,1855,194,0.99 [0.83-1.19],0.9326347397913436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKN3,Serine/threonine-protein kinase N3,1594,162,0.95 [0.78-1.17],0.6608821598637415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,1839,194,1.58 [1.28-1.95],1.918085107301712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G15,Phospholipase A2 group XV,1855,194,1.19 [0.78-1.82],0.4082985863256371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G1B,Phospholipase A2,1881,199,1.05 [0.82-1.35],0.6853140928155081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G2A,"Phospholipase A2, membrane associated",1857,196,0.97 [0.78-1.21],0.7910033074498892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G4A,Cytosolic phospholipase A2,1862,196,1.05 [0.91-1.20],0.525491971867066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,1864,195,0.50 [0.38-0.66],1.6719750616233164e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,1883,199,0.83 [0.67-1.03],0.0925296367390982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAU,Urokinase-type plasminogen activator,1864,195,0.72 [0.48-1.08],0.1097841405522256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,1849,196,2.08 [1.39-3.13],0.0004012757637703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",1614,168,0.61 [0.47-0.79],0.0001718786139663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1578,168,0.83 [0.57-1.21],0.325060866703333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1614,168,0.99 [0.85-1.14],0.8378069779872998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,1614,168,1.11 [0.91-1.35],0.3142983862119246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLG,Plasminogen,1605,168,2.10 [1.20-3.68],0.0092240062460678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN1,Perilipin-1,1796,193,0.68 [0.47-1.00],0.0490587175210621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,1860,197,1.11 [0.84-1.47],0.4578650716292063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,1860,197,0.92 [0.77-1.11],0.3797884786771446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLSCR3,Phospholipid scramblase 3,1612,168,1.11 [0.86-1.41],0.423803263699324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLTP,Phospholipid transfer protein,1877,199,0.86 [0.63-1.18],0.3534754071934884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC1,Plexin domain-containing protein 1,1794,193,1.11 [0.73-1.67],0.630132300875197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC2,Plexin domain-containing protein 2,1614,168,1.05 [0.63-1.75],0.8629527567458566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNA4,Plexin-A4,1858,196,1.05 [0.89-1.22],0.5734971940580991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,1878,198,5.81 [4.05-8.35],1.5256364578297559e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB3,Plexin-B3,1852,193,1.03 [0.80-1.33],0.8023392654653002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1853,194,1.00 [0.94-1.07],0.9033173683342952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMCH,Pro-MCH,1581,166,1.09 [0.91-1.31],0.357277882530047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMM2,Phosphomannomutase 2,1581,166,1.01 [0.79-1.30],0.91948328991658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMS1,PMS1 protein homolog 1,1585,165,0.94 [0.70-1.27],0.704834473829498
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMVK,Phosphomevalonate kinase,1794,193,0.99 [0.89-1.10],0.8293437341736711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIP,Pancreatic triacylglycerol lipase,1634,169,1.16 [0.96-1.41],0.1193442920934499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,1614,168,1.05 [0.89-1.23],0.5684644422370202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP2,Pancreatic lipase-related protein 2,1855,196,0.99 [0.95-1.03],0.6592439949834688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA1,Paraneoplastic antigen Ma1,1575,165,1.04 [0.82-1.32],0.7355851979106507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA2,Paraneoplastic antigen Ma2,1575,168,0.94 [0.66-1.35],0.7554481071588112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1817,191,0.95 [0.85-1.07],0.4322772496774371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL,Podocalyxin,1846,195,1.10 [0.49-2.46],0.8128106437798852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL2,Podocalyxin-like protein 2,1855,194,1.48 [0.98-2.24],0.0611905431283612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,1578,168,1.50 [1.19-1.88],0.0004926475411208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,1578,168,0.69 [0.40-1.18],0.1705556115906769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1846,195,1.27 [0.95-1.70],0.1029104371245217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,1575,165,0.95 [0.77-1.17],0.6181151695809446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,1634,169,0.82 [0.53-1.27],0.3760969759948244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON2,Serum paraoxonase/arylesterase 2,1827,197,0.94 [0.67-1.32],0.7160915054607626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,1862,196,0.89 [0.62-1.26],0.5055489935294148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POSTN,Periostin,1634,170,0.81 [0.55-1.18],0.2679129705201533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPBP,Platelet basic protein,1627,170,1.09 [0.91-1.29],0.3533677057798574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,1868,195,0.88 [0.68-1.14],0.3291183828481209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,1869,199,1.05 [0.93-1.20],0.4226548278252141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,1594,162,0.84 [0.63-1.11],0.2142218225385086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1634,170,1.07 [0.87-1.33],0.5127350852839136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPL,Periplakin,1578,168,0.74 [0.47-1.16],0.1870471725987516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1A,Protein phosphatase 1A,1794,193,0.98 [0.66-1.46],0.9226551537352624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1B,Protein phosphatase 1B,1578,168,0.87 [0.65-1.18],0.3784612523594531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1F,Protein phosphatase 1F,1627,168,1.03 [0.79-1.34],0.8225892007359525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,1846,195,1.08 [0.88-1.33],0.4629630427572883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1623,169,0.95 [0.80-1.13],0.583900450751967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1855,194,1.04 [0.92-1.18],0.5264637761706152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1594,162,0.91 [0.72-1.14],0.3958720648232156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1631,171,0.94 [0.78-1.14],0.5535089843892478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1631,171,1.38 [0.99-1.93],0.056573468550281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R2,Protein phosphatase inhibitor 2,1860,197,0.99 [0.85-1.16],0.9317610431852112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R9B,Neurabin-2,1882,195,1.07 [0.94-1.21],0.3294795272650315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1620,168,1.05 [0.94-1.18],0.398868146210489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,1839,194,1.18 [0.89-1.58],0.2488559838285213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPT1,Palmitoyl-protein thioesterase 1,1585,165,0.96 [0.78-1.18],0.6861526945243954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,1846,190,1.27 [1.13-1.43],4.972276642247682e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,1794,193,0.95 [0.75-1.19],0.6498935118118743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAME,Melanoma antigen preferentially expressed in tumors,1563,161,0.60 [0.32-1.12],0.1082992177752838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,1634,170,1.94 [1.31-2.87],0.0010249112858902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRC1,Protein regulator of cytokinesis 1,1623,169,0.57 [0.34-0.95],0.0317172152522921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,1874,198,2.01 [1.45-2.79],2.634337234401618e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX1,Peroxiredoxin-1,1800,193,0.99 [0.86-1.13],0.8437546687477588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,1606,167,0.75 [0.59-0.95],0.0160332566091965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1817,191,1.10 [0.93-1.30],0.2673838802144982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX5,"Peroxiredoxin-5, mitochondrial",1882,195,0.92 [0.77-1.10],0.3755955657673376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,1875,196,0.88 [0.71-1.07],0.2007171399209986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,1817,191,1.28 [0.82-1.99],0.2776444120031485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,1855,196,1.82 [1.03-3.21],0.0380068117164801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,1634,170,1.21 [0.93-1.56],0.1549219719242647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG3,Proteoglycan 3,1634,170,0.93 [0.72-1.21],0.5990077973430861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1817,191,1.05 [0.84-1.31],0.6814339599511597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1585,165,1.08 [0.68-1.71],0.751992072523236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1860,197,1.02 [0.88-1.18],0.7913238151211786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1611,167,0.96 [0.79-1.16],0.649112928205836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKCQ,Protein kinase C theta type,1817,191,0.95 [0.70-1.28],0.7289860782432656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKD2,Serine/threonine-protein kinase D2,1581,166,1.20 [0.88-1.63],0.2415835867299622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKG1,cGMP-dependent protein kinase 1,1596,165,0.95 [0.85-1.07],0.4266771359584004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1794,193,1.13 [0.94-1.35],0.191720767368708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,1868,195,1.14 [0.98-1.32],0.0895979463389896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRND,Prion-like protein doppel,1614,168,0.81 [0.61-1.06],0.1249928252658271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROC,Vitamin K-dependent protein C,1870,197,1.19 [0.74-1.92],0.4650984872325288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROCR,Endothelial protein C receptor,1581,166,1.05 [0.66-1.69],0.827189249593692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROK1,Prokineticin-1,1858,196,1.04 [0.85-1.28],0.6911910806483748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROS1,Vitamin K-dependent protein S,1639,170,0.74 [0.41-1.32],0.3069566095682333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR4,Proline-rich protein 4,1588,165,1.19 [0.97-1.45],0.0896658126465896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR5,Proline-rich protein 5,1578,168,0.77 [0.55-1.09],0.1471535250375115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,1575,165,1.44 [1.04-2.01],0.0300641275671759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS2,Trypsin-2,1871,198,1.06 [0.88-1.29],0.5356516871361405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,1578,168,1.38 [0.89-2.14],0.1506429296091295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,1858,197,2.05 [1.54-2.73],9.089285488830898e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,1614,168,0.71 [0.51-1.00],0.0477163725521129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,1846,193,1.82 [1.37-2.40],2.9638816431621697e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1796,193,1.01 [0.90-1.12],0.92684881139095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,1875,196,1.90 [1.16-3.09],0.0101256000873329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTN3,Myeloblastin,1820,193,1.04 [0.81-1.33],0.7680107704406118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRUNE2,Protein prune homolog 2,1594,162,0.77 [0.45-1.32],0.3398352524917264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,1627,169,2.76 [1.67-4.58],7.636903441373564e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAPL1,Proactivator polypeptide-like 1,1620,168,0.92 [0.70-1.22],0.5608893968473637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSCA,Prostate stem cell antigen,1620,168,1.01 [0.95-1.07],0.7542943137653891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1839,194,1.33 [1.18-1.51],6.326634440884498e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSIP1,PC4 and SFRS1-interacting protein,1858,196,1.06 [0.89-1.26],0.5109781746144013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMA1,Proteasome subunit alpha type-1,1794,193,0.96 [0.72-1.29],0.7943633331281862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMC3,26S proteasome regulatory subunit 6A,1563,161,0.74 [0.44-1.25],0.2579428621489701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,1631,171,0.94 [0.70-1.27],0.7062172670523787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,1585,165,1.14 [0.87-1.49],0.34652745300339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,1846,195,0.86 [0.68-1.08],0.2001421157559258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,1838,194,0.85 [0.60-1.19],0.3395175117096826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,1828,193,0.96 [0.67-1.37],0.8249823179461119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,1858,196,0.88 [0.69-1.13],0.3304367598257602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG4,Proteasome assembly chaperone 4,1578,168,0.92 [0.71-1.18],0.5037837688347869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,1858,196,1.11 [0.98-1.26],0.0934059265357993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,1794,193,1.09 [0.89-1.33],0.4091341552546567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1553,158,1.04 [0.90-1.19],0.5900636519407566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1796,193,0.94 [0.61-1.44],0.7668431155980086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,1855,195,1.88 [1.36-2.60],0.0001526033764374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGES2,Prostaglandin E synthase 2,1567,166,0.97 [0.75-1.27],0.8295178795068127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGR1,Prostaglandin reductase 1,1627,168,0.93 [0.79-1.09],0.3421628135605563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,1585,165,0.79 [0.67-0.94],0.0071166100392862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1858,196,1.23 [0.97-1.55],0.0905376974224002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,1796,193,1.35 [0.97-1.88],0.0750996316205395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTN,Pleiotrophin,1827,197,0.91 [0.71-1.18],0.4808165030238145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,1578,168,0.96 [0.70-1.30],0.7841329471117968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1839,194,1.03 [0.88-1.20],0.7478143194638326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1860,196,1.03 [0.90-1.19],0.6292754646913787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1576,168,0.96 [0.65-1.42],0.8252650835527887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,1627,168,1.87 [1.16-3.02],0.010642880841461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,1634,170,2.03 [1.10-3.77],0.0240890495381292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,1885,199,1.54 [1.01-2.34],0.0462271420936395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,1620,168,1.37 [1.06-1.78],0.0172675720247222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1620,168,1.53 [0.90-2.62],0.1185176330787243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,1854,196,2.31 [1.44-3.72],0.0005601784783976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1831,194,1.60 [1.14-2.25],0.0064587214823926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,1614,168,0.89 [0.61-1.30],0.5540398566593295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,1885,199,1.19 [0.73-1.95],0.488022379362529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1627,168,1.06 [0.66-1.70],0.8048501576369874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1596,165,0.90 [0.71-1.16],0.4205174669839118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,1790,190,0.91 [0.75-1.09],0.3059009422314869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTTG1,Securin,1594,162,1.17 [0.83-1.65],0.3796145177981281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,1858,196,1.30 [0.99-1.69],0.0561222600447886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVALB,Parvalbumin alpha,1866,195,0.93 [0.84-1.03],0.1796205837096587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,1868,195,1.49 [1.14-1.94],0.0035507173921077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXDNL,Peroxidasin-like protein,1623,169,0.76 [0.55-1.05],0.0994407673295638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,1796,193,0.94 [0.73-1.21],0.6136779398379398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYDC1,Pyrin domain-containing protein 1,1575,165,0.78 [0.53-1.16],0.2190647640984061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,1581,166,1.42 [1.25-1.62],5.3638181360062187e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PZP,Pregnancy zone protein,1639,170,0.81 [0.60-1.10],0.1821534556676006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,1852,196,0.80 [0.60-1.07],0.1301705996212679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,1869,198,2.29 [1.44-3.63],0.0004224665056768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QSOX1,Sulfhydryl oxidase 1,1601,166,1.37 [0.96-1.94],0.0803456711250128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB10,Ras-related protein Rab-10,1627,168,0.93 [0.71-1.22],0.6139018456704541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB11FIP3,Rab11 family-interacting protein 3,1627,168,1.02 [0.90-1.16],0.7573184779297581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB27B,Ras-related protein Rab-27B,1627,168,0.97 [0.81-1.16],0.7310050626850446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB2B,Ras-related protein Rab-2B,1623,169,0.91 [0.72-1.14],0.4175107105853332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB33A,Ras-related protein Rab-33A,1581,166,1.00 [0.81-1.24],0.9680617073439932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB37,Ras-related protein Rab-37,1817,191,0.97 [0.83-1.14],0.7320438458226748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB39B,Ras-related protein Rab-39B,1581,166,0.95 [0.79-1.16],0.6335754652540813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1575,168,1.12 [0.89-1.43],0.3333574372420662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB44,Ras-related protein Rab-44,1623,169,0.91 [0.66-1.26],0.5726452593357338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,1858,196,0.85 [0.65-1.11],0.2242283807464827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6B,Ras-related protein Rab-6B,1796,193,1.02 [0.78-1.35],0.8642503792000927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEP1,Rab GTPase-binding effector protein 1,1596,165,0.97 [0.80-1.17],0.7711719624012143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEPK,Rab9 effector protein with kelch motifs,1794,193,0.95 [0.75-1.20],0.6647281709330848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,1817,191,0.96 [0.78-1.18],0.700489963344465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAC3,Ras-related C3 botulinum toxin substrate 3,1585,165,1.15 [0.92-1.44],0.2107848514580766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD23B,UV excision repair protein RAD23 homolog B,1794,193,0.90 [0.69-1.19],0.46722367688777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD51,DNA repair protein RAD51 homolog 1,1594,162,1.17 [0.92-1.47],0.1991039702314405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALB,Ras-related protein Ral-B,1578,168,0.82 [0.49-1.37],0.4551309963119156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALY,RNA-binding protein Raly,1623,169,0.97 [0.72-1.33],0.8674972517507297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP1,Ran-specific GTPase-activating protein,1575,165,1.05 [0.79-1.40],0.7306538776636529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,1575,168,0.96 [0.60-1.54],0.876543036344422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANGAP1,Ran GTPase-activating protein 1,1794,193,0.98 [0.74-1.29],0.8905097471950985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAP1A,Ras-related protein Rap-1A,1578,168,0.83 [0.65-1.07],0.1471525083780488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,1594,162,1.07 [0.82-1.40],0.6081878644868528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,1794,193,1.38 [1.01-1.89],0.0418293923137638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,1875,199,1.24 [0.99-1.55],0.056225137000284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASA1,Ras GTPase-activating protein 1,1796,193,0.87 [0.58-1.29],0.4860561006586742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1563,161,0.93 [0.64-1.36],0.7213799678918182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASSF2,Ras association domain-containing protein 2,1794,193,1.08 [0.90-1.30],0.4177503746414139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,1631,171,1.89 [1.36-2.62],0.0001342003892396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,1809,194,0.68 [0.54-0.85],0.0008839943815639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM17,Splicing factor 45,1631,171,1.07 [0.89-1.30],0.4547170377114837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM19,Probable RNA-binding protein 19,1581,166,1.20 [0.88-1.65],0.2513513281448726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM25,RNA-binding protein 25,1563,161,0.95 [0.67-1.32],0.744683102607432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,1585,165,1.11 [0.93-1.33],0.2411821613532423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,1846,195,1.25 [1.08-1.46],0.0035542320818509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP5,Retinol-binding protein 5,1846,195,0.99 [0.82-1.19],0.8905244432290744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,1620,168,1.26 [1.03-1.54],0.0226330840418052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS,RNA-binding protein with multiple splicing,1578,168,1.02 [0.81-1.28],0.8878694137212656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS2,RNA-binding protein with multiple splicing 2,1575,165,1.02 [0.89-1.17],0.7932266065836262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCC1,Regulator of chromosome condensation,1623,169,0.98 [0.73-1.32],0.907936650865219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,1827,197,1.27 [1.01-1.59],0.0390284606902814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1575,165,2.02 [1.03-3.94],0.0394836834187375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REEP4,Receptor expression-enhancing protein 4,1631,171,0.98 [0.78-1.22],0.8332375692979834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,1857,196,2.17 [1.79-2.62],1.2371032095099193e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,1885,199,1.74 [1.45-2.07],8.876079660849586e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,1885,199,1.49 [1.25-1.78],1.2780772262632164e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,1623,169,0.82 [0.56-1.19],0.2939334137778787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,1857,196,2.23 [1.84-2.70],3.696183863421405e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELB,Transcription factor RelB,1578,168,0.75 [0.52-1.08],0.1258143150155857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1864,195,1.75 [1.17-2.63],0.0062971996910622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,1860,197,1.62 [1.45-1.80],4.661874375341631e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REPS1,RalBP1-associated Eps domain-containing protein 1,1578,168,0.99 [0.67-1.46],0.9602650260521874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REST,RE1-silencing transcription factor,1563,161,1.17 [0.78-1.75],0.452362502179696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1846,195,1.06 [0.77-1.45],0.735527488868829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RETN,Resistin,1864,199,1.25 [0.96-1.63],0.0963840788385451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REXO2,"Oligoribonuclease, mitochondrial",1581,166,0.86 [0.58-1.28],0.4587545005268063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RFC4,Replication factor C subunit 4,1623,169,0.89 [0.46-1.72],0.721942573917802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGCC,Regulator of cell cycle RGCC,1631,171,0.98 [0.81-1.18],0.8246538075079635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1594,162,1.00 [0.78-1.28],0.9819777492621302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,1868,195,1.49 [1.02-2.18],0.0381545153985149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,1868,195,1.39 [0.89-2.15],0.1445660718212565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS10,Regulator of G-protein signaling 10,1631,171,0.97 [0.76-1.23],0.7913819652799616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,1817,191,0.97 [0.80-1.18],0.791460575270685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RHOC,Rho-related GTP-binding protein RhoC,1830,194,1.02 [0.92-1.13],0.7400698684869909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RICTOR,Rapamycin-insensitive companion of mTOR,1578,168,0.79 [0.53-1.16],0.2263991500938302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1596,165,0.99 [0.77-1.27],0.9296822679303888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,1868,195,0.92 [0.76-1.13],0.4310429908625053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILPL2,RILP-like protein 2,1627,168,1.00 [0.86-1.15],0.9901433964322366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1581,166,1.15 [0.95-1.39],0.1480399251195448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,1631,171,1.06 [0.84-1.34],0.6173261701534365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN2,Prorelaxin H2,1594,165,0.98 [0.83-1.15],0.7785772421119203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,1634,169,2.00 [1.22-3.29],0.0061699627438189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,1575,165,1.33 [1.03-1.72],0.0283002798363411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE3,Eosinophil cationic protein,1854,197,0.99 [0.89-1.10],0.7886071661024933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,1573,161,2.01 [1.19-3.41],0.0093474331362807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,1615,165,1.63 [1.21-2.20],0.0013773748024058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASEH2A,Ribonuclease H2 subunit A,1631,171,0.85 [0.62-1.16],0.3021252576115066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,1879,199,3.01 [2.00-4.52],1.1429193852392405e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,1575,165,2.77 [1.89-4.08],2.112040749739199e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF168,E3 ubiquitin-protein ligase RNF168,1578,168,0.75 [0.49-1.15],0.18689589613608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF31,E3 ubiquitin-protein ligase RNF31,1578,168,0.69 [0.43-1.12],0.1357904484002989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF4,E3 ubiquitin-protein ligase RNF4,1594,162,0.79 [0.60-1.03],0.0869140199683226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF41,E3 ubiquitin-protein ligase NRDP1,1794,193,0.96 [0.79-1.16],0.6798439145157232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF43,E3 ubiquitin-protein ligase RNF43,1594,162,1.07 [0.83-1.39],0.6020268012284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,1575,165,0.92 [0.75-1.12],0.4031830088937376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,1857,196,1.58 [1.04-2.41],0.0318313246199716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO2,Roundabout homolog 2,1868,195,0.71 [0.42-1.21],0.210177312594467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO4,Roundabout homolog 4,1575,165,3.04 [1.35-6.87],0.0074961595275235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1860,197,1.44 [1.01-2.05],0.0431011136727904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RP2,Protein XRP2,1846,195,0.88 [0.67-1.17],0.3855384613316109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPA2,Replication protein A 32 kDa subunit,1578,168,1.14 [0.75-1.73],0.5450315980552319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPE,Ribulose-phosphate 3-epimerase,1594,162,0.96 [0.78-1.18],0.6669816590279238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,1585,165,0.85 [0.57-1.25],0.3987705697103354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPL14,60S ribosomal protein L14,1575,165,1.02 [0.70-1.47],0.9345519467372412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPS10,40S ribosomal protein S10,1581,166,1.23 [0.91-1.67],0.1730592172583188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRAS,Ras-related protein R-Ras,1585,165,1.02 [0.91-1.14],0.7287173912410467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,1794,193,1.09 [0.88-1.36],0.4297521723845461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1794,193,1.06 [0.88-1.27],0.5588342024144155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRP15,RRP15-like protein,1575,168,1.09 [0.91-1.31],0.3545324472028767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO1,R-spondin-1,1839,194,1.07 [0.75-1.54],0.7117948233784415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,1875,196,1.40 [0.93-2.11],0.1072815641789761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTBDN,Retbindin,1846,195,1.09 [0.73-1.62],0.6657393275577341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTKN2,Rhotekin-2,1581,166,1.09 [0.82-1.45],0.5356824298159734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1631,171,1.06 [0.91-1.24],0.4441534616043838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,1875,196,1.79 [1.26-2.56],0.0012403682813286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RUVBL1,RuvB-like 1,1794,193,0.97 [0.85-1.11],0.6578138501010136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RWDD1,RWD domain-containing protein 1,1868,195,1.00 [0.82-1.22],0.980948179741734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RYR1,Ryanodine receptor 1,1581,166,0.83 [0.52-1.32],0.4254319451655203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A11,Protein S100-A11,1842,196,1.03 [0.81-1.31],0.8294445370929271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A12,Protein S100-A12,1828,194,1.09 [0.92-1.30],0.2977007158452192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A13,Protein S100-A13,1578,168,0.61 [0.39-0.94],0.0265751297775173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,1631,171,0.62 [0.45-0.85],0.0031208655760925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,1793,192,0.87 [0.70-1.08],0.2193706035742701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A3,Protein S100-A3,1623,169,0.86 [0.60-1.23],0.4100469117700493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,1855,194,0.94 [0.76-1.16],0.5538657254382107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,1631,171,0.54 [0.38-0.76],0.0004110543562287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,1827,197,1.33 [1.11-1.60],0.0016675731647891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,1639,170,0.93 [0.57-1.52],0.7814160933689613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAFB2,Scaffold attachment factor B2,1631,171,1.33 [0.81-2.18],0.266910472967285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAG,S-arrestin,1575,168,0.87 [0.63-1.21],0.4116279351206886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,1858,196,1.14 [0.96-1.34],0.1314346570104988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAP18,Histone deacetylase complex subunit SAP18,1594,162,1.21 [1.04-1.42],0.016446794847225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SARG,Specifically androgen-regulated gene protein,1623,167,1.04 [0.92-1.19],0.5229126167769111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,1581,166,1.22 [0.88-1.68],0.2388410536318793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT1,Diamine acetyltransferase 1,1581,166,0.88 [0.62-1.24],0.4536718282301779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,1594,162,0.89 [0.72-1.11],0.3035181525950631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SATB1,DNA-binding protein SATB1,1631,171,0.84 [0.49-1.45],0.5333439247002312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SBSN,Suprabasin,1632,169,0.81 [0.55-1.21],0.3042168937854196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCAMP3,Secretory carrier-associated membrane protein 3,1846,195,1.01 [0.87-1.18],0.856625770054764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,1868,195,2.76 [1.91-3.99],6.024596247521794e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB1,Scavenger receptor class B member 1,1796,193,0.96 [0.74-1.23],0.7310299212247036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,1806,194,2.19 [1.57-3.03],2.980540270470787e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,1885,199,1.33 [1.01-1.76],0.0407001237357383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,1868,195,2.33 [1.57-3.45],2.494635868449756e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,1865,195,2.45 [1.75-3.44],1.9719028363611002e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,1857,196,1.13 [0.78-1.62],0.5191170591708892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,1856,195,1.27 [1.01-1.60],0.040201473620433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB2A2,Mammaglobin-A,1581,166,0.79 [0.44-1.41],0.4305784980846699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A1,Secretoglobin family 3A member 1,1596,165,0.95 [0.53-1.71],0.8635211867064152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A2,Secretoglobin family 3A member 2,1860,196,1.15 [1.00-1.32],0.0569237470499505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,1817,191,1.98 [1.58-2.47],3.181705430389187e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCIN,Adseverin,1575,168,0.93 [0.76-1.13],0.4703786245078317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,1868,195,0.77 [0.61-0.96],0.0221078872919008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2A,Sodium channel protein type 2 subunit alpha,1575,168,0.76 [0.54-1.08],0.127835152375361
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2B,Sodium channel subunit beta-2,1585,165,0.96 [0.54-1.72],0.891616357311495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3A,Sodium channel protein type 3 subunit alpha,1585,165,0.91 [0.60-1.39],0.6686023499679314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3B,Sodium channel subunit beta-3,1575,168,0.98 [0.69-1.40],0.9271607750181846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,1575,165,1.25 [0.92-1.70],0.1590000763438515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCP2,Non-specific lipid-transfer protein,1794,193,1.02 [0.86-1.21],0.8096338255350175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,1572,163,1.29 [0.97-1.72],0.0767569981841057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRG1,Scrapie-responsive protein 1,1627,168,0.88 [0.53-1.48],0.6399924261837613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRIB,Protein scribble homolog,1575,165,1.08 [0.92-1.26],0.3480303882740798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRN1,Secernin-1,1858,196,1.27 [1.02-1.59],0.0343067313408822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,1585,165,1.14 [0.83-1.56],0.4221014764606565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC1,Syndecan-1,1860,197,1.15 [0.86-1.54],0.3427746038461091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,1860,197,0.89 [0.69-1.15],0.3739884431324815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDCCAG8,Serologically defined colon cancer antigen 8,1623,169,0.98 [0.87-1.12],0.7954625107511808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDHB,Succinate dehydrogenase,1620,168,1.05 [0.84-1.31],0.6596153409325426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDK2,Protein sidekick-2,1596,165,1.13 [0.76-1.67],0.5489314076937026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEC31A,Protein transport protein Sec31A,1575,165,1.04 [0.86-1.26],0.6634874134508991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,1575,165,1.52 [1.10-2.11],0.0121700386171637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,1885,199,1.50 [1.20-1.87],0.0003287937153075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELENOP,Selenoprotein P,1639,170,1.42 [0.74-2.71],0.2933466172069186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,1639,170,1.01 [0.55-1.84],0.9808708853115922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELP,P-selectin,1871,198,1.17 [0.94-1.44],0.1583441645208855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELPLG,P-selectin glycoprotein ligand 1,1858,196,1.58 [1.06-2.35],0.025502830429965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,1860,197,1.47 [0.96-2.26],0.0744594169997663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,1596,165,1.35 [1.01-1.80],0.0395176666604431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4C,Semaphorin-4C,1846,195,1.30 [0.99-1.72],0.0577332567286465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4D,Semaphorin-4D,1868,195,1.24 [0.81-1.89],0.315694342350129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA6C,Semaphorin-6C,1578,168,0.69 [0.36-1.32],0.2656278896077634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,1883,199,2.68 [1.91-3.77],1.1996827769511427e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN3,Neuronal-specific septin-3,1631,171,0.87 [0.71-1.05],0.1460362967590748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN7,Septin-7,1594,162,0.81 [0.57-1.16],0.255763659922488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,1609,168,1.18 [0.82-1.68],0.3717419118768827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN9,Septin-9,1846,195,1.12 [0.73-1.72],0.6113585386228888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,1605,167,11.16 [1.83-68.00],0.0088664476793467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA11,Serpin A11,1885,199,1.06 [0.79-1.43],0.677100191555454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,1821,193,0.95 [0.87-1.04],0.242340161188755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA3,Alpha-1-antichymotrypsin,1632,170,1.63 [0.65-4.12],0.3009702464979453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA4,Kallistatin,1603,168,1.46 [0.79-2.68],0.225992843608861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA5,Plasma serine protease inhibitor,1610,168,1.01 [0.64-1.59],0.9696654917419316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,1639,170,4.19 [1.85-9.47],0.0005810235198209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA7,Thyroxine-binding globulin,1639,170,1.60 [0.76-3.38],0.2138165205367583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA9,Serpin A9,1834,194,0.97 [0.82-1.14],0.6889678895635003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB1,Leukocyte elastase inhibitor,1858,194,1.03 [0.90-1.18],0.6747139571226752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB5,Serpin B5,1827,197,0.92 [0.72-1.18],0.5034540114696355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB6,Serpin B6,1861,194,1.05 [0.85-1.29],0.6473959980859155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB8,Serpin B8,1882,195,1.01 [0.83-1.23],0.9222166333701738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB9,Serpin B9,1839,194,1.02 [0.68-1.51],0.9349525619955122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,1634,170,5.16 [2.06-12.95],0.0004708818527419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPIND1,Heparin cofactor 2,1634,170,1.48 [0.91-2.41],0.1153066829360729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,1885,199,0.98 [0.81-1.18],0.8412735321238336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE2,Glia-derived nexin,1627,168,0.97 [0.78-1.20],0.7845405905754237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF1,Pigment epithelium-derived factor,1609,168,1.60 [0.93-2.74],0.0902020999110009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF2,Alpha-2-antiplasmin,1598,168,2.70 [1.01-7.23],0.0485840612081412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPING1,Plasma protease C1 inhibitor,1634,170,3.59 [1.71-7.57],0.0007598474130785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINH1,Serpin H1,1594,162,0.97 [0.87-1.08],0.5797128980809036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,1591,163,0.56 [0.34-0.92],0.0231812189648561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI2,Serpin I2,1620,168,1.11 [0.89-1.40],0.3552400997049997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1796,193,0.90 [0.74-1.10],0.2967496308299468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,1831,193,0.67 [0.44-1.04],0.0745871968063455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,1585,165,1.07 [0.66-1.73],0.7796321396395727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,1855,194,1.83 [1.19-2.82],0.0058046970103754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L2,Seizure 6-like protein 2,1846,195,0.89 [0.54-1.48],0.6570683784499096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,1846,195,1.00 [0.85-1.19],0.9587856575159794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,1831,194,1.26 [0.94-1.69],0.12604470379108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP4,Secreted frizzled-related protein 4,1596,165,0.66 [0.47-0.94],0.0206789745565078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,1794,193,1.08 [0.88-1.33],0.4747315160172934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA2,Pulmonary surfactant-associated protein A2,1794,193,0.80 [0.62-1.03],0.0810757518096878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPD,Pulmonary surfactant-associated protein D,1860,197,1.07 [0.89-1.29],0.4823601435184759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SGSH,N-sulphoglucosamine sulphohydrolase,1606,168,1.16 [0.91-1.49],0.2279469236055443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2B3,SH2B adapter protein 3,1794,193,1.00 [0.88-1.13],0.9968289931284698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2D1A,SH2 domain-containing protein 1A,1858,196,1.12 [0.91-1.39],0.2797243512579379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1575,168,1.03 [0.81-1.32],0.8078885036360018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BP1,SH3 domain-binding protein 1,1620,168,0.73 [0.52-1.01],0.0558955308325031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,1582,162,0.95 [0.80-1.13],0.5658631884125491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,1614,168,1.00 [0.80-1.24],0.9984985923122558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,1634,169,0.98 [0.76-1.25],0.8631560001687104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHC1,SHC-transforming protein 1,1563,161,0.94 [0.81-1.09],0.3943408546928559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHD,SH2 domain-containing adapter protein D,1576,166,1.09 [0.96-1.24],0.1865328429945749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHH,Sonic hedgehog protein,1578,168,0.85 [0.60-1.22],0.3825649196291513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,1634,170,1.67 [1.07-2.59],0.0235309655687697
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",1860,196,1.03 [0.89-1.19],0.6758921306517761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHPK,Sedoheptulokinase,1594,162,1.08 [0.76-1.53],0.6614989579573202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIAE,Sialate O-acetylesterase,1852,194,1.27 [0.98-1.64],0.0705050842993452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,1862,196,1.74 [1.32-2.29],6.994099233188384e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,1858,196,2.12 [1.50-3.00],1.948145707251378e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,1796,193,0.99 [0.83-1.18],0.9412486980577118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,1864,195,1.05 [0.95-1.16],0.3097049827653729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,1875,196,3.27 [2.23-4.81],1.612851502721469e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,1860,197,1.96 [1.30-2.95],0.0013562579109473
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,1575,165,1.21 [0.90-1.63],0.215400916467572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,1871,195,0.91 [0.62-1.33],0.6225274902440983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIL1,Nucleotide exchange factor SIL1,1575,165,1.13 [0.74-1.75],0.5646891602466126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1866,198,1.22 [0.97-1.55],0.0932147541936976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,1850,194,1.87 [1.44-2.42],2.589330792720453e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,1578,168,1.01 [0.84-1.21],0.9363220867344092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,1846,195,0.98 [0.85-1.13],0.8092099671534474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1796,193,0.91 [0.70-1.17],0.4418762334197984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,1817,191,1.18 [0.93-1.49],0.1645644624275238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP1,Src kinase-associated phosphoprotein 1,1833,194,1.14 [0.95-1.37],0.1562312337418331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP2,Src kinase-associated phosphoprotein 2,1862,196,1.01 [0.90-1.14],0.8210689241255563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKIV2L,Helicase SKI2W,1581,166,0.93 [0.63-1.38],0.7238188216202395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLA2,Src-like-adapter 2,1631,171,1.02 [0.89-1.16],0.7803253661342257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,1817,191,1.23 [0.98-1.53],0.0714917766003493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF6,SLAM family member 6,1794,193,1.51 [1.16-1.97],0.0025653336264236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,1858,196,1.38 [1.12-1.71],0.0027740429312094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,1794,193,1.26 [0.99-1.61],0.0584287998327784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC12A2,Solute carrier family 12 member 2,1581,166,1.13 [0.66-1.92],0.6593410972408145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,1623,169,1.12 [0.91-1.37],0.2838553817697564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,1796,193,1.03 [0.84-1.28],0.7514827993462707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,1585,165,0.85 [0.60-1.19],0.3429341946540837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC27A4,Long-chain fatty acid transport protein 4,1796,193,0.96 [0.80-1.16],0.660200602435475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC28A1,Sodium/nucleoside cotransporter 1,1563,161,1.23 [1.00-1.52],0.053012972914046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,1563,161,0.78 [0.54-1.14],0.2016967647204204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,1796,193,1.63 [1.17-2.27],0.0035167988894921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A5,Zinc transporter ZIP5,1858,196,1.07 [0.87-1.31],0.5248313556805784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC44A4,Choline transporter-like protein 4,1585,165,0.91 [0.71-1.17],0.4732682910825204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,1634,170,1.18 [0.87-1.61],0.2890188509710756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC51B,Organic solute transporter subunit beta,1581,166,0.98 [0.78-1.23],0.8803982393056735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1596,165,0.97 [0.82-1.14],0.6938598281919968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1620,168,1.10 [0.86-1.43],0.4437816074883555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1563,161,1.00 [0.77-1.29],0.9989965533592966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIT2,Slit homolog 2 protein,1796,193,0.88 [0.68-1.14],0.3280466884110259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,1578,168,0.55 [0.35-0.86],0.0093601195522933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,1875,196,1.41 [1.04-1.91],0.0286410920350372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,1827,197,1.69 [1.31-2.20],7.606699504735942e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLK,STE20-like serine/threonine-protein kinase,1594,162,0.71 [0.54-0.94],0.0152118878772864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLMAP,Sarcolemmal membrane-associated protein,1620,168,1.11 [0.95-1.31],0.1921880807640634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,1619,168,0.85 [0.55-1.32],0.4683104258186625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD1,Mothers against decapentaplegic homolog 1,1794,193,1.03 [0.89-1.19],0.6655818484069524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD2,Mothers against decapentaplegic homolog 2,1623,169,0.98 [0.80-1.19],0.8102760559396935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD3,Mothers against decapentaplegic homolog 3,1623,169,0.93 [0.71-1.22],0.6126694996393727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,1846,195,0.92 [0.49-1.71],0.7819944472011346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,1796,193,0.94 [0.78-1.12],0.4736407857257507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMC3,Structural maintenance of chromosomes protein 3,1563,161,0.99 [0.73-1.34],0.9269876141340048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,1620,168,1.05 [0.85-1.30],0.6439088199410026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,1875,196,1.45 [1.00-2.09],0.0480991681765639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,1862,196,1.90 [1.44-2.50],5.759021472530177e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,1851,193,0.99 [0.78-1.27],0.9681531006757392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD3,Sphingomyelin phosphodiesterase 3,1578,168,0.95 [0.72-1.25],0.7081476764912783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1857,194,0.86 [0.71-1.04],0.1127991579793592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1623,169,0.81 [0.64-1.02],0.0704483681204318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMS,Spermine synthase,1575,168,1.03 [0.83-1.28],0.8079987324531545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMTN,Smoothelin,1611,168,1.00 [0.87-1.16],0.962296631985454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP23,Synaptosomal-associated protein 23,1860,197,0.96 [0.83-1.10],0.5379825847413074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP25,Synaptosomal-associated protein 25,1575,168,1.15 [0.86-1.52],0.3498426520639136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP29,Synaptosomal-associated protein 29,1855,194,1.00 [0.88-1.14],0.9941142753335728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,1631,171,0.80 [0.63-1.02],0.0748013543187234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,1596,165,0.88 [0.78-1.00],0.0448299401108527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,1839,194,1.23 [1.02-1.49],0.0303843260037327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1575,165,1.71 [1.16-2.53],0.0069280059469524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',1614,168,1.05 [0.79-1.39],0.7418470454760205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNU13,NHP2-like protein 1,1581,166,0.93 [0.72-1.19],0.545241633859298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,1596,165,0.88 [0.67-1.15],0.3458057680820807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX18,Sorting nexin-18,1620,168,1.35 [1.01-1.79],0.0419527633429867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX2,Sorting nexin-2,1623,169,1.01 [0.84-1.20],0.9550654144174944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,1575,165,1.35 [0.87-2.08],0.1805545640191716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,1860,197,1.02 [0.85-1.21],0.8611451732148931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],1831,196,0.97 [0.75-1.26],0.8470906742120667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",1864,195,0.76 [0.57-1.01],0.0563957468970606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD3,Extracellular superoxide dismutase,1634,169,0.96 [0.77-1.21],0.7374788752299846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORBS1,Sorbin and SH3 domain-containing protein 1,1631,171,0.80 [0.53-1.21],0.2947925167662635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,1794,193,1.35 [0.98-1.88],0.0694483737786743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,1864,195,0.74 [0.64-0.87],0.0001347680282602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORT1,Sortilin,1859,196,1.22 [0.89-1.67],0.22284085623266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOST,Sclerostin,1859,196,1.03 [0.75-1.40],0.8622563112937744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1585,165,1.05 [0.77-1.42],0.7700998335567028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX2,Transcription factor SOX-2,1630,171,0.85 [0.44-1.64],0.6226228832908064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,1585,165,1.50 [0.84-2.67],0.1721968978993562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1631,171,0.89 [0.55-1.46],0.6545063289393073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPAG1,Sperm-associated antigen 1,1631,171,1.00 [0.78-1.27],0.9687143852669972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARC,SPARC,1855,194,1.12 [0.94-1.34],0.2168076002754406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARCL1,SPARC-like protein 1,1858,197,1.65 [1.03-2.63],0.0364692335072805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPART,Spartin,1596,165,0.99 [0.82-1.20],0.9216910329023104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPESP1,Sperm equatorial segment protein 1,1627,168,1.19 [0.74-1.90],0.4705904819652581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,1864,195,2.17 [1.78-2.65],2.1178031642221292e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,1596,165,1.37 [1.00-1.86],0.0486550342157601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,1858,196,1.93 [1.64-2.27],1.2289207204934876e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK5,Serine protease inhibitor Kazal-type 5,1864,195,1.26 [0.88-1.80],0.2141196906228135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK6,Serine protease inhibitor Kazal-type 6,1875,196,1.06 [0.84-1.32],0.6394630147895961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK8,Serine protease inhibitor Kazal-type 8,1581,166,0.97 [0.65-1.43],0.8623444100600364
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,1857,193,1.55 [1.01-2.39],0.043982168292066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,1862,196,1.80 [1.35-2.40],7.015532012183801e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,1620,168,0.96 [0.88-1.05],0.4036384745634193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,1839,194,0.42 [0.27-0.66],0.0001757580899687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,1857,196,2.26 [1.70-3.02],2.6100871139536507e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,1850,194,1.69 [1.21-2.35],0.0021889009796911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPP1,Osteopontin,1883,199,1.07 [0.83-1.37],0.6149342852604065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1578,168,0.79 [0.55-1.13],0.1930020070915162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRING1,SREBP regulating gene protein,1563,161,1.00 [0.78-1.28],0.9980297679914524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,1594,162,0.83 [0.67-1.03],0.0878956083720548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR3,Small proline-rich protein 3,1614,168,0.98 [0.79-1.20],0.8208019210087736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRY2,Protein sprouty homolog 2,1817,191,1.00 [0.88-1.14],0.992443460209076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1575,168,1.02 [0.66-1.59],0.912302777647794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTLC1,Serine palmitoyltransferase 1,1614,168,0.85 [0.56-1.31],0.4644763580211087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRC,Proto-oncogene tyrosine-protein kinase Src,1850,193,1.03 [0.93-1.14],0.6241240917200397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRP14,Signal recognition particle 14 kDa protein,1846,195,0.96 [0.79-1.18],0.7159082990807545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPK2,SRSF protein kinase 2,1858,196,1.09 [0.95-1.25],0.2187414836128907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPX,Sushi repeat-containing protein SRPX,1627,168,1.24 [0.84-1.84],0.2802411787488371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSB,Lupus La protein,1796,193,0.97 [0.76-1.23],0.783724741810969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1578,168,1.03 [0.71-1.51],0.8596089559256466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1859,196,0.88 [0.80-0.97],0.0080357986269124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1871,198,1.02 [0.77-1.36],0.8840032503596716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,1563,161,0.63 [0.35-1.13],0.119618115033885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,1620,168,1.04 [0.79-1.36],0.777501135334275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,1596,165,0.83 [0.64-1.09],0.1781638153240217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1846,195,1.59 [1.27-1.99],5.443345839046018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1885,199,1.56 [1.04-2.33],0.0324363527539835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1578,168,0.66 [0.43-1.02],0.0635292252282995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAB2,Stabilin-2,1634,170,1.29 [0.76-2.17],0.3440024039017592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAM,Signal transducing adapter molecule 1,1623,169,0.71 [0.46-1.09],0.1164866261728488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAMBP,STAM-binding protein,1833,194,0.95 [0.78-1.15],0.5804653353909532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT2,Signal transducer and activator of transcription 2,1578,168,0.98 [0.82-1.17],0.8219314534374655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,1846,195,0.97 [0.89-1.06],0.5529566951151937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1563,161,1.02 [0.82-1.26],0.8908765763108015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,1868,195,1.47 [1.14-1.90],0.0032063786010487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,1862,195,1.57 [0.96-2.59],0.0742012556250922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STEAP4,Metalloreductase STEAP4,1575,168,0.93 [0.75-1.15],0.517463588206658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STIP1,Stress-induced-phosphoprotein 1,1860,194,1.01 [0.84-1.22],0.8966861574331916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK11,Serine/threonine-protein kinase STK11,1827,197,1.01 [0.85-1.19],0.95021036460687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK24,Serine/threonine-protein kinase 24,1796,193,0.97 [0.79-1.19],0.7887206904691393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK4,Serine/threonine-protein kinase 4,1860,197,1.00 [0.87-1.15],0.9756124535396036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STOML2,"Stomatin-like protein 2, mitochondrial",1563,161,0.93 [0.79-1.10],0.3884597193018102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX16,Syntaxin-16,1794,193,0.96 [0.76-1.20],0.7013104105338579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX1B,Syntaxin-1B,1585,165,0.92 [0.61-1.41],0.7131306372796751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX3,Syntaxin-3,1614,168,0.77 [0.48-1.22],0.268994560126355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX4,Syntaxin-4,1846,195,1.02 [0.83-1.25],0.8515915327645741
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX5,Syntaxin-5,1578,168,0.94 [0.66-1.32],0.7080816037645907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX6,Syntaxin-6,1794,193,1.05 [0.86-1.27],0.6282990944172584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX7,Syntaxin-7,1578,168,0.98 [0.71-1.35],0.8863804380610256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX8,Syntaxin-8,1858,196,1.09 [0.85-1.40],0.4994233106630935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP1,Syntaxin-binding protein 1,1631,171,0.95 [0.79-1.13],0.5580367395677732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP3,Syntaxin-binding protein 3,1794,193,0.89 [0.66-1.19],0.4372758255151109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGP1,SURP and G-patch domain-containing protein 1,1620,168,1.04 [0.74-1.46],0.8022725873459333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGT1,Protein SGT1 homolog,1794,193,1.00 [0.86-1.17],0.960273413946138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT1A1,Sulfotransferase 1A1,1868,195,1.00 [0.91-1.10],0.945908574170961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT2A1,Bile salt sulfotransferase,1858,196,1.00 [0.85-1.19],0.973103770821742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF1,Formylglycine-generating enzyme,1578,168,0.99 [0.80-1.22],0.9097232564402083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1868,195,1.15 [0.91-1.46],0.2476636549747826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUOX,"Sulfite oxidase, mitochondrial",1631,171,0.85 [0.69-1.05],0.1402867030105996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD1,Sushi domain-containing protein 1,1827,197,1.07 [0.82-1.40],0.6075853928857873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,1864,195,1.62 [1.08-2.41],0.0185399832242871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD4,Sushi domain-containing protein 4,1623,169,1.02 [0.73-1.44],0.9042482071507876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,1589,164,1.32 [0.88-1.96],0.1756422569446252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SV2A,Synaptic vesicle glycoprotein 2A,1585,165,1.22 [1.00-1.50],0.0542863818687252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SWAP70,Switch-associated protein 70,1620,168,1.05 [0.71-1.55],0.7968404793933018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,1596,165,0.87 [0.68-1.11],0.2673654301865383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1575,168,1.02 [0.79-1.33],0.8628415131532016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYT1,Synaptotagmin-1,1614,168,1.10 [0.73-1.65],0.6614673243362543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYTL4,Synaptotagmin-like protein 4,1627,168,0.96 [0.79-1.16],0.6606175845932274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1594,162,1.01 [0.88-1.16],0.9071453711357328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACC3,Transforming acidic coiled-coil-containing protein 3,1846,195,0.99 [0.89-1.10],0.8494656344051743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,1646,171,2.89 [1.89-4.41],9.30230879366417e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TADA3,Transcriptional adapter 3,1623,169,0.99 [0.69-1.40],0.9337360912855096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,1846,195,1.60 [1.20-2.15],0.0015211252987076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAGLN3,Transgelin-3,1563,161,1.03 [0.81-1.31],0.8210148679223468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TALDO1,Transaldolase,1631,170,0.94 [0.68-1.31],0.7312111214988275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TANK,TRAF family member-associated NF-kappa-B activator,1817,191,1.04 [0.87-1.24],0.7039185468280399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAP1,Antigen peptide transporter 1,1594,162,0.93 [0.71-1.21],0.57730800968356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARBP2,RISC-loading complex subunit TARBP2,1796,193,1.01 [0.86-1.19],0.8755333927409927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1585,165,1.08 [0.89-1.30],0.434407441945981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1623,169,0.80 [0.53-1.20],0.2783744468893351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAX1BP1,Tax1-binding protein 1,1614,168,1.03 [0.82-1.28],0.8121748841450729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,1796,193,0.92 [0.68-1.23],0.5617663059640696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D23,TBC1 domain family member 23,1846,195,1.01 [0.88-1.16],0.8932444230799993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D5,TBC1 domain family member 5,1858,196,0.97 [0.83-1.14],0.7487404692112983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCA,Tubulin-specific chaperone A,1596,165,0.99 [0.84-1.18],0.93162566026628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCB,Tubulin-folding cofactor B,1839,194,1.00 [0.88-1.13],0.9889065835351454
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCC,Tubulin-specific chaperone C,1839,194,1.00 [0.86-1.17],0.9921280987175228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,1794,193,1.03 [0.89-1.19],0.6980271642243339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBR1,T-box brain protein 1,1585,165,1.01 [0.75-1.35],0.964765729986112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,1838,194,0.90 [0.80-1.02],0.08766268828457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1B,T-cell leukemia/lymphoma protein 1B,1827,197,0.97 [0.82-1.15],0.7090727192287021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN1,Transcobalamin-1,1591,163,0.86 [0.55-1.34],0.5153554443573856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,1883,199,2.27 [1.65-3.14],5.814581729506914e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCOF1,Treacle protein,1627,168,1.21 [0.80-1.84],0.3719183698233904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,1594,162,0.95 [0.73-1.22],0.6729379879855304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCTN3,Tectonic-3,1627,168,0.90 [0.55-1.47],0.6664374533537939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDGF1,Teratocarcinoma-derived growth factor 1,1796,193,1.00 [0.91-1.09],0.9567375051220236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDO2,"Tryptophan 2,3-dioxygenase",1585,165,0.84 [0.57-1.24],0.387771310254362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,1623,169,0.93 [0.75-1.15],0.4828231267772388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDRKH,Tudor and KH domain-containing protein,1796,193,0.97 [0.84-1.13],0.7051825397974973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEF,Thyrotroph embryonic factor,1581,166,0.89 [0.63-1.27],0.5308966278484726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,1855,194,1.96 [1.16-3.30],0.0118697726350591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TERF1,Telomeric repeat-binding factor 1,1578,168,0.79 [0.46-1.33],0.3658326164164798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TET2,Methylcytosine dioxygenase TET2,1592,162,0.96 [0.81-1.13],0.6151486347001444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX101,Testis-expressed protein 101,1585,165,1.07 [0.81-1.40],0.651211972471897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX33,Testis-expressed protein 33,1594,162,1.11 [0.74-1.64],0.6184235140397689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TF,Serotransferrin,1639,170,1.24 [0.65-2.36],0.5228354117219506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFAP2A,Transcription factor AP-2-alpha,1575,168,1.09 [0.87-1.38],0.4436569178780242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,1854,194,1.47 [1.30-1.67],5.34778340801568e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,1860,196,1.91 [1.60-2.27],3.5287678289534334e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,1857,198,1.82 [1.49-2.21],2.498409071192349e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI,Tissue factor pathway inhibitor,1864,196,1.03 [0.70-1.52],0.8658085860763455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI2,Tissue factor pathway inhibitor 2,1853,194,1.33 [1.07-1.65],0.009233386846259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,1873,199,1.19 [0.86-1.64],0.2869471754667486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TG,Thyroglobulin,1623,169,1.03 [0.90-1.17],0.678280041274109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,1858,196,1.44 [1.14-1.82],0.0024340089578077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB1,Transforming growth factor beta-1 proprotein,1879,195,1.20 [0.89-1.62],0.2408421687479459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB2,Transforming growth factor beta-2 proprotein,1623,169,0.92 [0.71-1.20],0.5525741448733033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1858,196,0.55 [0.36-0.86],0.0086655363500407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR1,TGF-beta receptor type-1,1578,168,0.70 [0.33-1.48],0.3474031260211807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,1855,194,2.06 [1.59-2.67],3.418711603522967e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,1885,199,1.36 [0.92-2.03],0.1256400446674102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,1854,195,0.90 [0.76-1.07],0.2348514317820552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,1634,169,2.06 [1.25-3.40],0.004618679564879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,1559,161,0.94 [0.78-1.13],0.5009066292565172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,1860,197,1.93 [1.31-2.84],0.0008842839322912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,1864,195,1.22 [0.95-1.57],0.1149520788509725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS4,Thrombospondin-4,1866,196,0.96 [0.74-1.25],0.7764137769250286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,1851,195,0.58 [0.39-0.85],0.0052107975923059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THPO,Thrombopoietin,1827,197,1.31 [0.96-1.79],0.0891792742944156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THRAP3,Thyroid hormone receptor-associated protein 3,1581,166,0.93 [0.79-1.09],0.3709173144194569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THSD1,Thrombospondin type-1 domain-containing protein 1,1568,166,1.02 [0.68-1.54],0.9159626171497178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THTPA,Thiamine-triphosphatase,1620,169,1.04 [0.88-1.23],0.6357735082670348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,1868,195,1.06 [0.69-1.61],0.8018477876514288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIA1,Nucleolysin TIA-1 isoform p40,1799,192,1.02 [0.92-1.12],0.7463449896851758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,1885,199,1.26 [0.93-1.72],0.1402940563994578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1790,193,0.90 [0.68-1.20],0.4675775409868044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1594,162,1.37 [1.00-1.89],0.0525485017178614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1871,198,0.77 [0.59-1.01],0.0585573735015612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1627,168,0.97 [0.67-1.38],0.8464809542250153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1614,168,1.03 [0.87-1.21],0.7325481108377152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,1842,195,1.97 [1.37-2.84],0.0002601051128205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,1627,168,1.26 [0.71-2.24],0.4205570137466988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP3,Metalloproteinase inhibitor 3,1862,196,1.01 [0.92-1.11],0.8157603146155123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP4,Metalloproteinase inhibitor 4,1864,195,1.13 [0.83-1.54],0.4296961344547273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,1856,196,1.90 [1.11-3.26],0.0202234090093096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJAP1,Tight junction-associated protein 1,1855,194,0.98 [0.85-1.14],0.8127762854218366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJP3,Tight junction protein ZO-3,1575,168,0.97 [0.69-1.38],0.8806865897097232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TK1,"Thymidine kinase, cytosolic",1594,162,0.98 [0.71-1.35],0.9139440777983148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR1,Toll-like receptor 1,1578,168,1.81 [1.08-3.03],0.0248422569283037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR2,Toll-like receptor 2,1594,162,2.14 [1.12-4.10],0.0220462182783269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR3,Toll-like receptor 3,1882,195,1.14 [0.94-1.39],0.1868067461780745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR4,Toll-like receptor 4,1578,168,0.84 [0.48-1.46],0.5362273761524445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1585,165,1.05 [0.79-1.39],0.7309450006538545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED1,Transmembrane emp24 domain-containing protein 1,1594,162,0.96 [0.74-1.26],0.7962983291739272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED10,Transmembrane emp24 domain-containing protein 10,1581,166,1.04 [0.71-1.53],0.8503327788484671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED4,Transmembrane emp24 domain-containing protein 4,1581,166,0.89 [0.65-1.21],0.4512249176161907
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED8,Protein TMED8,1620,168,1.01 [0.88-1.15],0.9085227583735014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM106A,Transmembrane protein 106A,1623,169,1.01 [0.82-1.24],0.9500869391449096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM132A,Transmembrane protein 132A,1575,165,0.98 [0.78-1.24],0.8885054998925109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM25,Transmembrane protein 25,1631,171,1.18 [0.86-1.60],0.3009220092164272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMOD4,Tropomodulin-4,1563,161,0.94 [0.64-1.39],0.76043209682511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11B,Transmembrane protease serine 11B,1575,168,1.02 [0.83-1.24],0.881096945302811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11D,Transmembrane protease serine 11D,1609,168,1.22 [0.85-1.74],0.2732944459771278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,1846,195,1.37 [1.19-1.58],1.64348872115792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS5,Transmembrane protease serine 5,1827,193,1.41 [1.00-1.99],0.0488864054045322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,1864,195,1.11 [0.95-1.31],0.19803752301264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,1871,198,1.19 [0.94-1.52],0.1532712679930337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,1825,197,1.41 [1.12-1.78],0.003204429948379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1620,168,1.04 [0.79-1.35],0.7903772621449172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1817,191,1.01 [0.70-1.45],0.9690194516808902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1596,165,0.98 [0.78-1.22],0.8534541836036098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1839,194,2.57 [1.83-3.62],5.7149879332326094e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1839,194,1.49 [1.25-1.77],5.916601568108285e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1871,199,1.17 [0.90-1.53],0.2397049878770595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1882,195,2.13 [1.66-2.72],2.635493099454228e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1855,196,1.60 [1.12-2.28],0.009862973456672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1855,194,1.97 [1.47-2.65],7.195545349138001e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1857,196,1.95 [1.40-2.71],6.9610089672464e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1817,191,1.42 [1.09-1.85],0.0087709247991733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1857,196,2.73 [2.01-3.69],1.0157789976830612e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1596,165,1.34 [0.93-1.93],0.1169915772600803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1875,196,1.58 [1.16-2.15],0.0039843072751626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1864,195,2.98 [2.12-4.18],2.6662075346115957e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1864,195,1.48 [1.24-1.77],1.3685440931620152e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1868,195,1.68 [1.10-2.55],0.0153563011971657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1879,195,2.13 [1.61-2.83],1.3357420499791217e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1839,194,1.42 [1.15-1.74],0.0009153046875062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1868,195,1.31 [1.01-1.68],0.0395973133163484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1839,194,1.91 [1.49-2.44],3.535718745308458e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,1882,195,0.99 [0.62-1.58],0.9806759271624436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,1858,196,0.88 [0.71-1.08],0.2079087771669941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,1882,195,0.69 [0.45-1.06],0.090149424002408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1862,196,2.76 [1.84-4.14],8.867482801818826e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1884,199,1.01 [0.65-1.56],0.9703761084190766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,1839,194,1.18 [0.95-1.47],0.1257725745002879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1634,170,1.08 [0.74-1.57],0.6999651039992891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNIP1,TNFAIP3-interacting protein 1,1614,168,1.01 [0.86-1.19],0.9125831925677066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNN,Tenascin-N,1634,170,1.17 [0.84-1.62],0.3633649474646657
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",1827,197,0.95 [0.82-1.11],0.5454305101513661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNPO1,Transportin-1,1594,162,1.26 [0.84-1.88],0.2728409620045882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNR,Tenascin-R,1839,194,1.38 [1.02-1.87],0.0353889700768768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,1864,195,0.58 [0.38-0.89],0.0123417531309541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1627,168,1.05 [0.87-1.26],0.6410404766981559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1,DNA topoisomerase 1,1620,168,1.06 [0.95-1.19],0.3084990119289276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1MT,"DNA topoisomerase I, mitochondrial",1563,161,0.70 [0.48-1.01],0.057608423831883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP2B,DNA topoisomerase 2-beta,1578,168,1.02 [0.85-1.22],0.8088673582239092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOR1AIP1,Torsin-1A-interacting protein 1,1575,165,1.17 [0.91-1.50],0.2203371845746681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,1794,193,1.25 [0.93-1.68],0.1377081040307381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53BP1,TP53-binding protein 1,1578,168,0.98 [0.82-1.17],0.8302905675523481
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,1557,160,0.83 [0.63-1.09],0.1822942860410933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,1827,197,0.75 [0.46-1.24],0.2648517851682181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP73,Tumor protein p73,1585,165,0.93 [0.58-1.47],0.748203985882365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPBGL,Trophoblast glycoprotein-like,1585,165,0.80 [0.52-1.22],0.2948705615890916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPD52L2,Tumor protein D54,1596,165,0.97 [0.85-1.11],0.6817768248762965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,1627,168,0.36 [0.22-0.58],4.3338339480122105e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPM3,Tropomyosin alpha-3 chain,1581,166,1.03 [0.74-1.43],0.8443340453314707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,1794,193,0.92 [0.76-1.11],0.3746053394515873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,1841,195,1.44 [1.14-1.82],0.0021795810536465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP2,Tubulin polymerization-promoting protein family member 2,1594,162,1.02 [0.84-1.25],0.8142125460783598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP3,Tubulin polymerization-promoting protein family member 3,1796,193,0.70 [0.47-1.03],0.0727495365872983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPR,Nucleoprotein TPR,1581,166,0.89 [0.65-1.22],0.4781792910612967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPRKB,EKC/KEOPS complex subunit TPRKB,1563,161,0.87 [0.66-1.15],0.3240232152436389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,1876,195,1.18 [0.90-1.54],0.2377437609821482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSD1,Tryptase delta,1631,171,1.25 [0.83-1.87],0.283141080650834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSG1,Tryptase gamma,1578,168,0.64 [0.35-1.17],0.148856333475007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPT1,Translationally-controlled tumor protein,1817,191,1.08 [0.90-1.29],0.4339120519713502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,1858,196,0.95 [0.80-1.14],0.59342749319231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",1578,168,0.93 [0.63-1.37],0.7058147614253552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1581,166,1.05 [0.77-1.42],0.7698539698622051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1594,162,1.06 [0.89-1.25],0.5188309524280896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREH,Trehalase,1634,170,1.04 [0.86-1.26],0.6573725144650395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREM2,Triggering receptor expressed on myeloid cells 2,1855,196,1.00 [0.81-1.23],0.9733297879051932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML1,Trem-like transcript 1 protein,1634,169,1.01 [0.77-1.31],0.9510158196517292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML2,Trem-like transcript 2 protein,1864,195,1.33 [0.93-1.91],0.1216285965227619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,1875,196,1.05 [0.87-1.28],0.5969088981044368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,1858,196,1.05 [0.89-1.23],0.5622535699603846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,1588,162,1.17 [0.94-1.46],0.1553597618265708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1620,168,1.03 [0.90-1.18],0.6381136544360984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM26,Tripartite motif-containing protein 26,1563,161,0.87 [0.65-1.16],0.3467261526911315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM40,E3 ubiquitin ligase TRIM40,1585,165,0.95 [0.77-1.17],0.6266995405055031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM5,Tripartite motif-containing protein 5,1858,196,1.07 [0.93-1.23],0.3725340339522165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,1623,169,0.96 [0.82-1.13],0.6396059015200279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,1581,166,0.92 [0.69-1.23],0.5609591274983231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC1,Hamartin,1578,168,0.94 [0.75-1.17],0.5707193674127756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC22D1,TSC22 domain family protein 1,1631,171,1.11 [0.90-1.37],0.3129243043692739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,1860,197,0.82 [0.70-0.96],0.0162507364694753
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSLP,Thymic stromal lymphopoietin,1827,197,1.06 [0.87-1.28],0.5632988479889315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSNAX,Translin-associated protein X,1581,166,0.92 [0.63-1.35],0.6715482565552595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,1827,197,0.98 [0.79-1.22],0.8483248538699653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN15,Tetraspanin-15,1581,166,0.91 [0.68-1.23],0.5580609049993159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN7,Tetraspanin-7,1575,168,0.96 [0.80-1.16],0.6705360293641246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN8,Tetraspanin-8,1620,168,1.00 [0.87-1.15],0.9880704136180558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPYL1,Testis-specific Y-encoded-like protein 1,1578,168,0.95 [0.66-1.36],0.7811471696540355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TST,Thiosulfate sulfurtransferase,1795,193,1.03 [0.87-1.22],0.7167249656876877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,1585,165,0.96 [0.72-1.27],0.7624640759453735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,1581,166,0.92 [0.73-1.16],0.4748525069274717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTR,Transthyretin,1624,170,0.93 [0.55-1.55],0.7701330453314035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,1575,168,1.33 [0.76-2.35],0.3206305091105658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TWF2,Twinfilin-2,1634,170,1.04 [0.89-1.23],0.6010304227879866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXK,Tyrosine-protein kinase TXK,1594,162,0.90 [0.72-1.12],0.3449641511514623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXLNA,Alpha-taxilin,1839,194,1.05 [0.91-1.21],0.5021931841683042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXN,Thioredoxin,1601,164,0.93 [0.65-1.31],0.6638395928306755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC15,Thioredoxin domain-containing protein 15,1855,194,1.37 [0.89-2.11],0.1540871945007239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,1868,195,1.17 [0.98-1.39],0.0825535058508074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC9,Thioredoxin domain-containing protein 9,1614,168,0.94 [0.73-1.22],0.6627327262223568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNL1,Thioredoxin-like protein 1,1574,168,0.97 [0.83-1.13],0.6962160018132947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1864,195,0.95 [0.74-1.23],0.7216518851255016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYMP,Thymidine phosphorylase,1846,195,0.97 [0.81-1.16],0.7298326045943144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,1860,197,1.06 [0.68-1.65],0.8058851686275561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1578,168,1.18 [0.94-1.49],0.1549180232811675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,1846,195,0.93 [0.65-1.35],0.7093330679360339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,1623,169,1.02 [0.61-1.71],0.9374616610061196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1627,168,1.07 [0.85-1.35],0.580406820615563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1578,168,1.01 [0.77-1.31],0.9509240118462908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBQLN3,Ubiquilin-3,1581,166,0.88 [0.66-1.19],0.4075432680261489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBXN1,UBX domain-containing protein 1,1596,165,0.96 [0.78-1.18],0.7210843535670655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1620,168,0.99 [0.90-1.10],0.9099192059294428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,1581,166,0.98 [0.85-1.13],0.7530254805842966
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,1581,166,0.85 [0.51-1.40],0.5118244798909892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,1839,194,1.42 [1.07-1.88],0.0157492175781041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,1881,197,0.73 [0.60-0.90],0.0027136272314655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC5D,Netrin receptor UNC5D,1578,168,0.89 [0.51-1.55],0.6699832722908318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC79,Protein unc-79 homolog,1563,161,1.16 [0.90-1.48],0.2563134010201651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNG,Uracil-DNA glycosylase,1623,169,0.87 [0.56-1.35],0.5367378340823385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,1627,168,0.89 [0.77-1.02],0.085645064035281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3A,Uroplakin-3a,1575,168,0.87 [0.67-1.14],0.328500207094975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3BL1,Uroplakin-3b-like protein 1,1593,162,1.00 [0.76-1.33],0.9736733277079236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROD,Uroporphyrinogen decarboxylase,1596,165,0.84 [0.67-1.05],0.1221921309388533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,1585,165,1.10 [0.88-1.38],0.4028701216308984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USO1,General vesicular transport factor p115,1846,195,0.99 [0.86-1.13],0.8493813659100573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,1623,169,1.01 [0.83-1.23],0.9293121892554876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,1614,168,1.48 [1.07-2.05],0.0179018282895878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,1581,166,1.07 [0.90-1.26],0.4571232416240429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,1827,197,1.06 [0.93-1.20],0.3584245532332533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UXS1,UDP-glucuronic acid decarboxylase 1,1794,193,1.21 [0.96-1.53],0.0987323944883653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP5,Vesicle-associated membrane protein 5,1827,197,1.03 [0.82-1.29],0.7908847416346532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP8,Vesicle-associated membrane protein 8,1578,168,0.97 [0.82-1.14],0.6899892654738224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,1858,196,1.09 [0.94-1.26],0.257759836565137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,1837,194,2.11 [1.36-3.26],0.0008351956730988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASP,Vasodilator-stimulated phosphoprotein,1634,169,0.94 [0.78-1.14],0.5564659888775056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1846,195,1.10 [0.58-2.10],0.7747889768871643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAV3,Guanine nucleotide exchange factor VAV3,1575,168,1.03 [0.89-1.18],0.72675386948967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,1870,197,2.45 [1.66-3.61],7.020587120279151e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAN,Versican core protein,1868,195,1.12 [0.75-1.69],0.5746309987301033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCPKMT,Protein-lysine methyltransferase METTL21D,1563,161,0.94 [0.78-1.14],0.5495640877739064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFA,Vascular endothelial growth factor A,1877,195,1.20 [0.98-1.48],0.0778285472595028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFB,Vascular endothelial growth factor B,1578,168,1.03 [0.63-1.68],0.909277032341991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFC,Vascular endothelial growth factor C,1855,194,1.15 [0.93-1.43],0.2024314771658683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,1878,195,1.66 [1.21-2.27],0.0018060580587804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VGF,Neurosecretory protein VGF,1631,171,1.03 [0.65-1.64],0.8992675508015412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIM,Vimentin,1827,197,1.02 [0.91-1.13],0.7406963139803782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,1575,165,1.21 [0.68-2.13],0.5184591347673821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIT,Vitrin,1627,168,0.99 [0.68-1.44],0.9583716930867716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1846,195,1.28 [1.04-1.56],0.0168658010508546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,1634,169,1.07 [0.88-1.30],0.4894815882941788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN2,Vascular non-inflammatory molecule 2,1846,195,1.11 [0.84-1.45],0.4649518421078883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,1594,162,1.04 [0.84-1.30],0.7077759008125166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,1846,195,0.98 [0.84-1.14],0.7605930079680148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS4B,Vacuolar protein sorting-associated protein 4B,1623,169,0.98 [0.84-1.14],0.8153861167166149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,1846,195,0.97 [0.83-1.13],0.7072717274915832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,1623,169,1.23 [0.93-1.63],0.1494284733473461
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1581,166,1.30 [0.88-1.90],0.1841053864212543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1623,169,1.67 [1.39-2.02],5.3349133170350094e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1862,195,2.40 [1.85-3.10],2.802317029514486e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1856,197,1.12 [0.92-1.36],0.2454766519835251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,1614,168,0.56 [0.39-0.81],0.00219981287375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,1796,193,0.89 [0.69-1.16],0.3838740198785368
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,1594,162,0.79 [0.53-1.19],0.2582194524309182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1827,197,1.21 [0.97-1.49],0.0872556264530484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1868,195,0.97 [0.81-1.15],0.7082898192521094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,1794,193,1.28 [0.87-1.88],0.206094856921957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1596,165,0.91 [0.70-1.18],0.47340157368744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA1,von Willebrand factor A domain-containing protein 1,1872,196,0.99 [0.73-1.33],0.9312170056661072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA5A,von Willebrand factor A domain-containing protein 5A,1563,161,1.02 [0.86-1.21],0.8316393617708553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,1827,194,1.66 [1.23-2.23],0.0009140861591668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,1631,171,0.97 [0.72-1.31],0.838330523077164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWF,von Willebrand factor,1885,199,1.04 [0.88-1.24],0.6248265141491471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",1864,195,1.11 [0.79-1.54],0.5486739920138299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WAS,Wiskott-Aldrich syndrome protein,1817,191,1.05 [0.87-1.27],0.5953002319170837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,1827,197,0.99 [0.87-1.12],0.8272921685922916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,1796,193,0.98 [0.85-1.13],0.7718238089800016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASHC3,WASH complex subunit 3,1614,168,1.00 [0.83-1.20],0.9949180616350504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASL,Neural Wiskott-Aldrich syndrome protein,1578,168,0.83 [0.63-1.10],0.1918034713394004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,1623,169,1.06 [0.73-1.54],0.7612139960312383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC1,WAP four-disulfide core domain protein 1,1592,166,0.99 [0.76-1.29],0.939219193292157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,1872,196,1.12 [0.92-1.36],0.249782131988602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,1766,181,2.17 [1.71-2.74],1.1398439336015631e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1831,193,0.92 [0.67-1.26],0.5930667318949008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1857,196,1.58 [1.12-2.23],0.0086349759878471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,1875,196,0.62 [0.43-0.88],0.0072079078926608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,1817,191,2.07 [1.44-2.96],7.740302464358314e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1839,194,0.89 [0.70-1.13],0.3403842245433197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,1875,196,1.20 [1.01-1.44],0.0426076681733692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,1873,199,1.86 [1.35-2.56],0.000144370304008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XIAP,E3 ubiquitin-protein ligase XIAP,1578,168,1.01 [0.80-1.28],0.9214513039723282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,1855,194,0.89 [0.79-0.99],0.039837488790636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XRCC4,DNA repair protein XRCC4,1796,193,1.04 [0.73-1.48],0.8322446716035958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,1614,168,1.62 [1.02-2.57],0.04074715931551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1620,168,1.00 [0.91-1.11],0.9802047185234716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YES1,Tyrosine-protein kinase Yes,1846,195,1.00 [0.90-1.11],0.9627860004440236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,1623,169,1.02 [0.66-1.59],0.9317885278503658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,1581,166,0.83 [0.66-1.05],0.1235007862470835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YTHDF3,YTH domain-containing family protein 3,1817,191,1.04 [0.90-1.21],0.5568786886568872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YWHAQ,14-3-3 protein theta,1596,165,0.98 [0.81-1.19],0.8364579485677189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YY1,Transcriptional repressor protein YY1,1578,168,0.60 [0.34-1.06],0.0798571778380935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBP1,Z-DNA-binding protein 1,1578,168,1.08 [0.77-1.51],0.6645785937975893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,1794,193,0.96 [0.81-1.14],0.6471339188961074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,1827,197,1.03 [0.79-1.35],0.8321128095333149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,1581,166,0.71 [0.52-0.95],0.0211711153734557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZFYVE19,Abscission/NoCut checkpoint regulator,1620,168,1.01 [0.86-1.18],0.9125717631934772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZHX2,Zinc fingers and homeoboxes protein 2,1614,168,1.06 [0.72-1.56],0.7818739143256164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF174,Zinc finger protein 174,1578,168,0.63 [0.37-1.07],0.086253257327698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF75D,Zinc finger protein 75D,1594,162,0.85 [0.64-1.12],0.2371962303862381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF830,Zinc finger protein 830,1623,169,0.97 [0.80-1.18],0.7735769726999822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRD2,Protein ZNRD2,1620,168,1.13 [0.93-1.36],0.2246952052385834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1623,169,1.07 [0.81-1.41],0.6310913056756325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP3,Zona pellucida sperm-binding protein 3,1575,165,1.06 [1.00-1.13],0.0510109991746987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP4,Zona pellucida sperm-binding protein 4,1563,161,0.99 [0.60-1.64],0.9819699472132988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZPR1,Zinc finger protein ZPR1,1575,168,0.94 [0.79-1.11],0.4516123946165958
